|
Cayman Islands*
(州或其他管辖范围
成立公司或组织) |
| |
6770
(主要标准工业
分类代码号) |
| |
98-1584818
(I.R.S. Employer
识别码) |
|
|
Jaclyn L. Cohen
Raymond O. Gietz Weil, Gotshal & Manges LLP 767 Fifth Avenue New York, NY 10153 Tel: (212) 310-8000 |
| |
Charles S. Berkman
Chief Legal Officer OmniAb, Inc. 5980 Horton Street, Suite 600 Emeryville, CA 94608 Tel: (510) 250-7800 |
| |
Matthew T. Bush
R. Scott Shean Anthony A. Gostanian Latham & Watkins LLP 12670 High Bluff Drive San Diego, California 92130 Tel: (858) 523-5400 |
|
| 大型加速文件服务器☐ | | | Accelerated filer ☐ | |
| 非加速文件管理器 | | | 较小的报告公司 | |
| | | | 新兴成长型公司 | |
| | | | | | | Sincerely, | |
| | | | | | |
Matthew W. Foehr
总裁和首席执行官 OmniAb, Inc. |
|
| | |
Page
|
| |||
对其他信息的引用
|
| | | | 6 | | |
TRADEMARKS
|
| | | | 7 | | |
SELECTED DEFINITIONS
|
| | | | 8 | | |
有关前瞻性陈述的警示声明
|
| | | | 14 | | |
QUESTIONS AND ANSWERS
|
| | | | 16 | | |
委托书/招股说明书/信息说明书摘要
|
| | | | 45 | | |
市场价格和股息信息
|
| | | | 76 | | |
亚太地区和OMNIAB未经审计的备考简明合并财务信息
|
| | | | 78 | | |
RISK FACTORS
|
| | | | 92 | | |
亚太地区特别股东大会
|
| | | | 160 | | |
1号股东提案 - 企业合并提案
|
| | | | 167 | | |
第2号股东提案 - 本地化提案
|
| | | | 236 | | |
第三号股东提案 - 组织文件
PROPOSAL |
| | | | 238 | | |
第4号股东提案 - 不具约束力的治理提案
|
| | | | 241 | | |
第5号股东提案 - 股票发行提案
|
| | | | 245 | | |
第6号股东提案 - 激励计划提案
|
| | | | 248 | | |
第7号股东提案 - ESPP提案
|
| | | | 253 | | |
第8号股东提案 - 董事选举提案
|
| | | | 258 | | |
第9号股东提案 - 休会提案
|
| | | | 260 | | |
美国联邦所得税对亚太地区股东的重大影响
|
| | | | 261 | | |
分配和合并给配基股东带来的重大美国联邦所得税后果
|
| | | | 275 | | |
亚太地区和合并子公司信息
|
| | | | 280 | | |
亚太地区管理层对财务状况和运营结果的讨论和分析
|
| | | | 285 | | |
MANAGEMENT OF APAC
|
| | | | 293 | | |
有关配体的信息
|
| | | | 300 | | |
有关OMNIAB业务的信息
|
| | | | 301 | | |
OMNIAB管理层对财务状况的讨论和分析
AND RESULTS OF OPERATIONS |
| | | | 337 | | |
OMNIAB高管和董事薪酬
|
| | | | 356 | | |
业务合并后新OMNIAB的管理
|
| | | | 373 | | |
证券的实益所有权
|
| | | | 381 | | |
某些关系和关联人交易
|
| | | | 386 | | |
某些受益所有者的担保所有权和管理
OMNIAB |
| | | | 392 | | |
分离和分配
|
| | | | 394 | | |
合并后的公司证券说明
|
| | | | 395 | | |
公司治理与股东权利比较
|
| | | | 400 | | |
证券法对合并后公司证券转售的限制
|
| | | | 411 | | |
| | |
Page
|
| |||
持不同政见者的权利和评估权
|
| | | | 412 | | |
提交股东建议书
|
| | | | 413 | | |
未来股东提案
|
| | | | 414 | | |
向股东交付文件/HOUSEHOLDING
|
| | | | 415 | | |
其他股东通信
|
| | | | 416 | | |
LEGAL MATTERS
|
| | | | 416 | | |
EXPERTS
|
| | | | 416 | | |
您可以在哪里找到更多信息
|
| | | | 417 | | |
财务报表索引
|
| | | | F-1 | | |
合并财务报表索引
|
| | | | F-1 | | |
ANNEXES
|
| | | | A-1 | | |
招股说明书中不需要的信息
|
| | | | II-1 | | |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption
Scenario(1) |
| |
Maximum Redemption
Scenario(2) |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| ||||||||||||||||||
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | 18.0% | | | | | | 11,500,000 | | | | | | 9.9% | | | | | | — | | | | | | 0.0% | | |
Sponsor and related parties(3)(4)(6)
|
| | | | 7,250,000 | | | | | | 5.7% | | | | | | 7,250,000 | | | | | | 6.2% | | | | | | 17,250,000 | | | | | | 15.0% | | |
OmniAb’s (Ligand’s) stockholders(5)(6)
|
| | | | 97,731,592 | | | | | | 76.3% | | | | | | 97,731,592 | | | | | | 83.9% | | | | | | 97,731,592 | | | | | | 85.0% | | |
Total(7)(8) | | | |
|
127,981,592
|
| | | |
|
100.0%
|
| | | |
|
116,481,592
|
| | | |
|
100.0%
|
| | | |
|
114,981,592
|
| | | |
|
100.0%
|
| |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption Scenario
|
| |
Maximum Redemption
Scenario |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| ||||||||||||||||||
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | 20.7% | | | | | | 11,500,000 | | | | | | 11.6% | | | | | | — | | | | | | 0.0% | | |
赞助商及相关方
|
| | | | 5,333,333 | | | | | | 4.8% | | | | | | 5,333,333 | | | | | | 5.4% | | | | | | 16,052,083 | | | | | | 16.2% | | |
OmniAbs(配体)股东
|
| | | | 82,731,592 | | | | | | 74.5% | | | | | | 82,731,592 | | | | | | 83.0% | | | | | | 82,731,592 | | | | | | 83.8% | | |
Total
|
| | | | 111,064,925 | | | | | | 100.0% | | | | | | 99,564,925 | | | | | | 100.0% | | | | | | 98,783,675 | | | | | | 100.0% | | |
| | |
在新OmniAb中的份额所有权(1)
|
| | | | |||||||||||||||||||||||||||||||||||||||
| | |
无赎回情况
|
| |
50% Redemptions Scenario
|
| |
100% Redemptions Scenario
|
| | | | | | | | | | |||||||||||||||||||||||||||
其他稀释源
|
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| | | | ||||||||||||||||||||||||
APAC Warrants
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
APAC Public Warrants(2)
|
| | | | 7,666,667 | | | | | | 5.7% | | | | | | 7,666,667 | | | | | | 6.2% | | | | | | 7,666,667 | | | | | | 6.3% | | | | | | ||||||
亚太地区私募认股权证(3)
|
| | | | 8,233,333 | | | | | | 6.0% | | | | | | 8,233,333 | | | | | | 6.6% | | | | | | 8,233,333 | | | | | | 6.7% | | | | | | ||||||
远期购买中发行的亚太地区权证(4)
|
| | | | 1,666,667 | | | | | | 1.3% | | | | | | 1,666,667 | | | | | | 1.4% | | | | | | 1,666,667 | | | | | | 1.4% | | | | | | ||||||
在赎回支持(5)中发行的亚太地区认股权证
|
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 1,666,667 | | | | | | 1.4% | | | | | | ||||||
APAC Private Placement
根据 可发行的认股权证 转可兑换本票 Note(6) |
| | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | | | | | ||||||
OmniAb Prior Plans
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
OmniAb Options(7)
|
| | | | 13,587,254 | | | | | | 9.6% | | | | | | 13,587,254 | | | | | | 10.4% | | | | | | 13,587,254 | | | | | | 10.6% | | | | | | ||||||
OmniAb RSUs and OmniAb PSUs(8)
|
| | | | 1,402,039 | | | | | | 1.1% | | | | | | 1,402,039 | | | | | | 1.2% | | | | | | 1,402,039 | | | | | | 1.2% | | | | | | ||||||
新的OmniAb提出的计划
|
| | | | | | | | | | ||||||||||||||||||||||||||||||||||||
2022 Plan(9)
|
| | | | 18,235,000 | | | | | | 12.5% | | | | | | 16,625,000 | | | | | | 12.5% | | | | | | 16,415,000 | | | | | | 12.5% | | | | | | ||||||
ESPP(10)
|
| | | | 1,953,750 | | | | | | 1.5% | | | | | | 1,781,250 | | | | | | 1.5% | | | | | | 1,758,750 | | | | | | 1.5% | | | | | | ||||||
额外稀释剂来源合计(11)
|
| | |
|
53,244,710
|
| | | |
|
29.4%
|
| | | |
|
51,462,210
|
| | | |
|
30.6%
|
| | | |
|
52,896,377
|
| | | |
|
31.5%
|
| | | | |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
无赎回情况
|
| |
50% Redemptions Scenario(1)
|
| |
100% Redemptions Scenario(2)
|
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| ||||||||||||||||||
Base Scenario(4)
|
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 114,981,592 | | | | | $ | 10.25 | | |
不包括保荐人溢价股份和泛抗体溢价股份(5)
|
| | | | 111,064,925 | | | | | $ | 11.83 | | | | | | 99,564,925 | | | | | $ | 12.01 | | | | | | 98,783,675 | | | | | $ | 11.93 | | |
承担亚太地区公共事务的行使
Warrants(6) |
| | | | 135,648,259 | | | | | $ | 10.34 | | | | | | 124,148,259 | | | | | $ | 10.35 | | | | | | 122,648,259 | | | | | $ | 10.32 | | |
承担APAC Private的行使
Placement Warrants(7) |
| | | | 136,214,925 | | | | | $ | 10.34 | | | | | | 124,714,925 | | | | | $ | 10.35 | | | | | | 123,214,925 | | | | | $ | 10.33 | | |
假设在远期发行的亚太地区认股权证的行使
Purchase (8) |
| | | | 129,648,259 | | | | | $ | 10.29 | | | | | | 118,148,259 | | | | | $ | 10.29 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
假设行使在赎回后盾中发行的亚太认股权证(9)
|
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
承担APAC Private的行使
可发行的配售权证 Pursuant to Convertible Promissory Note(10) |
| | | | 128,481,592 | | | | | $ | 10.27 | | | | | | 116,981,592 | | | | | $ | 10.28 | | | | | | 115,481,592 | | | | | $ | 10.25 | | |
包括OmniAbRSU和OmniAbPSU的转换(11)
|
| | | | 129,383,631 | | | | | $ | 10.16 | | | | | | 117,883,631 | | | | | $ | 10.15 | | | | | | 116,383,631 | | | | | $ | 10.12 | | |
包括根据2022年计划(12)为发行保留的股份
|
| | | | 146,216,592 | | | | | $ | 8.99 | | | | | | 133,106,592 | | | | | $ | 8.99 | | | | | | 131,396,592 | | | | | $ | 8.97 | | |
包括根据esp为发行保留的股份(13)
|
| | | | 129,935,342 | | | | | $ | 10.25 | | | | | | 118,262,842 | | | | | $ | 10.25 | | | | | | 116,740,342 | | | | | $ | 10.22 | | |
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario |
| |
100% Redemptions
Scenario |
| |||||||||
| | |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |||||||||
Base Scenario
|
| | | $ | 1.31 | | | | | $ | 1.20(3)(a) | | | | | $ | 1.18(3)(b) | | |
不包括保荐人溢价股份和泛抗体溢价股份(3)(C)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
假设行使亚太地区的公共认股权证(3)(D)
|
| | | $ | 1.40 | | | | | $ | 1.28 | | | | | $ | 1.27 | | |
假设行使亚太地区私募认股权证(3)(E)
|
| | | $ | 1.41 | | | | | $ | 1.29 | | | | | $ | 1.27 | | |
假设亚太地区认股权证的行使
Forward Purchase(3)(f) |
| | | $ | 1.33 | | | | | $ | 1.22 | | | | | $ | 1.20 | | |
假设亚太地区认股权证的行使
Redemption Backstop(3)(g) |
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.20 | | |
假设根据可转换本票(3)(H)行使亚太地区私募认股权证
|
| | | $ | 1.32 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括OmniAbRSU和OmniAbPSU的转换(3)(I)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario |
| |
100% Redemptions
Scenario |
| |||||||||
| | |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |||||||||
包括根据2022年计划(3)(J)为发行而保留的股份
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括根据esp(3)(K)为发行保留的股份
|
| | | $ | 1.33 | | | | | $ | 1.21 | | | | | $ | 1.19 | | |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption
Scenario(1) |
| |
Maximum Redemption
Scenario(2) |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| ||||||||||||||||||
APAC’s public shareholders
|
| | | | 23,000,000 | | | | | | 18.0% | | | | | | 11,500,000 | | | | | | 9.9% | | | | | | — | | | | | | 0.0% | | |
Sponsor and related parties(3)(4)(6)
|
| | | | 7,250,000 | | | | | | 5.7% | | | | | | 7,250,000 | | | | | | 6.2% | | | | | | 17,250,000 | | | | | | 15.0% | | |
OmniAb’s (Ligand’s)
stockholders (5)(6) |
| | | | 97,731,592 | | | | | | 76.3% | | | | | | 97,731,592 | | | | | | 83.9% | | | | | | 97,731,592 | | | | | | 85.0% | | |
Total(7)(8) | | | |
|
127,981,592
|
| | | |
|
100.0%
|
| | | |
|
116,481,592
|
| | | |
|
100.0%
|
| | | |
|
114,981,592
|
| | | |
|
100.0%
|
| |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption Scenario
|
| |
Maximum Redemption
Scenario |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| ||||||||||||||||||
APAC’s public shareholders
|
| | | | 23,000,000 | | | | | | 20.7% | | | | | | 11,500,000 | | | | | | 11.6% | | | | | | — | | | | | | 0.0% | | |
赞助商及相关方
|
| | | | 5,333,333 | | | | | | 4.8% | | | | | | 5,333,333 | | | | | | 5.4% | | | | | | 16,052,083 | | | | | | 16.3% | | |
OmniAb’s (Ligand’s)
stockholders |
| | | | 82,731,592 | | | | | | 74.5% | | | | | | 82,731,592 | | | | | | 83.0% | | | | | | 82,731,592 | | | | | | 83.8% | | |
Total
|
| | | | 111,064,925 | | | | | | 100.0% | | | | | | 99,564,925 | | | | | | 100.0% | | | | | | 98,783,675 | | | | | | 100.0% | | |
| | |
Share Ownership in New OmniAb(1)
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemptions Scenario
|
| |
50% Redemptions Scenario
|
| |
100% Redemptions Scenario
|
| |||||||||||||||||||||||||||
其他稀释源
|
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of
then Outstanding Shares |
| ||||||||||||||||||
APAC Warrants
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
APAC Public Warrants(2)
|
| | | | 7,666,667 | | | | | | 5.7% | | | | | | 7,666,667 | | | | | | 6.2% | | | | | | 7,666,667 | | | | | | 6.3% | | |
亚太地区私募认股权证(3)
|
| | | | 8,233,333 | | | | | | 6.0% | | | | | | 8,233,333 | | | | | | 6.6% | | | | | | 8,233,333 | | | | | | 6.7% | | |
远期购买中发行的亚太地区权证(4)
|
| | | | 1,666,667 | | | | | | 1.3% | | | | | | 1,666,667 | | | | | | 1.4% | | | | | | 1,666,667 | | | | | | 1.4% | | |
在赎回支持(5)中发行的亚太地区认股权证
|
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 1,666,667 | | | | | | 1.4% | | |
亚太地区可根据可转换本票发行的私募认股权证(6)
|
| | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | |
OmniAb Prior Plans
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OmniAb Options(7)
|
| | | | 13,587,254 | | | | | | 9.6% | | | | | | 13,587,254 | | | | | | 10.4% | | | | | | 13,587,254 | | | | | | 10.6% | | |
OmniAb RSUs and OmniAb PSUs(8)
|
| | | | 1,402,039 | | | | | | 1.1% | | | | | | 1,402,039 | | | | | | 1.2% | | | | | | 1,402,039 | | | | | | 1.2% | | |
New OmniAb Proposed Plans
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2022 Plan(9)
|
| | | | 18,235,000 | | | | | | 12.5% | | | | | | 16,625,000 | | | | | | 12.5% | | | | | | 16,415,000 | | | | | | 12.5% | | |
ESPP(10)
|
| | | | 1,953,750 | | | | | | 1.5% | | | | | | 1,781,250 | | | | | | 1.5% | | | | | | 1,758,750 | | | | | | 1.5% | | |
额外稀释剂来源合计(11)
|
| | |
|
53,244,710
|
| | | |
|
29.4%
|
| | | |
|
51,462,210
|
| | | |
|
30.6%
|
| | | |
|
52,896,377
|
| | | |
|
31.5%
|
| |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario(1) |
| |
100% Redemptions
Scenario(2) |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| ||||||||||||||||||
Base Scenario(4)
|
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 114,981,592 | | | | | $ | 10.25 | | |
不包括保荐人溢价股份和
OmniAb Earnout Shares(5) |
| | | | 111,064,925 | | | | | $ | 11.83 | | | | | | 99,564,925 | | | | | $ | 12.01 | | | | | | 98,783,675 | | | | | $ | 11.93 | | |
假设行使亚太地区公共认股权证(6)
|
| | | | 135,648,259 | | | | | $ | 10.34 | | | | | | 124,148,259 | | | | | $ | 10.35 | | | | | | 122,648,259 | | | | | $ | 10.32 | | |
假设行使亚太地区私募认股权证(7)
|
| | | | 136,214,925 | | | | | $ | 10.34 | | | | | | 124,714,925 | | | | | $ | 10.35 | | | | | | 123,214,925 | | | | | $ | 10.33 | | |
假设亚太地区认股权证的行使
issued in the Forward Purchase(8) |
| | | | 129,648,259 | | | | | $ | 10.29 | | | | | | 118,148,259 | | | | | $ | 10.29 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
假设亚太地区认股权证的行使
issued in the Redemption Backstop(9) |
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
假设根据可转换本票(10)可发行的亚太地区私募认股权证的行使
|
| | | | 128,481,592 | | | | | $ | 10.27 | | | | | | 116,981,592 | | | | | $ | 10.28 | | | | | | 115,481,592 | | | | | $ | 10.25 | | |
包括OmniAbRSU和OmniAbPSU的转换(11)
|
| | | | 129,383,631 | | | | | $ | 10.16 | | | | | | 117,883,631 | | | | | $ | 10.15 | | | | | | 116,383,631 | | | | | $ | 10.12 | | |
包括根据2022年计划(12)为发行保留的股份
|
| | | | 146,216,592 | | | | | $ | 8.99 | | | | | | 133,106,592 | | | | | $ | 8.99 | | | | | | 131,396,592 | | | | | $ | 8.97 | | |
包括根据esp为发行保留的股份(13)
|
| | | | 129,935,342 | | | | | $ | 10.25 | | | | | | 118,262,842 | | | | | $ | 10.25 | | | | | | 116,740,342 | | | | | $ | 10.22 | | |
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario |
| |
100% Redemptions
Scenario |
| |||||||||
| | |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |||||||||
Base Scenario
|
| | | $ | 1.31 | | | | | $ | 1.20(3)(a) | | | | | $ | 1.18(3)(b) | | |
不包括保荐人溢价股份和泛抗体溢价股份(3)(C)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
假设行使亚太地区的公共认股权证(3)(D)
|
| | | $ | 1.40 | | | | | $ | 1.28 | | | | | $ | 1.27 | | |
假设行使亚太地区私募认股权证(3)(E)
|
| | | $ | 1.41 | | | | | $ | 1.29 | | | | | $ | 1.27 | | |
假设亚太地区认股权证的行使
Forward Purchase(3)(f) |
| | | $ | 1.33 | | | | | $ | 1.22 | | | | | $ | 1.20 | | |
假设亚太地区认股权证的行使
Redemption Backstop(3)(g) |
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.20 | | |
假设根据可转换本票(3)(H)行使亚太地区私募认股权证
|
| | | $ | 1.32 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括OmniAbRSU和OmniAbPSU的转换(3)(I)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括根据2022年计划(3)(J)为发行而保留的股份
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括根据esp(3)(K)为发行保留的股份
|
| | | $ | 1.33 | | | | | $ | 1.21 | | | | | $ | 1.19 | | |
(单位为千,份额除外)
|
| |
No Redemptions
Scenario |
| |
50% Redemption
Scenario |
| |
Maximum
Redemption Scenario |
| |||||||||
Unredeemed public shares
|
| | | | 23,000,000 | | | | | | 11,500,000 | | | | | | — | | |
Trust proceeds to New OmniAb
|
| | | $ | 235,750 | | | | | $ | 117,875 | | | | | $ | — | | |
延期承销佣金(1)
|
| | | $ | 4,025 | | | | | $ | 4,025 | | | | | $ | 4,025 | | |
有效递延承销费(%)
|
| | | | 1.71% | | | | | | 3.41% | | | | | | —% | | |
每股有效递延承销费
|
| | | $ | 0.18 | | | | | $ | 0.35 | | | | | $ | — | | |
Sources
|
| |
Uses
|
| ||||||||||||
信托账户中持有的有价证券(1)
|
| | | $ | 236,098,332 | | | |
Cash to balance sheet
|
| | | $ | 230,873,332 | | |
Ligand Contribution(2)
|
| | | | 15,000,000 | | | |
Deferred Underwriting Fee(3)
|
| | | | 4,025,000 | | |
Forward Purchase(4)
|
| | | | 15,000,000 | | | |
交易和其他费用(5)
|
| | | | 31,200,000 | | |
Total sources
|
| | | $ | 266,098,332 | | | |
Total uses
|
| | | $ | 266,098,332 | | |
Sources
|
| |
Uses
|
| ||||||||||||
信托账户中持有的现金和投资(1)
|
| | | $ | 0 | | | |
Cash to balance sheet
|
| | | $ | 94,775,000 | | |
Ligand Contribution(2)
|
| | | | 15,000,000 | | | |
Deferred Underwriting Fee(5)
|
| | | | 4,025,000 | | |
Forward Purchase(3)
|
| | | | 15,000,000 | | | |
交易和其他费用(6)
|
| | | | 31,200,000 | | |
Redemption Backstop(4)
|
| | | | 100,000,000 | | | | | | | | | — | | |
Total sources
|
| | | $ | 130,000,000 | | | |
Total uses
|
| | | $ | 130,000,000 | | |
| | |
Pro Forma Combined
(Assuming No Redemptions) |
| |
Pro Forma Combined
(Assuming Maximum Redemptions) |
| ||||||
| | |
(千,不包括每股和每股数据)
|
| |||||||||
未经审计的形式汇总压缩汇总 | | | | | | | | | | | | | |
截至2022年6月30日的六个月营业报表数据
|
| | | | | | | | | | | | |
Revenue
|
| | | $ | 16,822 | | | | | $ | 16,822 | | |
Operating expenses
|
| | | | 43,950 | | | | | | 43,950 | | |
Loss from operations
|
| | | | (27,128) | | | | | | (27,128) | | |
Net loss
|
| | | | (20,346) | | | | | | (20,346) | | |
每股基本和摊薄净亏损
|
| | | $ | (0.18) | | | | | $ | (0.21) | | |
基本和稀释后加权平均流通股
|
| | | | 111,064,925 | | | | | | 98,783,675 | | |
| | |
Pro Forma Combined
(Assuming No Redemptions) |
| |
Pro Forma Combined
(Assuming Maximum Redemptions) |
| ||||||
| | |
(千,不包括每股和每股数据)
|
| |||||||||
未经审计的形式汇总压缩汇总 | | | | | | | | | | | | | |
截至2021年12月31日的年度经营报表数据
|
| | | | | | | | | | | | |
Revenue
|
| | | $ | 34,748 | | | | | $ | 34,748 | | |
Operating expenses
|
| | | | 70,827 | | | | | | 70,827 | | |
Loss from operations
|
| | | | (36,079) | | | | | | (36,079) | | |
Net loss
|
| | | | (30,860) | | | | | | (30,860) | | |
每股基本和摊薄净亏损
|
| | | $ | (0.28) | | | | | $ | (0.31) | | |
基本和稀释后加权平均流通股
|
| | | | 111,064,925 | | | | | | 98,783,675 | | |
选定的未经审计的备考形式浓缩组合 | | | | | | | | | | | | | |
Balance Sheet Data as of June 30, 2022 | | | | | | | | | | | | | |
Total assets
|
| | | $ | 527,384 | | | | | $ | 391,286 | | |
Total liabilities
|
| | | $ | 69,937 | | | | | $ | 69,937 | | |
Total stockholders’ equity
|
| | | $ | 457,447 | | | | | $ | 321,349 | | |
| | |
Ligand
|
| |||||||||
| | |
High
|
| |
Low
|
| ||||||
截至2020年12月31日的日历年度 | | | | | | | | | | | | | |
First Quarter
|
| | | $ | 122.08 | | | | | $ | 57.24 | | |
Second Quarter
|
| | | $ | 124.97 | | | | | $ | 67.25 | | |
Third Quarter
|
| | | $ | 127.80 | | | | | $ | 87.44 | | |
Fourth Quarter
|
| | | $ | 108.00 | | | | | $ | 78.26 | | |
截至2021年12月31日的日历年度 | | | | | | | | | | | | | |
First Quarter
|
| | | $ | 219.75 | | | | | $ | 98.62 | | |
Second Quarter
|
| | | $ | 159.97 | | | | | $ | 110.26 | | |
Third Quarter
|
| | | $ | 146.17 | | | | | $ | 102.01 | | |
Fourth Quarter
|
| | | $ | 169.98 | | | | | $ | 126.00 | | |
截至2022年12月31日的日历年度 | | | | | | | | | | | | | |
First Quarter
|
| | | $ | 156.27 | | | | | $ | 88.50 | | |
Second Quarter
|
| | | $ | 118.38 | | | | | $ | 72.57 | | |
第三季度(截至2022年9月1日)
|
| | | $ | 108.25 | | | | | $ | 87.26 | | |
| | |
Ligand
|
| |||
March 23, 2022
|
| | | $ | 109.83 | | |
September 26, 2022
|
| | | $ | 77.13 | | |
| | |
假设没有赎回
|
| |
假设最大赎回
|
| ||||||||||||||||||
| | |
Shares
|
| |
%
|
| |
Shares
|
| |
%
|
| ||||||||||||
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | 18.0% | | | | | | — | | | | | | 0.0% | | |
Sponsor and related parties(1)(2)
|
| | | | 7,250,000 | | | | | | 5.7% | | | | | | 17,250,000 | | | | | | 15.0% | | |
OmniAb’s (Ligand’s) stockholders(3)(6)
|
| | | | 97,731,592 | | | | | | 76.3% | | | | | | 97,731,592 | | | | | | 85.0% | | |
Pro Forma Common Stock(4)(5)
|
| | | | 127,981,592 | | | | | | 100.0% | | | | | | 114,981,592 | | | | | | 100.0% | | |
| | |
OmniAb
(Historical) |
| |
APAC
(Historical) |
| |
Autonomous
Entity Adjustments (Note 3) |
| | | | | | | |
Transaction
Accounting Adjustments (Assuming No Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming No Redemptions) |
| |
Additional
Transaction Accounting Adjustments (Assuming Maximum Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming Maximum Redemptions) |
| |||||||||||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
现金和现金等价物
|
| | | $ | — | | | | | $ | 159 | | | | | $ | 5,000 | | | | | | (a) | | | | | $ | 236,098 | | | | | | (b) | | | | | $ | 231,677 | | | | | $ | (236,098) | | | | | | (m) | | | | | $ | 95,579 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (4,025) | | | | | | (c) | | | | | | | | | | | | 100,000 | | | | | | (n) | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (20,555) | | | | | | (d) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 15,000 | | | | | | (e) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | | 8,180 | | | | | | — | | | | | | | | | | | | | | | | | | (8,180) | | | | | | (j) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
Prepaid expenses
|
| | | | 1,081 | | | | | | 533 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,614 | | | | | | | | | | | | | | | | | | 1,614 | | |
Other current assets
|
| | | | 3,970 | | | | | | — | | | | | | | | | | | | | | | | | | (3,280) | | | | | | (d) | | | | | | 690 | | | | | | | | | | | | | | | | | | 690 | | |
Total current assets
|
| | | | 13,231 | | | | | | 692 | | | | | | 5,000 | | | | | | | | | | | | 215,058 | | | | | | | | | | | | 233,981 | | | | | | (136,098) | | | | | | | | | | | | 97,883 | | |
信托账户中持有的投资
|
| | | | — | | | | | | 236,098 | | | | | | | | | | | | | | | | | | (236,098) | | | | | | (b) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
Deferred income taxes
|
| | | | 822 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 822 | | | | | | | | | | | | | | | | | | 822 | | |
Intangible assets, net
|
| | | | 169,050 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 169,050 | | | | | | | | | | | | | | | | | | 169,050 | | |
Goodwill
|
| | | | 83,979 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 83,979 | | | | | | | | | | | | | | | | | | 83,979 | | |
财产和设备,净额
|
| | | | 16,090 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 16,090 | | | | | | | | | | | | | | | | | | 16,090 | | |
运营租赁资产
|
| | | | 22,011 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 22,011 | | | | | | | | | | | | | | | | | | 22,011 | | |
Other assets
|
| | | | 1,451 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,451 | | | | | | | | | | | | | | | | | | 1,451 | | |
Total assets
|
| | | | 306,634 | | | | | | 236,790 | | | | | | 5,000 | | | | | | | | | | | | (21,040) | | | | | | | | | | | | 527,384 | | | | | | (136,098) | | | | | | | | | | | | 391,286 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | | 7,383 | | | | | | 4,540 | | | | | | | | | | | | | | | | | | (4,319) | | | | | | (d) | | | | | | 221 | | | | | | | | | | | | | | | | | | 221 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (1,962) | | | | | | (d) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (5,421) | | | | | | (j) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accrued liabilities
|
| | | | 2,982 | | | | | | 1,305 | | | | | | | | | | | | | | | | | | (915) | | | | | | (d) | | | | | | 390 | | | | | | | | | | | | | | | | | | 390 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (1,112) | | | | | | (d) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (1,870) | | | | | | (j) | | | | | | | | | | | | | | | | | | | | | | | | | | |
可转换本票
|
| | | | — | | | | | | 750 | | | | | | | | | | | | | | | | | | (750) | | | | | | (i) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
衍生品 - 远期购买和支持
Securities |
| | | | — | | | | | | 383 | | | | | | | | | | | | | | | | | | (383) | | | | | | (f) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
或有负债的流动部分
|
| | | | 2,179 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2,179 | | | | | | | | | | | | | | | | | | 2,179 | | |
递延收入的当前部分
|
| | | | 10,199 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 10,199 | | | | | | | | | | | | | | | | | | 10,199 | | |
经营租赁的当前部分
liabilities |
| | | | 1,225 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,225 | | | | | | | | | | | | | | | | | | 1,225 | | |
融资租赁负债的当期部分
|
| | | | 3 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3 | | | | | | | | | | | | | | | | | | 3 | | |
流动负债总额
|
| | | | 23,971 | | | | | | 6,978 | | | | | | — | | | | | | | | | | | | (16,732) | | | | | | | | | | | | 14,217 | | | | | | — | | | | | | | | | | | | 14,217 | | |
长期或有负债
|
| | | | 4,323 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,323 | | | | | | | | | | | | | | | | | | 4,323 | | |
应付延期承销费
|
| | | | — | | | | | | 8,050 | | | | | | | | | | | | | | | | | | (8,050) | | | | | | (c) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
递延所得税净额
|
| | | | 18,304 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 18,304 | | | | | | | | | | | | | | | | | | 18,304 | | |
长期经营租赁负债
|
| | | | 25,411 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 25,411 | | | | | | | | | | | | | | | | | | 25,411 | | |
递延收入的长期部分
|
| | | | 7,384 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 7,384 | | | | | | | | | | | | | | | | | | 7,384 | | |
其他长期负债
|
| | | | 298 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 298 | | | | | | | | | | | | | | | | | | 298 | | |
Total liabilities
|
| | | | 79,691 | | | | | | 15,028 | | | | | | — | | | | | | | | | | | | (24,782) | | | | | | | | | | | | 69,937 | | | | | | — | | | | | | | | | | | | 69,937 | | |
承付款和或有事项 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
可能赎回的A类普通股
|
| | | | — | | | | | | 236,098 | | | | | | | | | | | | | | | | | | (236,098) | | | | | | (g) | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
| | |
OmniAb
(Historical) |
| |
APAC
(Historical) |
| |
Autonomous
Entity Adjustments (Note 3) |
| | | | | | | |
Transaction
Accounting Adjustments (Assuming No Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming No Redemptions) |
| |
Additional
Transaction Accounting Adjustments (Assuming Maximum Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming Maximum Redemptions) |
| |||||||||||||||||||||
Stockholders’ equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Preference shares
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Ordinary shares
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | | | | 2 | | | | | | (g) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (2) | | | | | | (h) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Class B
|
| | | | — | | | | | | 1 | | | | | | | | | | | | | | | | | | (1) | | | | | | (h) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
母公司净投资
|
| | | | 226,943 | | | | | | — | | | | | | 5,000 | | | | | | (a) | | | | | | (889) | | | | | | (j) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (231,054) | | | | | | (k) | | | | | | | | | | | | | | | | | | | | | | | | | | |
New OmniAb Common Stock
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | | | | — | | | | | | (e) | | | | | | 13 | | | | | | (2) | | | | | | (m) | | | | | | 12 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 3 | | | | | | (h) | | | | | | | | | | | | 1 | | | | | | (n) | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 10 | | | | | | (k) | | | | | | | | | | | | | | | | | | | | | | | | | | |
新增实收资本
|
| | | | — | | | | | | — | | | | | | | | | | | | | | | | | | 4,025 | | | | | | (c) | | | | | | 457,434 | | | | | | (236,096) | | | | | | (m) | | | | | | 321,337 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (9,200) | | | | | | (d) | | | | | | | | | | | | 99,999 | | | | | | (n) | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 236,096 | | | | | | (g) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 15,000 | | | | | | (e) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 383 | | | | | | (f) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 750 | | | | | | (i) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 231,044 | | | | | | (k) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (20,664) | | | | | | (l) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accumulated deficit
|
| | | | — | | | | | | (14,337) | | | | | | | | | | | | | | | | | | (6,327) | | | | | | (d) | | | | | | — | | | | | | | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 20,664 | | | | | | (l) | | | | | | | | | | | | | | | | | | | | | | | | | | |
股东权益总额
|
| | | | 226,943 | | | | | | (14,336) | | | | | | 5,000 | | | | | | | | | | | | 239,840 | | | | | | | | | | | | 457,447 | | | | | | (136,098) | | | | | | | | | | | | 321,349 | | |
总负债和股东权益
|
| | | $ | 306,634 | | | | | $ | 236,790 | | | | | $ | 5,000 | | | | | | | | | | | $ | (21,040) | | | | | | | | | | | $ | 527,384 | | | | | $ | (136,098) | | | | | | | | | | | $ | 391,286 | | |
|
| | |
OmniAb
(Historical) |
| |
APAC
(Historical) |
| |
Autonomous
Entity Adjustments (Note 3) |
| |
Transaction
Accounting Adjustments (Assuming No Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming No Redemptions) |
| |
Additional
Transaction Accounting Adjustments (Assuming Maximum Redemptions) (Note 3) |
| | | | | | | |
Pro Forma
Combined (Assuming Maximum Redemptions) |
| |||||||||||||||||||||
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Royalty
|
| | | $ | 402 | | | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | $ | 402 | | | | | | | | | | | | | | | | | $ | 402 | | |
许可证和里程碑收入
|
| | | | 6,426 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | 6,426 | | | | | | | | | | | | | | | | | | 6,426 | | |
Service revenue
|
| | | | 9,994 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | 9,994 | | | | | | | | | | | | | | | | | | 9,994 | | |
Total revenue
|
| | | | 16,822 | | | | | | — | | | | | | — | | | | | | — | | | | | | | | | | | | 16,822 | | | | | | — | | | | | | | | | | | | 16,822 | | |
Operating expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
研发
|
| | | | 22,256 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | 22,256 | | | | | | | | | | | | | | | | | | 22,256 | | |
一般和行政
|
| | | | 9,115 | | | | | | 6,399 | | | | | | | | | | | | (60) | | | | | | (Aa) | | | | | | 15,454 | | | | | | | | | | | | | | | | | | 15,454 | | |
无形资产摊销
|
| | | | 6,518 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | 6,518 | | | | | | | | | | | | | | | | | | 6,518 | | |
其他运营费用(收入) - 净值
|
| | | | (278) | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | (278) | | | | | | | | | | | | | | | | | | (278) | | |
总运营费用
|
| | |
|
37,611
|
| | | |
|
6,399
|
| | | |
|
—
|
| | | |
|
(60)
|
| | | | | | | | | |
|
43,950
|
| | | |
|
—
|
| | | | | | | | | |
|
43,950
|
| |
Loss from operations
|
| | |
|
(20,789)
|
| | | |
|
(6,399)
|
| | | |
|
—
|
| | | |
|
60
|
| | | | | | | | | |
|
(27,128)
|
| | | |
|
—
|
| | | | | | | | | |
|
(27,128)
|
| |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
信托账户中的投资收益
|
| | | | — | | | | | | 348 | | | | | | | | | | | | (348) | | | | | | (抄送) | | | | | | | | | | | | — | | | | | | | | | | | | — | | |
远期购买公允价值变动和
Backstop Securities |
| | | | — | | | | | | 65 | | | | | | | | | | | | (65) | | | | | | (Dd) | | | | | | | | | | | | — | | | | | | | | | | | | — | | |
Other income, net
|
| | | | — | | | | | | 413 | | | | | | — | | | | | | (413) | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Loss before income taxes
|
| | | | (20,789) | | | | | | (5,986) | | | | | | — | | | | | | (353) | | | | | | | | | | | | (27,128) | | | | | | — | | | | | | | | | | | | (27,128) | | |
Income tax benefit
|
| | | | 4,231 | | | | |
|
—
|
| | | | | | | | | | | 2,551 | | | | | | (EE) | | | | | | 6,782 | | | | | | — | | | | | | | | | | | | 6,782 | | |
Net loss
|
| | | $ | (16,558) | | | | | $ | (5,986) | | | | | $ | — | | | | | $ | 2,198 | | | | | | | | | | | $ | (20,346) | | | | | $ | — | | | | | | | | | | | $ | (20,346) | | |
视为股息 - 远期购买和支持证券
|
| | | | — | | | | | | (225) | | | | | | | | | | | | 225 | | | | | | (FF) | | | | | | | | | | | | — | | | | | | | | | | | | — | | |
可归因于普通业务的净亏损
shareholders |
| | | $ | (16,558) | | | | | $ | (6,211) | | | | | $ | — | | | | | $ | 2,423 | | | | | | | | | | | $ | (20,346) | | | | | $ | — | | | | | | | | | | | $ | (20,346) | | |
基本和稀释后加权平均流通股
|
| | | | | | | | | | 28,750,000 | | | | | | | | | | | | 82,314,925 | | | | | | (GG) | | | | | | 111,064,925 | | | | | | (12,281,250) | | | | | | (HH) | | | | | | 98,783,675 | | |
每股基本和摊薄净亏损
|
| | | | | | | | | $ | (0.21) | | | | | | | | | | | | | | | | | | | | | | | $ | (0.18) | | | | | | | | | | | | | | | | | $ | (0.21) | | |
| | |
Year Ended
December 31, 2021 |
| |
For the period
from February 5, 2021 (inception) through December 31, 2021 |
| | | | | | | | | | |
Transaction
Accounting Adjustments (Assuming No Redemptions) (Note 3) |
| | | | | | | |
Year Ended
December 31, 2021 |
| |
Additional
Transaction Accounting Adjustments (Assuming Maximum Redemptions) (Note 3) |
| | | | | | | |
Year Ended
December 31, 2021 |
| ||||||||||||||||||
| | |
OmniAb
(Historical) |
| |
APAC
(Historical) |
| |
Autonomous
Entity Adjustments (Note 3) |
| | | | | | | | | | |
Pro Forma
Combined (Assuming No Redemptions) |
| | | | | | | |
Pro Forma
Combined (Assuming Maximum Redemptions) |
| |||||||||||||||||||||||||||
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
许可证和里程碑收入
|
| | | $ | 14,664 | | | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 14,664 | | | | | | | | | | | | | | | | | $ | 14,664 | | |
Service revenue
|
| | | | 20,084 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | 20,084 | | | | | | | | | | | | | | | | | | 20,084 | | |
Total revenue
|
| | | | 34,748 | | | | | | — | | | | | | — | | | | | | | | | — | | | | | | | | | | | | 34,748 | | | | | | — | | | | | | | | | | | | 34,748 | | |
Operating expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
研发
|
| | | | 39,232 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | 39,232 | | | | | | | | | | | | | | | | | | 39,232 | | |
一般和行政
|
| | | | 16,947 | | | | | | 516 | | | | | | | | | | | | | | | (46) | | | | | | (Aa) | | | | | | 17,417 | | | | | | | | | | | | | | | | | | 17,417 | | |
无形资产摊销
|
| | | | 12,968 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | 12,968 | | | | | | | | | | | | | | | | | | 12,968 | | |
Other operating expense – net
|
| | | | 1,210 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | 1,210 | | | | | | | | | | | | | | | | | | 1,210 | | |
总运营费用
|
| | |
|
70,357
|
| | | |
|
516
|
| | | |
|
—
|
| | | | | | |
|
(46)
|
| | | | | | | | | |
|
70,827
|
| | | |
|
—
|
| | | | | | | | | |
|
70,827
|
| |
Loss from operations
|
| | |
|
(35,609)
|
| | | |
|
(516)
|
| | | |
|
—
|
| | | | | | |
|
46
|
| | | | | | | | | |
|
(36,079)
|
| | | |
|
—
|
| | | | | | | | | |
|
(36,079)
|
| |
Other income (expense): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (7) | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | (7) | | | | | | | | | | | | | | | | | | (7) | | |
Other income, net
|
| | | | 1,266 | | | | | | — | | | | | | | | | | | | | | | (6,327) | | | | | | (Bb) | | | | | | (5,061) | | | | | | | | | | | | | | | | | | (5,061) | | |
Other income, net
|
| | | | 1,259 | | | | | | — | | | | | | — | | | | | | | | | (6,327) | | | | | | | | | | | | (5,068) | | | | | | — | | | | | | | | | | | | (5,068) | | |
Loss before income taxes
|
| | | | (34,350) | | | | | | (516) | | | | | | — | | | | | | | | | (6,281) | | | | | | | | | | | | (41,147) | | | | | | — | | | | | | | | | | | | (41,147) | | |
Income tax benefit
|
| | | | 7,308 | | | | |
|
—
|
| | | | | | | | | | | | | | 2,979 | | | | | | (EE) | | | | | | 10,287 | | | | | | — | | | | | | | | | | | | 10,287 | | |
Net loss
|
| | | $ | (27,042) | | | | | $ | (516) | | | | | $ | — | | | | | | | | $ | (3,302) | | | | | | | | | | | $ | (30,860) | | | | | $ | — | | | | | | | | | | | $ | (30,860) | | |
基本和稀释加权平均股份
outstanding |
| | | | | | | | | | 15,178,572 | | | | | | | | | | | | | | | 95,886,353 | | | | | | (GG) | | | | | | 111,064,925 | | | | | | (12,281,250) | | | | | | (HH) | | | | | | 98,783,675 | | |
每股基本和摊薄净亏损
|
| | | | | | | | | $ | (0.03) | | | | | | | | | | | | | | | | | | | | | | | | | | $ | (0.28) | | | | | | | | | | | | | | | | | $ | (0.31) | | |
| | |
Six Months
Ended June 30, 2022 |
| |
Year Ended
December 31, 2021 |
| ||||||
向OmniAb普通股持有人发行新的OmniAb普通股
|
| | | | 82,731,592 | | | | | | 82,731,592 | | |
假设亚太地区的股票自2021年1月1日起发行,对亚太地区加权平均流通股的影响
|
| | | | — | | | | | | 13,571,428 | | |
远期申购发行OmniAb新普通股
|
| | | | 1,500,000 | | | | | | 1,500,000 | | |
排除保荐人溢价股份(1)
|
| | | | (1,916,667) | | | | | | (1,916,667) | | |
| | | | | 82,314,925 | | | | | | 95,886,353 | | |
| | |
Six Months Ended June 30, 2022
|
| |
Year Ended December 31, 2021
|
| ||||||||||||||||||
| | |
Assuming No
Redemptions |
| |
Assuming
Maximum Redemptions |
| |
Assuming No
Redemptions |
| |
Assuming
Maximum Redemptions |
| ||||||||||||
预计净亏损(千)
|
| | | $ | (20,346) | | | | | $ | (20,346) | | | | | $ | (30,860) | | | | | $ | (30,860) | | |
形式加权平均流通股、基本股和稀释股
|
| | | | 111,064,925 | | | | | | 98,783,675 | | | | | | 111,064,925 | | | | | | 98,783,675 | | |
预计每股净亏损,基本和
diluted |
| | | $ | (0.18) | | | | | $ | (0.21) | | | | | $ | (0.28) | | | | | $ | (0.31) | | |
形式加权平均股份计算,
basic and diluted |
| | | | | | | | | | | | | | | | | | | | | | | | |
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | — | | | | | | 23,000,000 | | | | | | — | | |
Sponsor & related parties(1)(2)
|
| | | | 5,333,333 | | | | | | 16,052,083 | | | | | | 5,333,333 | | | | | | 16,052,083 | | |
OmniAb’s (Ligand’s) stockholders(3)(5)
|
| | | | 82,731,592 | | | | | | 82,731,592 | | | | | | 82,731,592 | | | | | | 82,731,592 | | |
形式加权平均份额计算,基本和稀释(4)
|
| | | | 111,064,925 | | | | | | 98,783,675 | | | | | | 111,064,925 | | | | | | 98,783,675 | | |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption
Scenario(1) |
| |
Maximum Redemption
Scenario(2) |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| ||||||||||||||||||
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | 18% | | | | | | 11,500,000 | | | | | | 9.9% | | | | | | — | | | | | | 0.0% | | |
Sponsor and related
parties(3)(4)(6) |
| | | | 7,250,000 | | | | | | 5.7% | | | | | | 7,250,000 | | | | | | 6.2% | | | | | | 17,250,000 | | | | | | 15.0% | | |
OmniAb’s (Ligand’s) stockholders(5)(6)
|
| | | | 97,731,592 | | | | | | 76.3% | | | | | | 97,731,592 | | | | | | 83.9% | | | | | | 97,731,592 | | | | | | 85.0% | | |
Total(7)(8) | | | |
|
127,981,592
|
| | | |
|
100.0%
|
| | | |
|
116,481,592
|
| | | |
|
100.0%
|
| | | |
|
114,981,592
|
| | | |
|
100.0%
|
| |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemption Scenario
|
| |
50% Redemption Scenario
|
| |
Maximum Redemption
Scenario |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| |
Number of
Shares |
| |
Percentage
of Outstanding Shares |
| ||||||||||||||||||
亚太地区的公众股东
|
| | | | 23,000,000 | | | | | | 20.7% | | | | | | 11,500,000 | | | | | | 11.6% | | | | | | — | | | | | | 0.0% | | |
赞助商及相关方
|
| | | | 5,333,333 | | | | | | 4.8% | | | | | | 5,333,333 | | | | | | 5.4% | | | | | | 16,052,083 | | | | | | 16.2% | | |
OmniAbs(配体)股东
|
| | | | 82,731,592 | | | | | | 74.5% | | | | | | 82,731,592 | | | | | | 83.0% | | | | | | 82,731,592 | | | | | | 83.8% | | |
Total
|
| | | | 111,064,925 | | | | | | 100.0% | | | | | | 99,564,925 | | | | | | 100.0% | | | | | | 98,783,675 | | | | | | 100.0% | | |
| | |
在新OmniAb中的份额所有权(1)
|
| |||||||||||||||||||||||||||||||||
| | |
无赎回情况
|
| |
50% Redemptions Scenario
|
| |
100% Redemptions Scenario
|
| |||||||||||||||||||||||||||
其他稀释源
|
| |
Number of
Underlying Shares |
| |
Percentage of then
Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of then
Outstanding Shares |
| |
Number of
Underlying Shares |
| |
Percentage of then
Outstanding Shares |
| ||||||||||||||||||
APAC Warrants
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
APAC Public Warrants(2)
|
| | | | 7,666,667 | | | | | | 5.7% | | | | | | 7,666,667 | | | | | | 6.2% | | | | | | 7,666,667 | | | | | | 6.3% | | |
APAC Private Placement
Warrants(3) |
| | | | 8,233,333 | | | | | | 6.0% | | | | | | 8,233,333 | | | | | | 6.6% | | | | | | 8,233,333 | | | | | | 6.7% | | |
APAC Warrants issued in
the Forward Purchase(4) |
| | | | 1,666,667 | | | | | | 1.3% | | | | | | 1,666,667 | | | | | | 1.4% | | | | | | 1,666,667 | | | | | | 1.4% | | |
APAC Warrants issued in
the “Redemption Backstop”(5) |
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 1,666,667 | | | | | | 1.4% | | |
APAC Private Placement
Warrants Issuable Pursuant to Convertible Promissory Note(6) |
| | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | | | | | 500,000 | | | | | | 0.4% | | |
OmniAb Prior Plans
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
OmniAb Options(7)
|
| | | | 13,587,254 | | | | | | 9.6% | | | | | | 13,587,254 | | | | | | 10.4% | | | | | | 13,587,254 | | | | | | 10.6% | | |
OmniAb RSUs and OmniAb PSUs(8)
|
| | | | 1,402,039 | | | | | | 1.1% | | | | | | 1,402,039 | | | | | | 1.2% | | | | | | 1,402,039 | | | | | | 1.2% | | |
新的OmniAb提出的计划
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2022 Plan(9)
|
| | | | 18,235,000 | | | | | | 12.5% | | | | | | 16,625,000 | | | | | | 12.5% | | | | | | 16,415,000 | | | | | | 12.5% | | |
ESPP(10)
|
| | | | 1,953,750 | | | | | | 1.5% | | | | | | 1,781,250 | | | | | | 1.5% | | | | | | 1,758,750 | | | | | | 1.5% | | |
额外稀释剂来源合计(11)
|
| | |
|
53,244,710
|
| | | |
|
29.4%
|
| | | |
|
51,462,210
|
| | | |
|
30.6%
|
| | | |
|
52,896,377
|
| | | |
|
31.5%
|
| |
| | |
在新OmniAb中的份额所有权
|
| |||||||||||||||||||||||||||||||||
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario(1) |
| |
100% Redemptions
Scenario(2) |
| |||||||||||||||||||||||||||
| | |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| |
Number of
Shares |
| |
Value per
Share(3) |
| ||||||||||||||||||
Base Scenario(4)
|
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 114,981,592 | | | | | $ | 10.25 | | |
不包括赞助商分红
Shares and OmniAb Earnout Shares(5) |
| | | | 111,064,925 | | | | | $ | 11.83 | | | | | | 99,564,925 | | | | | $ | 12.01 | | | | | | 98,783,675 | | | | | $ | 11.93 | | |
假设行使亚太地区公共认股权证(6)
|
| | | | 135,648,259 | | | | | $ | 10.34 | | | | | | 124,148,259 | | | | | $ | 10.35 | | | | | | 122,648,259 | | | | | $ | 10.32 | | |
Assuming Exercise of APAC
私募认股权证(7) |
| | | | 136,214,925 | | | | | $ | 10.34 | | | | | | 124,714,925 | | | | | $ | 10.35 | | | | | | 123,214,925 | | | | | $ | 10.33 | | |
假设行使远期购买中发行的亚太地区认股权证(8)
|
| | | | 129,648,259 | | | | | $ | 10.29 | | | | | | 118,148,259 | | | | | $ | 10.29 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
假设行使在赎回后盾中发行的亚太认股权证(9)
|
| | | | 127,981,592 | | | | | $ | 10.27 | | | | | | 116,481,592 | | | | | $ | 10.27 | | | | | | 116,648,259 | | | | | $ | 10.26 | | |
假设根据可转换本票(10)可发行的亚太地区私募认股权证的行使
|
| | | | 128,481,592 | | | | | $ | 10.27 | | | | | | 116,981,592 | | | | | $ | 10.28 | | | | | | 115,481,592 | | | | | $ | 10.25 | | |
Including Conversion of
OmniAb RSUs and OmniAb PSUs(11) |
| | | | 129,383,631 | | | | | $ | 10.16 | | | | | | 117,883,631 | | | | | $ | 10.15 | | | | | | 116,383,631 | | | | | $ | 10.12 | | |
包括根据2022年计划(12)为发行保留的股份
|
| | | | 146,216,592 | | | | | $ | 8.99 | | | | | | 133,106,592 | | | | | $ | 8.99 | | | | | | 131,396,592 | | | | | $ | 8.97 | | |
包括根据esp为发行保留的股份(13)
|
| | | | 129,935,342 | | | | | $ | 10.25 | | | | | | 118,262,842 | | | | | $ | 10.25 | | | | | | 116,740,342 | | | | | $ | 10.22 | | |
| | |
No Redemptions
Scenario |
| |
50% Redemptions
Scenario |
| |
100% Redemptions
Scenario |
| |||||||||
| | |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |
Post-
Transaction Equity Value |
| |||||||||
Base Scenario
|
| | | $ | 1.31 | | | | | $ | 1.20(3)(a) | | | | | $ | 1.18(3)(b) | | |
不包括保荐人溢价股份和泛抗体溢价股份(3)(C)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
假设行使亚太地区的公共认股权证(3)(D)
|
| | | $ | 1.40 | | | | | $ | 1.28 | | | | | $ | 1.27 | | |
假设行使亚太地区私募认股权证(3)(E)
|
| | | $ | 1.41 | | | | | $ | 1.29 | | | | | $ | 1.27 | | |
假设亚太地区认股权证的行使
Forward Purchase(3)(f) |
| | | $ | 1.33 | | | | | $ | 1.22 | | | | | $ | 1.20 | | |
假设亚太地区认股权证的行使
Redemption Backstop(3)(g) |
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.20 | | |
假设根据可转换本票(3)(H)行使亚太地区私募认股权证
|
| | | $ | 1.32 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括OmniAbRSU和OmniAbPSU的转换(3)(I)
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括根据2022年计划(3)(J)为发行而保留的股份
|
| | | $ | 1.31 | | | | | $ | 1.20 | | | | | $ | 1.18 | | |
包括根据esp(3)(K)为发行保留的股份
|
| | | $ | 1.33 | | | | | $ | 1.21 | | | | | $ | 1.19 | | |
(单位为千,份额除外)
|
| |
No
Redemptions |
| |
50%
Redemption |
| |
Maximum
Redemption |
| |||||||||
未赎回的公共股
|
| | | | 23,000,000 | | | | | | 11,500,000 | | | | | | — | | |
信任继续到新的OmniAb
|
| | | $ | 235,750 | | | | | $ | 117,875 | | | | | $ | — | | |
延期承销佣金(1)
|
| | | $ | 4,025 | | | | | $ | 4,025 | | | | | $ | 4,025 | | |
有效递延承销费(%)
|
| | | | 1.71% | | | | | | 3.41% | | | | | | —% | | |
每股有效递延承销费
|
| | | $ | 1.18 | | | | | $ | 0.35 | | | | | $ | — | | |
| | |
2022
|
| |
2023
|
| |
2024
|
| |
2025
|
| |
2026
|
| |
2027
|
| |
2028
|
| |
2029
|
| |
2030
|
| |
2031
|
| |
2032
|
| |
2033
|
| ||||||||||||||||||||||||||||||||||||
Total Revenue(1)
|
| | | $ | 72^ | | | | | $ | 101 | | | | | $ | 108 | | | | | $ | 164 | | | | | $ | 182 | | | | | $ | 239 | | | | | $ | 336 | | | | | $ | 398 | | | | | $ | 465 | | | | | $ | 584 | | | | | $ | 751 | | | | | $ | 987 | | |
EBITDA(2) | | | | $ | 7 | | | | | $ | 6 | | | | | $ | (13) | | | | | $ | 29 | | | | | $ | 40 | | | | | $ | 90 | | | | | $ | 179 | | | | | $ | 232 | | | | | $ | 290 | | | | | $ | 400 | | | | | $ | 562 | | | | | $ | 792 | | |
FCF (EBITDA – Capex)
|
| | | $ | (9) | | | | | $ | (4) | | | | | $ | (23) | | | | | $ | 24 | | | | | $ | 35 | | | | | $ | 85 | | | | | $ | 174 | | | | | $ | 227 | | | | | $ | 285 | | | | | $ | 395 | | | | | $ | 557 | | | | | $ | 787 | | |
| | |
2034
|
| |
2035
|
| |
2036
|
| |
2037
|
| |
2038
|
| |
2039
|
| |
2040
|
| |
2041
|
| |
2042
|
| |
2043
|
| |
2044
|
| |
2045
|
| ||||||||||||||||||||||||||||||||||||
Total Revenue(1)
|
| | | $ | 1,225 | | | | | $ | 1,524 | | | | | $ | 1,800 | | | | | $ | 2,100 | | | | | $ | 2,411 | | | | | $ | 2,735 | | | | | $ | 3,108 | | | | | $ | 3,450 | | | | | $ | 3,608 | | | | | $ | 3,997 | | | | | $ | 4,187 | | | | | $ | 4,258 | | |
EBITDA(2) | | | | $ | 1,024 | | | | | $ | 1,317 | | | | | $ | 1,586 | | | | | $ | 1,881 | | | | | $ | 2,184 | | | | | $ | 2,502 | | | | | $ | 2,868 | | | | | $ | 3,203 | | | | | $ | 3,354 | | | | | $ | 3,735 | | | | | $ | 3,917 | | | | | $ | 3,980 | | |
FCF (EBITDA –
Capex) |
| | | $ | 1,019 | | | | | $ | 1,312 | | | | | $ | 1,581 | | | | | $ | 1,876 | | | | | $ | 2,179 | | | | | $ | 2,497 | | | | | $ | 2,863 | | | | | $ | 3,198 | | | | | $ | 3,349 | | | | | $ | 3,730 | | | | | $ | 3,912 | | | | | $ | 3,795 | | |
Stage of Development
|
| |
Probability of Success
|
| |
Time in Stage
|
|
Research to Phase 1
|
| |
35.2%
|
| |
4 years
|
|
Phase 1 to Phase 2
|
| |
54.7%
|
| |
1 year
|
|
Phase 2 to Phase 3
|
| |
34.1%
|
| |
2 years
|
|
Phase 3 to Filing
|
| |
68.1%
|
| |
3 years
|
|
Filing to Approval
|
| |
95.4%
|
| |
1 year
|
|
专利到期审批
|
| | | | |
12 years
|
|
| | |
2022
|
| |
2023
|
| |
2024
|
| |||||||||
Total Revenue
|
| | | $ | 65.0^ | | | | | $ | 83.4 | | | | | $ | 90.1 | | |
EBITDA | | | | $ | 6.2 | | | | | $ | 11.0 | | | | | $ | 10.2 | | |
FCF (EBITDA – Capex)
|
| | | $ | (10.0) | | | | | $ | 1.0 | | | | | $ | 0.2 | | |
| 多元化的药物研发部门 | | | | | | | |
|
Evotec
|
| | | $ | 5,337 | | |
|
AbCellera
|
| | | $ | 1,999 | | |
|
Absci
|
| | | $ | 514 | | |
| 下一代发现和生产技术部门 | | | | | | | |
|
Ginkgo Bioworks
|
| | | $ | 3,345 | | |
|
Twist Biosciences
|
| | | $ | 2,336 | | |
|
Adaptive
|
| | | $ | 1,397 | | |
|
Codexis
|
| | | $ | 1,139 | | |
| 启用计算的药物发现部门 | | | | | | | |
|
Relay Therapeutics
|
| | | $ | 1,739 | | |
|
Schrodinger
|
| | | $ | 1,792 | | |
|
Exscientia
|
| | | $ | 1,457 | | |
Name of Director
|
| |
Position
|
|
Matthew W. Foehr | | | 第一类董事兼首席执行官 | |
John L. Higgins | | | 三类董事,新一届泛抗董事会主席 | |
Carolyn Bertozzi, Ph.D. | | | Class III Director | |
Sarah Boyce | | | Class II Director | |
Jennifer Cochran, Ph.D. | | | Class I Director | |
Sunil Patel | | | Class II Director | |
Joshua Tamaroff | | | Class III Director | |
Name
|
| |
Age
|
| |
Position
|
|
Thompson Dean | | |
64
|
| | 董事执行主席兼执行主席 | |
David Burgstahler | | |
53
|
| | 董事首席执行官总裁 | |
Sriram Venkataraman | | |
50
|
| | 常务副总裁 | |
Robert Girardi | | |
40
|
| | 常务副总裁 | |
John Cafasso | | |
49
|
| | 首席财务官 | |
Benjamin Silbert | | |
51
|
| | General Counsel | |
William E. Klitgaard | | |
69
|
| | Director | |
Lâle White | | |
67
|
| | Director | |
Wendel Barr | | |
60
|
| | Director | |
Charles Harwood | | |
69
|
| | Director | |
Business
|
| |
Acquisition Date
|
| |
收购的技术
|
|
开放式单抗技术(OMT) | | | January 2016 | | |
OmniRat
OmniMouse
OmniFlic
|
|
Crystal | | | October 2017 | | |
OmniChicken
GEM screening
|
|
Ab Initio | | | July 2019 | | | Antigen design | |
Icagen | | | April 2020 | | | 离子通道技术 | |
xCella | | | September 2020 | | | 开发筛选 | |
Taurus | | | September 2020 | | | OmniTaur | |
Metric
|
| |
June 30,
2022 |
| |
December 31,
2021 |
| |
%
Change |
| |
December 31,
2021 |
| |
December 31,
2020 |
| |
%
Change |
| |
December 31,
2020 |
| |
December 31,
2019 |
| |
%
Change |
| |||||||||||||||||||||||||||
Active partners
|
| | | | 64 | | | | | | 57 | | | | | | 12% | | | | | | 57 | | | | | | 55 | | | | | | 4% | | | | | | 55 | | | | | | 49 | | | | | | 12% | | |
Active programs
|
| | | | 275 | | | | | | 252 | | | | | | 9% | | | | | | 252 | | | | | | 207 | | | | | | 22% | | | | | | 207 | | | | | | 184 | | | | | | 13% | | |
Active clinical
programs |
| | | | 25 | | | | | | 25 | | | | | | — | | | | | | 25 | | | | | | 16 | | | | | | 56% | | | | | | 16 | | | | | | 12 | | | | | | 33% | | |
Approved products
|
| | | | 2 | | | | | | 2 | | | | | | — | | | | | | 2 | | | | | | 0 | | | |
not meaningful
|
| | | | — | | | | | | — | | | | | | — | | |
| | |
Three Months Ended
June 30, |
| | | | | | | | | | | | | |||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
Royalty
|
| | | $ | 139 | | | | | $ | — | | | | | $ | 139 | | | | | | NM(1) | | |
License fees
|
| | | | 1,050 | | | | | | 1,100 | | | | | | (50) | | | | | | (5)% | | |
Milestone revenue
|
| | | | 1,275 | | | | | | — | | | | | | 1,275 | | | | | | NM(1) | | |
Service revenue
|
| | | | 4,735 | | | | | | 4,485 | | | | | | 250 | | | | | | 6% | | |
Total revenue
|
| | |
$
|
7,199
|
| | | |
$
|
5,585
|
| | | |
$
|
1,614
|
| | | | | 29% | | |
| | |
Six Months Ended
June 30, |
| | | |||||||||||||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
Royalty
|
| | | $ | 402 | | | | | $ | — | | | | | $ | 402 | | | | | | NM(1) | | |
License fees
|
| | | | 2,055 | | | | | | 1,750 | | | | | | 305 | | | | | | 17% | | |
Milestone revenue
|
| | | | 4,371 | | | | | | 2,064 | | | | | | 2,307 | | | | | | 112% | | |
Service revenue
|
| | | | 9,994 | | | | | | 9,377 | | | | | | 617 | | | | | | 7% | | |
Total revenue
|
| | |
$
|
16,822
|
| | | |
$
|
13,191
|
| | | |
$
|
3,631
|
| | | | | 28% | | |
| | |
Three Months Ended
June 30, |
| | | | | | | | | | | | | |||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
研发
|
| | | $ | 11,484 | | | | | $ | 8,941 | | | | | $ | 2,543 | | | | | | 28% | | |
一般和行政
|
| | | | 5,003 | | | | | | 4,821 | | | | | | 182 | | | | | | 4% | | |
无形资产摊销
|
| | | | 3,113 | | | | | | 3,231 | | | | | | (118) | | | | | | (4)% | | |
其他运营费用(收入),净额
|
| | | | 165 | | | | | | (764) | | | | | | 929 | | | | | | (122)% | | |
总运营费用
|
| | |
$
|
19,765
|
| | | |
$
|
16,229
|
| | | |
$
|
3,536
|
| | | | | 22% | | |
| | |
Six Months Ended
June 30, |
| | | | | | | | | | | | | |||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
研发
|
| | | $ | 22,256 | | | | | $ | 18,282 | | | | | $ | 3,974 | | | | | | 22% | | |
一般和行政
|
| | | | 9,115 | | | | | | 8,906 | | | | | | 209 | | | | | | 2% | | |
无形资产摊销
|
| | | | 6,518 | | | | | | 6,462 | | | | | | 56 | | | | | | 1% | | |
其他运营费用(收入),净额
|
| | | | (278) | | | | | | 271 | | | | | | (549) | | | | | | (203)% | | |
总运营费用
|
| | |
$
|
37,611
|
| | | |
$
|
33,921
|
| | | |
$
|
3,690
|
| | | | | 11% | | |
| | |
Three Months Ended
June 30, |
| | | | | | | | | | | | | |||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
所得税优惠前亏损
|
| | | $ | (12,566) | | | | | $ | (10,644) | | | | | $ | (1,922) | | | | | | 18% | | |
Income tax benefit
|
| | | | 2,290 | | | | | | 2,019 | | | | | | 271 | | | | | | 13% | | |
Net loss
|
| | | $ | (10,276) | | | | | $ | (8,625) | | | | | $ | (1,651) | | | | | | 19% | | |
Effective Tax Rate
|
| | |
|
18.2%
|
| | | |
|
19.0%
|
| | | | | | | | | | | | | |
| | |
Six Months Ended
June 30, |
| | | | | | | | | | | | | |||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
Change
|
| |
% Change
|
| ||||||||||||
所得税优惠前亏损
|
| | | $ | (20,789) | | | | | $ | (20,736) | | | | | $ | (53) | | | | | | 0% | | |
Income tax benefit
|
| | | | 4,231 | | | | | | 4,656 | | | | | | (425) | | | | | | (9)% | | |
Net loss
|
| | | $ | (16,558) | | | | | $ | (16,080) | | | | | $ | (478) | | | | | | 3% | | |
Effective Tax Rate
|
| | |
|
20.4%
|
| | | |
|
22.5%
|
| | | | | | | | | | | | | |
(Dollars in thousands)
|
| |
2021
|
| |
2020
|
| |
Change
|
| |
% Change
|
| ||||||||||||
License fees
|
| | | $ | 4,500 | | | | | $ | 4,260 | | | | | $ | 240 | | | | | | 6% | | |
Milestone revenue
|
| | | | 10,164 | | | | | | 7,125 | | | | | | 3,039 | | | | | | 43% | | |
Service revenue
|
| | | | 20,084 | | | | | | 11,883 | | | | | | 8,201 | | | | | | 69% | | |
Total revenue
|
| | | $ | 34,748 | | | | | $ | 23,268 | | | | | $ | 11,480 | | | | | | 49% | | |
(Dollars in thousands)
|
| |
2021
|
| |
2020
(As Restated) |
| |
Change
|
| |
% Change
|
| ||||||||||||
研发
|
| | | $ | 39,232 | | | | | $ | 24,796 | | | | | $ | 14,436 | | | | | | 58% | | |
一般和行政
|
| | | | 16,947 | | | | | | 10,225 | | | | | | 6,722 | | | | | | 66% | | |
无形资产摊销
|
| | | | 12,968 | | | | | | 11,800 | | | | | | 1,168 | | | | | | 10% | | |
其他运营费用净额
|
| | | | 1,210 | | | | | | 2,070 | | | | | | (860) | | | | | | (42)% | | |
总运营费用
|
| | | $ | 70,357 | | | | | $ | 48,891 | | | | | $ | 21,466 | | | | | | 44% | | |
(Dollars in thousands)
|
| |
2021
|
| |
2020
|
| |
Change
|
| |
% Change
|
| ||||||||||||
Interest expense
|
| | | $ | (7) | | | | | $ | (5) | | | | | $ | (2) | | | | | | 40% | | |
Other income, net
|
| | | | 1,266 | | | | | | 1,900 | | | | | | (634) | | | | | | (33)% | | |
其他收入(支出)净额合计
|
| | | $ | 1,259 | | | | | $ | 1,895 | | | | | $ | (636) | | | | | | (34)% | | |
(Dollars in thousands)
|
| |
2021
|
| |
2020
(As Restated) |
| |
Change
|
| |
% Change
|
| ||||||||||||
所得税优惠前亏损
|
| | | $ | (34,350) | | | | | $ | (23,728) | | | | | $ | (10,622) | | | | | | 45% | | |
所得税优惠(费用)
|
| | | | 7,308 | | | | | | 6,171 | | | | | | 1,137 | | | | | | 18% | | |
Net loss
|
| | | $ | (27,042) | | | | | $ | (17,557) | | | | | $ | (9,485) | | | | | | 54% | | |
Effective Tax Rate
|
| | | | 21% | | | | | | 26% | | | | | | | | | | | | | | |
(Dollars in thousands)
|
| |
2020
|
| |
2019
(As Restated) |
| |
Change
|
| |
% Change
|
| ||||||||||||
License fee
|
| | | $ | 4,260 | | | | | $ | 5,700 | | | | | $ | (1,440) | | | | | | (25)% | | |
Milestone revenue
|
| | | | 7,125 | | | | | | 7,050 | | | | | | 75 | | | | | | 1% | | |
Service revenue
|
| | | | 11,883 | | | | | | 5,568 | | | | | | 6,315 | | | | | | 113% | | |
Total revenue
|
| | | $ | 23,268 | | | | | $ | 18,318 | | | | | $ | 4,950 | | | | | | 27% | | |
(Dollars in thousands)
|
| |
2020
(As Restated) |
| |
2019
(As Restated) |
| |
Change
|
| |
% Change
|
| ||||||||||||
研发
|
| | | $ | 24,796 | | | | | $ | 13,208 | | | | | $ | 11,588 | | | | | | 88% | | |
一般和行政
|
| | | | 10,225 | | | | | | 8,651 | | | | | | 1,574 | | | | | | 18% | | |
无形资产摊销
|
| | | | 11,800 | | | | | | 10,304 | | | | | | 1,496 | | | | | | 15% | | |
其他运营费用(收入),净额
|
| | | | 2,070 | | | | | | (818) | | | | | | 2,888 | | | | | | (353)% | | |
总运营费用
|
| | | $ | 48,891 | | | | | $ | 31,345 | | | | | $ | 17,546 | | | | | | 56% | | |
(Dollars in thousands)
|
| |
2020
|
| |
2019
|
| |
Change
|
| |
% Change
|
| ||||||||||||
Interest expense
|
| | | $ | (5) | | | | | $ | — | | | | | $ | (5) | | | | | | NM(1) | | |
Other income, net
|
| | | | 1,900 | | | | | | — | | | | | | 1,900 | | | |
NM(1)
|
| |||
其他收入(支出)净额合计
|
| | | $ | 1,895 | | | | | $ | — | | | | | $ | 1,895 | | | |
NM(1)
|
|
(Dollars in thousands)
|
| |
2020
(As Restated) |
| |
2019
(As Restated) |
| |
Change
|
| |
% Change
|
| ||||||||||||
所得税优惠前亏损
|
| | | $ | (23,728) | | | | | $ | (13,027) | | | | | $ | (10,701) | | | | | | 82% | | |
所得税优惠(费用)
|
| | | | 6,171 | | | | | | (562) | | | | | | 6,733 | | | | | | (1,198)% | | |
Net loss
|
| | | $ | (17,557) | | | | | $ | (13,589) | | | | | $ | (3,968) | | | | | | 29% | | |
Effective tax rate
|
| | | | 26% | | | | | | (4)% | | | | | | | | | | | | | | |
| | |
Six Months Ended
June 30, |
| |
Year ended
|
| ||||||||||||||||||||||||
(Dollars in thousands)
|
| |
2022
|
| |
2021
|
| |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||
净现金提供人(使用于): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating activities
|
| | | $ | 7,788 | | | | | $ | 3,511 | | | | | $ | (5,672) | | | | | $ | 3,619 | | | | | $ | (5,195) | | |
Investing activities
|
| | | $ | (8,237) | | | | | $ | (1,611) | | | | | $ | (4,025) | | | | | $ | (26,980) | | | | | $ | (12,095) | | |
Financing activities
|
| | | $ | 449 | | | | | $ | (1,900) | | | | | $ | 9,697 | | | | | $ | 23,361 | | | | | $ | 17,290 | | |
姓名和主要职务
|
| |
Year
|
| |
Salary
($) |
| |
Stock
Awards(1) ($) |
| |
Option
Awards(1) ($) |
| |
Non-Equity
Incentive Plan Compensation(2) ($) |
| |
All Other
Compensation(3) ($) |
| |
Total
($) |
| |||||||||||||||||||||
Matthew W. Foehr
|
| | | | 2021 | | | | | | 518,933 | | | | | | 3,146,844 | | | | | | 1,226,357 | | | | | | 259,467 | | | | | | 130,603(4) | | | | | | 5,282,204 | | |
首席执行官
|
| | | | 2020 | | | | | | 503,750 | | | | | | 1,242,269 | | | | | | 1,303,366 | | | | | | 277,063 | | | | | | 158,001(5) | | | | | | 3,484,449 | | |
Charles S. Berkman
|
| | | | 2021 | | | | | | 451,682 | | | | | | 1,665,811 | | | | | | 649,308 | | | | | | 203,257 | | | | | | 10,890 | | | | | | 2,980,948 | | |
首席法务官兼秘书
|
| | | | 2020 | | | | | | 441,917 | | | | | | 644,168 | | | | | | 675,820 | | | | | | 176,767 | | | | | | 6,180 | | | | | | 1,944,852 | | |
Name
|
| |
Total Stock
Option Target Value (40%) |
| |
Number of
Stock Options Granted(1) |
| |
Total RSU
Target Value (27%) |
| |
Number of
RSUs Granted(2) |
| |
Total PSU
Target Value (33%) |
| |
Number of
PSUs Granted (at Target)(2) |
| ||||||||||||||||||
Matthew W. Foehr
|
| | | | 1,360,000 | | | | | | 13,136 | | | | | | 918,000 | | | | | | 6,595 | | | | | | 1,122,000 | | | | | | 8,060 | | |
Charles S. Berkman
|
| | | | 720,000 | | | | | | 6,955 | | | | | | 486,000 | | | | | | 3,491 | | | | | | 594,000 | | | | | | 4,267 | | |
TSR百分位数与纳斯达克生物技术指数
|
| |
% OF TARGET PAID
|
| |||
95th percentile
|
| | | | 200% | | |
55th percentile
|
| | | | 100% | | |
30th percentile
|
| | | | 50% | | |
|
| | | | 0% | | |
OmniAb程序数量
|
| |
% of Target Paid
|
| |||
35 or more
|
| | | | 150% | | |
25
|
| | | | 100% | | |
15
|
| | | | 50% | | |
|
| | | | 0% | | |
Objective
|
| |
Weighting
|
| |
Threshold
(0%) |
| |
Target
(100%) |
| |
Maximum
(150%) |
| |
Actual
Performance |
| |
Percentage
Earned |
|
Incremental Revenue(1)
|
| |
50%
|
| |
$10 million
|
| |
$15 million
|
| |
$20 million
|
| |
$109 million
|
| |
150%
|
|
| | |
Option Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
Name
|
| |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
| |
Number of
Securities Underlying Unexercised Options (#) Unexercisable(1) |
| |
Equity
Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
| |
Option
Exercise Price |
| |
Option
Expiration Date |
| |
Number of
Shares or Units of Stock That Have Not Vested (#)(2) |
| |
Market
Value of Shares or Units of Stock That Have Not Vested ($)(3) |
| |
Equity
Incentive Plan Awards: Number of Unearned Shares, Unit or Other Rights That Have Not Vested (#) |
| |
Equity
incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3) |
| |||||||||||||||||||||||||||
Matthew W.Foehr
|
| | | | 63,210 | | | | | | — | | | | | | — | | | | | | 74.42 | | | | | | 2/11/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 40,358 | | | | | | — | | | | | | — | | | | | | 56.26 | | | | | | 2/10/2025 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 25,938 | | | | | | — | | | | | | — | | | | | | 85.79 | | | | | | 2/11/2026 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 24,348 | | | | | | — | | | | | | — | | | | | | 100.38 | | | | | | 2/24/2027 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 19,007 | | | | | | 1,267 | | | | | | — | | | | | | 159.01 | | | | | | 3/2/2028 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 24,212 | | | | | | 9,969 | | | | | | — | | | | | | 117.97 | | | | | | 2/11/2029 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 15,222 | | | | | | 17,988 | | | | | | — | | | | | | 95.68 | | | | | | 2/13/2030 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 2,737 | | | | | | 10,399 | | | | | | — | | | | | | 177.50 | | | | | | 2/3/2031 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 14,015(4) | | | | | | 2,164,757 | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,396(5) | | | | | | 1,142,386 | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,060(6) | | | | | | 1,244,948 | | |
Charles S. Berkman
|
| | | | 1,948 | | | | | | — | | | | | | — | | | | | | 56.26 | | | | | | 2/10/2025 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 4,153 | | | | | | — | | | | | | — | | | | | | 85.79 | | | | | | 2/11/2026 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 6,830 | | | | | | — | | | | | | — | | | | | | 100.38 | | | | | | 2/24/2027 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 8,711 | | | | | | 581 | | | | | | — | | | | | | 159.01 | | | | | | 3/2/2028 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 10,377 | | | | | | 4,272 | | | | | | — | | | | | | 117.97 | | | | | | 2/11/2029 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 7,893 | | | | | | 9,327 | | | | | | — | | | | | | 95.68 | | | | | | 2/13/2030 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | 1,450 | | | | | | 5,505 | | | | | | — | | | | | | 177.50 | | | | | | 2/3/2031 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,114(7) | | | | | | 1,098,828 | | | | | | — | | | | | | — | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,835(5) | | | | | | 592,354 | | |
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,267(6) | | | | | | 659,081 | | |
Service
|
| |
Annual Retainer
(Chair) |
| |
Annual Retainer
(Member) |
| ||||||
Audit Committee
|
| | | $ | 20,000 | | | | | $ | 10,000 | | |
人力资本管理和薪酬委员会
|
| | | | 15,000 | | | | | | 7,500 | | |
提名和公司治理委员会
|
| | | | 10,000 | | | | | | 5,000 | | |
| | |
Target Value of
RSU Award(1) |
| |
Target Value of
Option Award(2) |
| |
Total Target Value
of Award |
| |||||||||
Initial Grant
|
| | | $ | 145,000 | | | | | $ | 280,000 | | | | | $ | 425,000 | | |
Annual Grant
|
| | | | 85,000 | | | | | | 175,000 | | | | | | 260,000 | | |
Service
|
| |
Annual Retainer
(Chair) |
| |
Annual Retainer
(Member) |
| ||||||
Audit Committee
|
| | | $ | 20,000 | | | | | $ | 10,000 | | |
人力资本管理和薪酬委员会
|
| | | | 15,000 | | | | | | 7,500 | | |
提名和公司治理委员会
|
| | | | 10,000 | | | | | | 5,000 | | |
| | |
Target Value of
RSU Award(1) |
| |
Target Value of
Option Award(2) |
| |
Total Target Value
of Award |
| |||||||||
Initial Grant
|
| | | $ | 145,000 | | | | | $ | 280,000 | | | | | $ | 425,000 | | |
Annual Grant
|
| | | | 85,000 | | | | | | 175,000 | | | | | | 260,000 | | |
Name
|
| |
Age
|
| |
Position
|
|
Matthew W. Foehr | | |
50
|
| | 董事首席执行官总裁 | |
Charles S. Berkman | | |
53
|
| | 首席法务官兼秘书 | |
Kurt A. Gustafson | | |
54
|
| | 财务执行副总裁兼首席财务官总裁 | |
Name
|
| |
Age
|
| |
Position
|
|
Matthew W. Foehr | | |
50
|
| | 董事一级提名者总裁和首席执行官 | |
John L. Higgins(1) | | |
52
|
| | 董事三类提名者,新一届全抗体董事会主席 | |
Carolyn R. Bertozzi, Ph.D(3) | | |
55
|
| | 董事三类提名者 | |
Sarah Boyce(1) | | |
50
|
| | 董事二类提名者 | |
Jennifer Cochran, Ph.D.(2)(3) | | |
50
|
| | 董事一级提名者 | |
Sunil Patel(1)(2) | | |
51
|
| | 董事二类提名者 | |
Joshua Tamaroff(2)(3) | | |
37
|
| | 董事三类提名者 | |
| |
董事会多样性矩阵(截至2022年9月1日)
|
| | ||||||||
| |
Total Number of Directors
|
| | |
7
|
| | ||||
| | | | | |
Female
|
| | |
Male
|
| |
| | Part I: Gender Identity | | | ||||||||
| |
Directors
|
| | | 3 | | | | 4 | | |
| | 第二部分:人口统计背景 | | | ||||||||
| |
Asian
|
| | | 0 | | | | 1 | | |
| |
White
|
| | | 3 | | | | 4 | | |
| |
两个或多个种族或民族
|
| | | 0 | | | | 1 | | |
| |
LGBTQ+
|
| | |
1
|
| |
| | |
业务合并前的
|
| |
企业合并后
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Assuming No
Redemptions |
| |
Assuming Maximum
Redemptions |
| ||||||||||||||||||
| | |
Class A
Ordinary Shares |
| |
Class B
Ordinary Shares |
| | | | | | | |
Common Stock
|
| |
Common Stock
|
| ||||||||||||||||||||||||||||||||||||
受益人姓名和地址(1)
|
| |
Number
of Shares |
| |
% of
Class |
| |
Number
of Shares |
| |
% of
Class |
| |
% of Total
Voting Power |
| |
Number
of Shares |
| |
% of
Outstanding Shares |
| |
Number
of Shares |
| |
% of
Outstanding Shares |
| |||||||||||||||||||||||||||
Avista Acquisition LP II(2)(3)
|
| | | | — | | | | | | — | | | | | | 5,645,000 | | | | | | 100% | | | | | | 19.6% | | | | | | 7,145,000 | | | | | | 6.32% | | | | | | 17,145,000 | | | | | | 17.1% | | |
Thompson Dean(2)(3)
|
| | | | — | | | | | | — | | | | | | 5,645,000 | | | | | | — | | | | | | 19.6% | | | | | | 7,145,000 | | | | | | 6.32% | | | | | | 17,145,000 | | | | | | 17.1% | | |
David Burgstahler(2)(3)
|
| | | | — | | | | | | — | | | | | | 5,645,000 | | | | | | — | | | | | | 19.6% | | | | | | 7,145,000 | | | | | | 6.32% | | | | | | 17,145,000 | | | | | | 17.1% | | |
William E. Klitgaard(2)
|
| | | | — | | | | | | — | | | | | | 35,000 | | | | | | * | | | | | | * | | | | | | 35,000 | | | | | | * | | | | | | 35,000 | | | | | | * | | |
Lâle White(2)
|
| | | | — | | | | | | — | | | | | | 35,000 | | | | | | * | | | | | | * | | | | | | 35,000 | | | | | | * | | | | | | 35,000 | | | | | | * | | |
Wendel Barr(2)
|
| | | | — | | | | | | — | | | | | | 35,000 | | | | | | * | | | | | | * | | | | | | 35,000 | | | | | | * | | | | | | 35,000 | | | | | | * | | |
亚太地区的所有董事和高管(11人)(2)
|
| | | | — | | | | | | — | | | | | | 5,750,000 | | | | | | 100% | | | | | | 20% | | | | | | 7,250,000 | | | | | | 6.4% | | | | | | 17,250,000 | | | | | | 17.3% | | |
完成业务合并后的新OmniAb董事和高管(9)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Matthew W. Foehr(10)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,962,396 | | | | | | 1.7% | | | | | | 1,962,396 | | | | | | 1.9% | | |
Charles S. Berkman(11)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 380,818 | | | | | | * | | | | | | 380,818 | | | | | | * | | |
Kurt Gustafson
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
John Higgins(12)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,935,852 | | | | | | 3.4% | | | | | | 3,935,852 | | | | | | 3.9% | | |
Carolyn Bertozzi, Ph.D.
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Sarah Boyce(13)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 57,203 | | | | | | * | | | | | | 57,203 | | | | | | * | | |
Jennifer Cochran, Ph.D.(14)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 9,261 | | | | | | * | | | | | | 9,261 | | | | | | * | | |
Sunil Patel(15)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 254,570 | | | | | | * | | | | | | 254,570 | | | | | | * | | |
Joshua Tamaroff(20)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
新OmniAb的所有董事和高管
业务合并完成后 (9 individuals) |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,600,099 | | | | | | 5.7% | | | | | | 6,600,099 | | | | | | 6.4% | | |
Other 5% Shareholders(9) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beryl Capital Management LLC(4)
|
| | | | 1,716,936 | | | | | | 7.5 | | | | | | — | | | | | | — | | | | | | 6.0% | | | | | | 1,716,936 | | | | | | 1.5% | | | | | | — | | | | | | — | | |
Polar Asset Management Partners Inc.(5)
|
| | | | 1,549,998 | | | | | | 6.7 | | | | | | — | | | | | | — | | | | | | 5.4% | | | | | | 1,549,998 | | | | | | 1.4% | | | | | | — | | | | | | — | | |
Citadel Advisors LLC(6)
|
| | | | 1,417,784 | | | | | | 6.2 | | | | | | — | | | | | | — | | | | | | 4.9% | | | | | | 1,417,784 | | | | | | 1.3% | | | | | | — | | | | | | — | | |
HGC投资管理公司(7)
|
| | | | 1,386,830 | | | | | | 6.0 | | | | | | — | | | | | | — | | | | | | 4.8% | | | | | | 1,386,830 | | | | | | 1.2% | | | | | | — | | | | | | — | | |
Integrated Core Strategies(8)
|
| | | | 1,269,543 | | | | | | 5.5 | | | | | | — | | | | | | — | | | | | | 4.4% | | | | | | 1,269,543 | | | | | | 1.1% | | | | | | — | | | | | | — | | |
BlackRock, Inc.(16)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 13,439,759 | | | | | | 11.9% | | | | | | 13,439,759 | | | | | | 13.4% | | |
The Vanguard Group(17)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 8,412,002 | | | | | | 7.5% | | | | | | 8,412,002 | | | | | | 8.4% | | |
Janus Henderson Group plc(18)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,061,317 | | | | | | 6.3% | | | | | | 7,061,317 | | | | | | 7.1% | | |
威廉·布莱尔投资管理公司(19)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 6,861,671 | | | | | | 6.1% | | | | | | 6,861,671 | | | | | | 6.9% | | |
| | |
Common stock
beneficially owned before the Distribution |
| |
Common stock
beneficially owned after the Distribution |
| ||||||||||||||||||
受益人姓名和地址
|
| |
Number
of Shares |
| |
% of
Outstanding Shares |
| |
Number
of Shares |
| |
% of
Outstanding Shares |
| ||||||||||||
5% Beneficial Owners | | | | | | | | | | | | | | | | | | | | | | | | | |
Ligand制药公司(1)
|
| | | | 1,000 | | | | | | 100% | | | | | | — | | | | | | — | | |
BlackRock, Inc.(2)
|
| | | | — | | | | | | — | | | | | | 2,742,808 | | | | | | 16.3% | | |
The Vanguard Group(3)
|
| | | | — | | | | | | — | | | | | | 1,716,735 | | | | | | 10.2% | | |
Janus Henderson Group plc(4)
|
| | | | — | | | | | | — | | | | | | 1,441,085 | | | | | | 8.5% | | |
威廉·布莱尔投资管理公司(5)
|
| | | | — | | | | | | — | | | | | | 1,400,341 | | | | | | 8.3% | | |
被提名的高管和董事候选人 | | | | | | | | | | | | | | | | | | | | | | | | | |
Matthew W. Foehr(6)
|
| | | | — | | | | | | — | | | | | | 400,489 | | | | | | 2.3% | | |
Charles S. Berkman(7)
|
| | | | — | | | | | | — | | | | | | 77,718 | | | | | | * | | |
Kurt Gustafson
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Carolyn Bertozzi, Ph.D.
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Sarah Boyce(8)
|
| | | | — | | | | | | — | | | | | | 11,674 | | | | | | * | | |
Jennifer Cochran, Ph.D.(9)
|
| | | | — | | | | | | — | | | | | | 1,890 | | | | | | * | | |
John L. Higgins(10)
|
| | | | — | | | | | | — | | | | | | 803,235 | | | | | | 4.6% | | |
Sunil Patel(11)
|
| | | | — | | | | | | — | | | | | | 51,953 | | | | | | * | | |
Joshua Tamaroff
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
所有高管和董事提名人员(9人)
|
| | | | — | | | | | | — | | | | | | 1,346,959 | | | | | | 7.6% | | |
| | |
Delaware
|
| |
Cayman Islands
|
|
企业合并的股东/股东批准
|
| |
合并通常需要获得所有流通股的多数批准。
收购方发行的股份不到20%的合并一般不需要收购方股东批准。
一家公司持有另一家公司90%或以上股权的合并,可以在没有第二家公司董事会或股东投票的情况下完成。
|
| |
根据《开曼群岛公司法》进行的合并需要特别决议,以及相关公司章程可能规定的任何其他授权。在组成公司中持有某些担保权益的各方也必须同意。
所有合并(母公司/子公司合并除外)都需要股东批准 - 规模较小的合并也不例外。
与收购要约/合同收购股权有关的投标人(即不是开曼群岛公司法下的法定合并)收购开曼群岛90%或更多股份的情况
|
|
| | |
Delaware
|
| |
Cayman Islands
|
|
| | | | | |
收购要约涉及的公司时,可以强制收购其余股东的股份,从而成为唯一股东。
开曼群岛公司亦可透过开曼群岛法院批准的“安排方案”收购,但须在特别召开的股东大会上获出席股东亲自或委派代表出席并于股东大会上投票的75%的股东同意。
|
|
股东/股东投票处理日常事务
|
| | 一般情况下,对付诸股东表决的日常公司事项的批准,需要亲自出席会议或由受委代表出席会议并有权就主题事项投票的多数股份持有人的赞成票。 | | | 根据开曼群岛公司法及亚太区经修订及重述的组织章程大纲及细则,须经股东批准的日常公司事项可由普通决议案(该决议案由有权就该决议案投票并于股东大会或特别大会上投票,并包括一致通过的书面决议案)批准。 | |
持不同政见者的权利和评估权
|
| | 一般情况下,上市公司的股东不拥有与合并相关的评估权。 | | | 对合并持异议的少数股东有权获得其股份的公允价值,如有必要,可能最终由法院决定。 | |
检查账簿和记录
|
| | 任何股东都可以在正常营业时间内出于正当目的检查公司的账簿和记录。 | | | 股东通常无权查阅或获取公司的股东名册或其他公司记录的副本。 | |
股东/股东诉讼
|
| | 股东可在符合程序要求的情况下提起衍生品诉讼(包括根据不具约束力的治理建议采用特拉华州作为独家论坛)。 | | | 在开曼群岛,代表公司提起诉讼的决定通常由公司董事会作出。股东可能有权代表 提起衍生诉讼 | |
| | |
Delaware
|
| |
Cayman Islands
|
|
| | | | | | 公司,但仅在某些有限的情况下。 | |
董事的受托责任
|
| | 董事必须对公司及其股东履行注意义务和忠诚诚信义务。 | | |
董事对开曼群岛豁免的公司负有受托责任,包括为所授予的目的行使权力、独立判断、不谋取秘密利润、避免利益冲突以及真诚行事以维护公司的整体最佳利益。
除受托责任外,亚太区董事还应尽到谨慎、勤勉和技巧的义务。这种义务是对公司负有的,但在某些有限的情况下可能直接对债权人或股东负有义务。
|
|
董事和高级管理人员的赔偿
|
| | 一般允许公司对其真诚行事的董事和高级管理人员进行赔偿,并以合理地相信符合或不反对公司最大利益的人的方式行事。 | | | 开曼群岛豁免公司一般可对其董事或高级管理人员进行赔偿,但欺诈、故意疏忽或故意违约除外。 | |
董事的有限责任
|
| | 允许限制或免除董事对公司或其股东的金钱责任,但违反忠实义务、故意不当行为、非法回购或分红或不正当个人利益除外。 | | | 董事的责任可以是无限的,除了他们自己的欺诈、故意疏忽或故意违约。 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
反收购条款和其他股东保护
|
| | 亚太地区的组织章程大纲和章程并未对相关股东收购亚太地区作出限制。 | | | 拟议的章程中包含的反收购条款和其他股东保护措施包括禁止股东通过书面同意采取行动。DGCL第203条禁止特拉华州公司与“有利害关系的股东”(即拥有New OmniAb有投票权股票的15%或以上的股东)进行“业务合并”,除非在某些例外情况下,自“有利害关系的股东”成为有投票权的股份后三(3)年内。 | | | | |
董事人数和资格
|
| | 亚太地区的组织章程大纲和章程规定,亚太地区董事会的董事人数不得少于一(1)人,并可通过普通决议增加或减少董事人数。 | | | 在优先股持有人与其若干股东之间有关董事选举的任何权利以及经修订及重订的登记权协议的规限下,董事人数将不时仅由新OmniAb董事会通过的决议案厘定。最初的新OmniAb董事会将由七(7)名成员组成。 | | | Ligand董事会由十(10)名成员组成。Ligand董事会可不时仅通过决议扩大其成员。 | |
法定股本/股本
|
| | 根据亚太地区的组织章程大纲和章程,亚太地区的法定股本为55,500美元,分为(A)500,000,000股亚太地区A类普通股,每股面值0.0001美元,以及(B)50,000,000股亚太地区B类普通股 | | | 新OmniAb将获授权发行1,100,000,000股股本,包括(I)1,000,000,000股普通股,每股面值0.0001美元;及(Ii)100,000,000股优先股,每股面值0.0001美元。在 上 | | | 根据Ligand的章程,Ligand目前被授权发行65,000,000股股票,包括(A)60,000,000股普通股,每股面值0.001美元,以及(B)5,000,000股优先股,每股面值0.001美元。 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
| | | 股,每股面值0.0001美元,以及(C)500万股优先股,每股面值0.0001美元。根据亚太地区的组织备忘录和章程,增加股本需要股东通过普通决议批准。 | | | 业务合并完成后,新OmniAb预计将有约127,681,885股新OmniAb普通股(假设没有赎回)流通股。在业务合并完成后,预计新OmniAb将不会有任何已发行的优先股。 | | | | |
董事会分类
|
| | 亚太地区的组织备忘录和章程没有规定设立一个分类委员会。 | | | 新OmniAb的拟议公司章程规定,新OmniAb董事会最初将分为三(3)个类别,即I类、II类和III类,每个类别的成员交错任职三年。 | | | Ligand修订和重述的公司注册证书并未规定设立机密董事会。 | |
Election of Directors
|
| | 根据亚太地区公司章程的定义,在企业合并之前,只有B类股东可以通过普通决议任命董事。董事任期至当选后的第二届年会,或直至其继任者正式当选并符合资格为止,但须受该董事提早去世、辞职或免职的规限。 | | | (Br)董事由股东选举产生,每一位董事的任期直至其继任者在其任期届满年度的年度会议上被正式选举或获得资格为止,或者直至其先前去世、辞职、丧失资格或被免职为止。 | | |
在Ligand的年度大会上,股东选举董事任职至下一次年度会议,或直到他或她的继任者被正式选举并具有资格,但须受董事提前去世、辞职或罢免的限制。
董事选举由Ligand普通股股东在年度股东大会上投下的多数票决定。
|
|
Removal of Directors
|
| | 在公司合并之前,按照亚太地区公司章程的定义,只有B类股东才能通过普通决议罢免董事。 | | | 在优先股持有人任何特殊权利的规限下,董事会或任何个人董事可随时被免职,但仅限于出于原因且仅经AT持有人的赞成票 | | | 在符合任何系列优先股持有人权利的情况下,任何或所有董事均可随时经多数投票权持有人的赞成票罢免,不论是否有任何理由。 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
| | | | | | 至少三分之二(66%和2/3%)的公司当时有权在董事选举中投票的所有有表决权股票的流通股的投票权。 | | | 资本全部流通股的权力 | |
Voting
|
| | 亚太区普通股持有人就提交股东表决的每一事项,每持有一股亚太区普通股可投一票;惟A类普通股持有人无权于业务合并前就董事的委任或免任投票,而B类普通股持有人就批准在开曼群岛以外地区继续经营亚太区的任何特别决议案投票时,每持有一股该等股份有10票(而在业务合并前,有关该等事项的细则只可由B类普通股持有人通过特别决议案修订)。 | | |
除非法律或新OmniAb建议的注册证书另有要求,新OmniAb普通股的持有者将拥有关于新OmniAb的所有投票权。新OmniAb普通股的股票持有人有权就普通股股东有权投票的每一件适当提交给新OmniAbs股东的事项,就每一股该等股份投一票。
除非适用法律另有要求,否则新OmniAb普通股持有人将无权就仅与一个或多个尚未发行的新OmniAb优先股系列的条款有关的新OmniAb建议注册证书的任何修订投票,前提是该受影响的新OmniAb优先股系列的持有人根据建议注册证书或适用法律有权单独或与一个或多个其他此类系列的持有人一起就该修订投票。
|
| | 除法律或Ligand修订和重述的公司注册证书及章程另有要求外,Ligand普通股持有人有权就提交给股东的事项投票,并有权根据本公司的章程获得任何股东大会的通知,并有权就法律规定的事项和以法律规定的方式投票。 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
Cumulative Voting
|
| | 开曼群岛法律没有明确禁止累积投票权,但亚太地区的组织备忘录和章程细则没有规定累积投票权。 | | | 特拉华州法律只有在章程规定的情况下才允许累积投票;然而,拟议的章程和拟议的公司章程并不授权累积投票。 | | | 特拉华州法律仅在公司的公司注册证书中有规定的情况下才允许累计投票;然而,Ligand当前修订和重新发布的公司注册证书并不授权累计投票。 | |
董事会空缺
|
| | 亚太地区的组织章程大纲和章程细则规定,亚太地区董事会的任何空缺,包括因董事会扩大而产生的空缺,可由当时在任的其余董事多数票填补,即使少于法定人数或由唯一剩余的董事填补。 | | | 建议的公司章程细则规定,新全方位抗体董事会的任何空缺,包括因董事会扩大而产生的空缺,只能由当时在任的其余董事(即使少于法定人数)或由唯一剩余的董事(不包括通过一个或多个已发行优先股系列的单独投票选出的任何董事)的多数票填补。 | | | Ligand修订和重述的公司注册证书规定,Ligand董事会的任何空缺,包括因董事会扩大而产生的空缺,可由当时在任的其余董事多数票填补,即使少于法定人数或由唯一剩余的董事填补。 | |
股东/股东书面同意诉讼
|
| | 由当其时有权收取股东大会通知、出席股东大会及于股东大会上投票的所有成员或其代表签署的书面决议案(包括特别决议案)的效力及作用,犹如该决议案已在亚太区正式召开及举行的股东大会上通过一样。 | | | 根据建议的公司章程细则,新OmniAb股东须采取或准许采取的任何行动必须在股东周年大会或特别会议上作出,不得以书面同意方式作出。尽管有上述规定,任何系列优先股持有人要求或允许采取的任何行动,可在与该系列优先股有关的适用指定证书明确规定的范围内,无需召开会议、无需事先通知和投票而采取。 | | |
根据Ligand的章程,股东不得采取任何行动,除非是在年度会议或特别会议上,不得采取任何行动
应由股东书面同意。
|
|
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
公司注册证书/公司章程大纲修正案
|
| | 亚太地区的组织章程大纲和章程细则规定,其组织章程大纲的大部分条款可由其成员通过特别决议进行修订,而与其股本有关的某些修订可由其成员通过普通决议进行。 | | |
根据特拉华州的法律,章程修正案一般需要获得新的OmniAb董事会的批准,以及当时已发行的有投票权股票的多数投票权,作为一个类别一起投票。
根据建议的公司章程细则,除DGCL要求的任何表决外,建议的公司章程细则的若干关键条款须由当时有权就该等股份投票的新OmniAb已发行股份总投票权的至少三分之二(662/3%)的持有人投赞成票才可修订,并作为一个类别一起投票。
|
| | 根据特拉华州法律,章程修正案一般需要得到董事会的批准,以及当时已发行的有投票权股票的多数投票权,作为一个类别一起投票。 | |
Amendment of the Bylaws
|
| | 亚太地区的组织备忘录和章程规定,除第29.4条和第47.2条外,其组织章程可由其成员通过特别决议予以修订。 | | |
根据拟议的附例,新的OmniAbBoard明确授权通过、修订或废除附例。
股东还有权通过、修订或废除章程;但是,除适用法律或拟议的公司注册证书(包括关于一个或多个优先股系列的任何指定证书)所要求的任何类别或系列新OmniAb股票的持有者投票外,股东通过、修订或废除章程应
|
| |
《Ligand章程》一般可由Ligand所有当时有权在董事选举中投票的流通股的多数表决权的赞成票通过;但章程的某些部分应要求持有至少66%(66-2/3%)有表决权的当时流通股的持有者投赞成票,才能改变或修改。
配对局也有权
|
|
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
| | | | | | 要求持有至少三分之二(66%和2/3%)投票权的所有当时有表决权股票的持有者投赞成票,这些股份一般有权在董事选举中投票,作为一个类别一起投票。 | | | amend the bylaws. | |
Quorum
|
| |
董事会。亚太地区董事会的多数成员,除非另有规定。
股东。三分之一的股份持有人为亲自出席或由受委代表出席的个人,或如公司或其他非自然人由其正式授权的代表或受委代表出席,则构成法定人数。
|
| |
董事会。在新的OmniAb董事会的所有会议上,除非建议的公司注册证书另有规定,否则董事总数的过半数构成处理业务的法定人数。
股东。在所有股东会议上,持有已发行和已发行股票的多数投票权并有权投票、亲自出席、或通过远程通信(如适用)或由其代表出席的股东应构成处理事务的法定人数。
|
| |
董事会。在Ligand董事会的所有会议上,大多数董事应构成处理业务的法定人数
股东。除法规或公司注册证书另有规定外,持有已发行和已发行股票的大多数并有权在会上投票的人,无论是亲自出席还是由受委代表出席,均构成股东处理业务的所有会议的法定人数。
|
|
Interested Directors
|
| | 任何人都不应被取消董事的资格,或被该办公室阻止作为卖方、买方或其他身份与亚太地区订立合同,任何此类合同或由亚太地区或代表亚太地区签订的任何合同或交易,如董事在其中以任何方式有利害关系,也不应被废止,任何如此订约或如此有利害关系的董事也不负责任 | | | 新的OmniAb将受DGCL第203条管辖。 | | | Ligand受DGCL第203条管辖。 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
| | | 任何该等合约或交易所实现或产生的任何利润,均须向亚太区结算,而该等合约或交易是由该等董事持有职位或由此而建立的受托关系所致。董事可就其有利害关系的任何合约或交易投票,但任何董事在该等合约或交易中的权益性质,须由其在审议该合约或交易及就该合约或交易投票时或之前披露。 | | | | | | | |
股东/股东特别大会
|
| | [br]董事、首席执行官或者董事长可以召集股东大会。 | | | 在一个或多个系列优先股持有人享有特别权利的规限下,为任何目的或任何目的,特别会议可于任何时间由新泛抗体董事会、新泛抗体董事会主席、行政总裁或总裁或在其指示下召开。 | | | 除非法规或公司注册证书另有规定,否则为任何一个或多个目的召开的股东特别会议,只能由Ligand董事会主席、Ligand董事会根据全体Ligand董事会多数成员批准的决议召开,或由Ligand秘书在收到一份或多份书面要求后召开,该书面要求要求根据章程第7条召开股东特别会议,并在符合章程第7条的规定的前提下,根据根据章程第7(D)条确定的记录日期,流通股至少10%(10%)的投票权 | |
| | |
APAC
|
| |
New OmniAb
|
| |
Ligand
|
|
| | | | | | | | | Ligand. | |
股东大会通知
|
| |
任何股东大会应至少提前五整天发出通知。每份通知均须指明会议的地点、日期和时间,以及在大会上处理的事务的一般性质,并须按下文所述的方式发出,或按亚太区议会所订明的其他方式发出,但如亚太区议会就以下事项达成协议,则须当作已妥为召开:
(A)如属周年大会,所有有权出席并在会上表决的成员;
and
(Br)(B)如为特别股东大会,有权出席会议并于会上表决的股东的过半数,合共持有给予该项权利的股份面值不少于95%。
|
| | 除非DGCL另有规定,否则任何股东大会的通知应在会议日期前不少于10天至不超过60天发送或以其他方式发给每一位有权在该会议上投票的股东。通知须列明召开会议的地点(如有)、日期及时间、远距离通讯方式(如有),使股东及受委代表可被视为亲身出席该会议并于会议上投票;如属特别会议,则须指明召开该会议的目的。 | | | 除非DGCL另有规定,否则任何股东大会的通知应在会议日期前不少于10天至不超过60天发送或以其他方式发给每一位有权在该会议上投票的股东。通知应指明会议的地点、日期和时间、股东和代表持有人可被视为亲自出席会议并在会议上投票的远程通信手段(如有),以及就特别会议而言,召开会议的目的。 | |
| Avista Public Acquisition Corp.II | | | | | | | |
|
在Avista Public Acquisition Corp.II财务报表中提及的‘’公司‘’指的是Avista Public Acquisition Corp.II。
|
| | | | | | |
|
独立注册会计师事务所报告
|
| | | | F-2 | | |
|
Balance Sheet as of December 31, 2021
|
| | | | F-3 | | |
|
2021年2月5日(初始)至2021年12月31日期间的运营说明书
|
| | | | F-4 | | |
|
2021年2月5日(初始)至2021年12月31日期间股东赤字变动报表
|
| | | | F-5 | | |
|
2021年2月5日(初始)至2021年12月31日期间现金流量表
|
| | | | F-6 | | |
|
财务报表附注
|
| | | | F-7 | | |
| Avista Public Acquisition Corp.II | | | | | | | |
|
在Avista Public Acquisition Corp.II财务报表中提及的‘’公司‘’指的是Avista Public Acquisition Corp.II。
|
| | |||||
|
截至2022年6月30日(未经审计)和2021年12月31日(已审计)的简明综合资产负债表
|
| | | | F-23 | | |
|
截至三个月和六个月的未经审计的简明合并经营报表
2022年6月30日,截至2021年6月30日的三个月,以及自2021年2月5日起 2021 (inception) Through June 30, 2021 |
| | | | F-24 | | |
|
三家公司股东权益(亏损)变动简明综合报表
截至2022年6月30日的六个月,截至2021年6月30日的三个月,以及截至2021年6月30日的期间 from February 5, 2021 (inception) Through June 30, 2021 |
| | | | F-25 | | |
|
截至2022年6月30日的6个月和2021年2月5日(开始)至2021年6月30日期间的未经审计的现金流量简明合并报表
|
| | | | F-26 | | |
|
未经审计的简明合并财务报表附注
|
| | | | F-27 | | |
| OmniAb, Inc. | | | | | | | |
|
独立注册会计师事务所报告
|
| | | | F-47 | | |
|
截至2021年12月31日和2020年12月31日的合并资产负债表
|
| | | | F-48 | | |
|
截至2021年12月、2020年和2019年12月的年度综合经营报表
|
| | | | F-49 | | |
|
截至2021年12月31日、2020年12月31日和2019年12月31日的母公司净投资变动表
|
| | | | F-50 | | |
|
截至2021年12月31日、2020年12月31日和2019年12月31日的年度现金流量表
|
| | | | F-51 | | |
|
合并财务报表附注
|
| | | | F-52 | | |
| OmniAb, Inc. | | | | | | | |
|
精简合并资产负债表
|
| | | | F-74 | | |
|
业务简明合并报表
|
| | | | F-75 | | |
|
母公司净投资变动简明合并报表
|
| | | | F-76 | | |
|
现金流量表简明合并报表
|
| | | | F-77 | | |
|
简明合并财务报表附注
|
| | | | F-78 | | |
| ASSETS | | | | | | | |
| Current assets: | | | | | | | |
|
Cash
|
| | | $ | 189,971 | | |
|
Prepaid expenses
|
| | | | 744,542 | | |
|
Total current assets
|
| | | | 934,513 | | |
|
信托账户中持有的现金
|
| | | | 235,750,000 | | |
|
TOTAL ASSETS
|
| | | $ | 236,684,513 | | |
| 负债和股东亏损 | | | | | | | |
| 流动负债: | | | | | | | |
|
Accounts payable
|
| | | | 15,440 | | |
|
Accrued expenses
|
| | | | 107,734 | | |
|
Accrued offering costs
|
| | | | 314,153 | | |
|
Due to related party
|
| | | | 884 | | |
|
流动负债总额
|
| | | | 438,211 | | |
|
应付延期承销费
|
| | | | 8,050,000 | | |
|
TOTAL LIABILITIES
|
| | | | 8,488,211 | | |
| Commitments (see Note 6) | | | | | | | |
|
A类普通股,面值0.0001美元,可能会被赎回;
23,000,000 shares at redemption value |
| | | | 235,750,000 | | |
| 股东亏损 | | | | | | | |
|
优先股,面值0.0001美元;授权500万股;
未发行且未偿还的债券 |
| | | | — | | |
|
A类普通股,面值0.0001美元;授权发行5亿股;
未发行和发行任何股份(不包括23,000,000股受 限制的股份 possible redemption) |
| | | | — | | |
|
B类普通股,面值0.0001美元;授权5000万股;
5,750,000 shares issued and outstanding |
| | | | 575 | | |
|
新增实收资本
|
| | | | — | | |
|
Accumulated deficit
|
| | | | (7,554,273) | | |
|
股东亏损总额
|
| | | | (7,553,698) | | |
|
总负债和股东赤字
|
| | | $ | 236,684,513 | | |
|
组建和运营成本
|
| | | $ | 516,442 | | |
|
Net loss
|
| | | $ | (516,442) | | |
| | | | | | | | |
|
基本和稀释后加权平均流通股,A类普通股
|
| | | | 9,857,143 | | |
|
A类普通股每股基本及摊薄净亏损
|
| | | $ | (0.03) | | |
|
基本和稀释后加权平均流通股、B类普通股
|
| | | | 5,321,429 | | |
|
B类普通股每股基本及摊薄净亏损
|
| | | $ | (0.03) | | |
| | |
Class A Ordinary Shares
|
| |
Class B Ordinary Shares
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance at February 5, 2021 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
向保荐人发行B类普通股
|
| | | | — | | | | | | — | | | | | | 5,750,000 | | | | | | 575 | | | | | | 24,425 | | | | | | — | | | | | | 25,000 | | |
分配给公开认股权证的首次公开发行(IPO)成本收益(扣除发行成本)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 9,232,604 | | | | | | — | | | | | | 9,232,604 | | |
向保荐人出售私募认股权证所得收益(扣除发行成本)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 12,298,375 | | | | | | — | | | | | | 12,298,375 | | |
重新计量A类普通股至赎回价值
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (21,555,404) | | | | | | (7,037,831) | | | | | | (28,593,235) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (516,442) | | | | | | (516,442) | | |
Balance at December 31, 2021
|
| | | | — | | | | | $ | — | | | | | | 5,750,000 | | | | | $ | 575 | | | | | $ | — | | | | | $ | (7,554,273) | | | | | $ | (7,553,698) | | |
| 经营活动现金流: | | | | | | | |
|
Net loss
|
| | | $ | (516,442) | | |
| 经营性资产和负债变动: | | | | | | | |
|
Prepaid expenses
|
| | | | (744,542) | | |
|
Accounts payable
|
| | | | 15,440 | | |
|
Due to related party
|
| | | | 884 | | |
|
Accrued expenses
|
| | | | 107,734 | | |
|
经营活动中使用的净现金
|
| | | | (1,136,926) | | |
| 投资活动现金流: | | | | | | | |
|
将现金投资到信托账户
|
| | | | (235,750,000) | | |
|
投资活动中使用的净现金
|
| | | | (235,750,000) | | |
| 融资活动的现金流: | | | | | | | |
|
向保荐人发行B类普通股所得款项
|
| | | | 25,000 | | |
|
首次公开发行的收益,扣除支付的承销商折扣后的净额
|
| | | | 225,400,000 | | |
|
出售私募认股权证的收益
|
| | | | 12,350,000 | | |
|
从赞助商备注中获得收益
|
| | | | 175,000 | | |
|
保荐人说明的偿还
|
| | | | (175,000) | | |
|
支付产品费用
|
| | | | (698,103) | | |
|
融资活动提供的现金净额
|
| | | | 237,076,897 | | |
|
Net change in cash
|
| | | | 189,971 | | |
|
Cash – beginning of period
|
| | | | — | | |
|
Cash – end of period
|
| | | $ | 189,971 | | |
| 非现金投融资活动 | | | | | | | |
|
重新计量A类普通股至赎回价值
|
| | | $ | 28,593,235 | | |
|
计入应计发售成本的发售成本
|
| | | $ | 314,153 | | |
|
应付延期承销费
|
| | | $ | 8,050,000 | | |
|
Gross proceeds
|
| | | $ | 230,000,000 | | |
| Less: | | | | | | | |
|
分配给公开认股权证的收益
|
| | | | (9,813,334) | | |
|
分配给A类普通股的发行成本
|
| | | | (13,029,901) | | |
| Plus: | | | | | | | |
|
账面价值增加到赎回价值
|
| | | | 28,593,235 | | |
|
可能赎回的A类普通股
|
| | | $ | 235,750,000 | | |
| | |
For the Period from February 5,
2021 (inception) Through December 31, 2021 |
| |||||||||
| | |
Class A
|
| |
Class B
|
| ||||||
每股基本和稀释后净亏损: | | | | | | | | | | | | | |
Numerator:
|
| | | | | | | | | | | | |
Net loss
|
| | | $ | (335,384) | | | | | $ | (181,058) | | |
Denominator:
|
| | | | | | | | | | | | |
基本和稀释后加权平均流通股
|
| | | | 9,857,143 | | | | | | 5,321,429 | | |
每股基本和摊薄净亏损
|
| | | $ | (0.03) | | | | | $ | (0.03) | | |
| | |
June 30, 2022
|
| |
December 31, 2021
|
| ||||||
| | |
(Unaudited)
|
| |
(Audited)
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash
|
| | | $ | 159,194 | | | | | $ | 189,971 | | |
Prepaid expenses
|
| | | | 532,817 | | | | | | 744,542 | | |
Total current assets
|
| | | | 692,011 | | | | | | 934,513 | | |
信托账户中持有的投资
|
| | | | 236,098,332 | | | | | | 235,750,000 | | |
TOTAL ASSETS
|
| | | $ | 236,790,343 | | | | | $ | 236,684,513 | | |
负债和股东亏损 | | | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 4,539,648 | | | | | $ | 15,440 | | |
Accrued expenses
|
| | | | 933,720 | | | | | | 107,734 | | |
Accrued offering costs
|
| | | | 314,153 | | | | | | 314,153 | | |
可转换本票
|
| | | | 750,000 | | | | | | — | | |
Due to related party
|
| | | | 57,666 | | | | | | 884 | | |
衍生品 - 远期购买和后盾证券
|
| | | | 383,390 | | | | | | — | | |
流动负债总额
|
| | | | 6,978,577 | | | | | | 438,211 | | |
应付延期承销费
|
| | | | 8,050,000 | | | | | | 8,050,000 | | |
TOTAL LIABILITIES
|
| | | | 15,028,577 | | | | | | 8,488,211 | | |
Commitments (see Note 6) | | | | | | | | | | | | | |
A类普通股,面值0.0001美元,可能赎回;赎回价值2300万股
|
| | | | 236,098,332 | | | | | | 235,750,000 | | |
股东亏损 | | | | | | | | | | | | | |
优先股,面值0.0001美元;授权500万股;无
issued and outstanding |
| | | | — | | | | | | — | | |
A类普通股,面值0.0001美元;授权股份5亿股;无已发行和流通股(不包括可能赎回的2300万股)
|
| | | | — | | | | | | — | | |
B类普通股,面值0.0001美元;授权发行5000万股;已发行和已发行股票575万股
|
| | | | 575 | | | | | | 575 | | |
新增实收资本
|
| | | | — | | | | | | — | | |
Accumulated deficit
|
| | | | (14,337,141) | | | | | | (7,554,273) | | |
股东亏损总额
|
| | | | (14,336,566) | | | | | | (7,553,698) | | |
总负债和股东赤字
|
| | | $ | 236,790,343 | | | | | $ | 236,684,513 | | |
| | |
Three Months
Ended June 30, 2022 |
| |
Three Months
Ended June 30, 2021 |
| |
Six Months
Ended June 30, 2022 |
| |
For the Period
from February 5, 2021 (inception) through June 30, 2021 |
| ||||||||||||
组建和运营成本
|
| | | $ | 2,578,263 | | | | | $ | 2,185 | | | | | $ | 6,399,478 | | | | | $ | 9,971 | | |
Loss from operations
|
| | | | (2,578,263) | | | | | | (2,185) | | | | | | (6,399,478) | | | | | | (9,971) | | |
信托账户中的投资收益
|
| | | | 297,047 | | | | | | — | | | | | | 348,332 | | | | | | — | | |
远期购买公允价值变动和
Backstop Securities |
| | | | 656,300 | | | | | | — | | | | | | 64,990 | | | | | | — | | |
Net loss
|
| | | $ | (1,624,916) | | | | | $ | (2,185) | | | | | $ | (5,986,156) | | | | | $ | (9,971) | | |
视为股息 - 远期购买和后盾证券
|
| | | | — | | | | | | — | | | | | | (225,000) | | | | | | — | | |
普通股股东应占净亏损
|
| | | $ | (1,624,916) | | | | | $ | (2,185) | | | | | $ | (6,211,156) | | | | | $ | (9,971) | | |
基本和稀释后加权平均流通股,A类普通股
|
| | | | 23,000,000 | | | | | | — | | | | | | 23,000,000 | | | | | | — | | |
A类普通股每股基本及摊薄净亏损
|
| | | $ | (0.06) | | | | | $ | — | | | | | $ | (0.21) | | | | | $ | — | | |
基本和稀释后加权平均流通股,B类普通股(1)
|
| | | | 5,750,000 | | | | | | 5,000,000 | | | | | | 5,750,000 | | | | | | 5,000,000 | | |
B类普通股每股基本及摊薄净亏损
|
| | | $ | (0.06) | | | | | $ | (0.00) | | | | | $ | (0.21) | | | | | $ | (0.00) | | |
| | |
Class A
Ordinary Shares |
| |
Class B
Ordinary Shares |
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholder’s Deficit |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance at January 1, 2022
|
| | | | — | | | | | $ | — | | | | | | 5,750,000 | | | | | $ | 575 | | | | | $ | — | | | | | $ | (7,554,273) | | | | | $ | (7,553,698) | | |
远期采购协议重新分类
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (223,380) | | | | | | (223,380) | | |
视为股息 - 远期购买和支持证券
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (225,000) | | | | | | (225,000) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,361,240) | | | | | | (4,361,240) | | |
Balance at March 31, 2022
|
| | | | — | | | | | | — | | | | | | 5,750,000 | | | | | | 575 | | | | | | — | | | | | | (12,363,893) | | | | | | (12,363,318) | | |
A类普通股重新计量至赎回金额
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (348,332) | | | | | | (348,332) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,624,916) | | | | | | (1,624,916) | | |
Balance at June 30, 2022
|
| | | | — | | | | | $ | — | | | | | | 5,750,000 | | | | | $ | 575 | | | | | $ | — | | | | | $ | (14,337,141) | | | | | $ | (14,336,566) | | |
| | |
Class A Ordinary
Shares |
| |
Class B Ordinary
Shares |
| |
Additional
Paid- in Capital |
| |
Accumulated
Deficit |
| |
Total
Shareholders’ Equity |
| |||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance at February 5, 2021 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
向保荐人发行B类普通股(1)
|
| | | | — | | | | | | — | | | | | | 5,750,000 | | | | | | 575 | | | | | | 24,425 | | | | | | — | | | | | | 25,000 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (7,786) | | | | | | (7,786) | | |
Balance at March 31, 2021
|
| | | | — | | | | | | — | | | | | | 5,750,000 | | | | | | 575 | | | | | | 24,425 | | | | | | (7,786) | | | | | | 17,214 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (2,185) | | | | | | (2,185) | | |
Balance at June 30, 2021
|
| | | | — | | | | | $ | — | | | | | | 5,750,000 | | | | | $ | 575 | | | | | $ | 24,425 | | | | | $ | (9,971) | | | | | $ | 15,029 | | |
| | |
Six Months
Ended June 30, 2022 |
| |
For the Period
from February 5, 2021 (inception) through June 30, 2021 |
| ||||||
经营活动现金流: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (5,986,156) | | | | | $ | (9,971) | | |
将净亏损与经营活动中使用的现金净额进行调整: | | | | | | | | | | | | | |
信托账户中的投资收益
|
| | | | (348,332) | | | | | | — | | |
远期买入和后备证券公允价值变动
|
| | | | (64,990) | | | | | | — | | |
保荐人为换取发行B类普通股支付的组建费用
|
| | | | — | | | | | | 9,961 | | |
经营性资产和负债变动: | | | | | | | | | | | | | |
Prepaid expenses
|
| | | | 211,725 | | | | | | — | | |
Accounts payable
|
| | | | 4,524,208 | | | | | | — | | |
Due to related party
|
| | | | 56,782 | | | | | | 5 | | |
Accrued expenses
|
| | | | 825,986 | | | | | | — | | |
经营活动中使用的净现金
|
| | | | (780,777) | | | | | | (5) | | |
融资活动的现金流: | | | | | | | | | | | | | |
本票 - 关联方收益
|
| | | | — | | | | | | 119,275 | | |
支付产品费用
|
| | | | — | | | | | | (83,125) | | |
可转换本票收益
|
| | | | 750,000 | | | | | | — | | |
融资活动提供的现金净额
|
| | | | 750,000 | | | | | | 36,150 | | |
Net Change in Cash
|
| | | | (30,777) | | | | | | 36,145 | | |
Cash – Beginning of period
|
| | | | 189,971 | | | | | | — | | |
Cash – End of period
|
| | | $ | 159,194 | | | | | $ | 36,145 | | |
补充披露非现金投融资活动: | | | | | | | | | | | | | |
应赎回的A类普通股重新计量至赎回金额
|
| | | $ | 348,332 | | | | | $ | — | | |
远期买入和后备证券的初步分类
|
| | | $ | 448,380 | | | | | $ | — | | |
保荐人为换取发行B类普通股而支付的延期发行费用
|
| | | $ | — | | | | | $ | 15,039 | | |
本票 - 关联方包含的延期发售成本
|
| | | $ | — | | | | | $ | 55,725 | | |
计入应计发售成本的延期发售成本
|
| | | $ | — | | | | | $ | 443,381 | | |
|
Gross proceeds
|
| | | $ | 230,000,000 | | |
| Less: | | | | | | | |
|
分配给公开认股权证的收益
|
| | | | (9,813,334) | | |
|
分配给A类普通股的发行成本
|
| | | | (13,029,901) | | |
| Plus: | | | | | | | |
|
账面价值增加到赎回价值
|
| | | | 28,593,235 | | |
|
可能赎回的A类普通股,2021年12月31日
|
| | | $ | 235,750,000 | | |
| Plus: | | | | | | | |
|
A类普通股重新计量至赎回金额
|
| | | $ | 348,332 | | |
|
可能赎回的A类普通股,2022年6月30日
|
| | | $ | 236,098,332 | | |
| | |
Three Months Ended
June 30, 2022 |
| |
Three Months Ended
June 30, 2021 |
| |
Six Months Ended
June 30, 2022 |
| |
For the Period from
February 5, 2021 (Inception) Through June 30, 2021 |
| ||||||||||||||||||||||||||||||||||||
| | |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
| |
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||
每单位基本和摊薄净亏损
share: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,299,933) | | | | | $ | (324,983) | | | | | $ | — | | | | | $ | (2,185) | | | | | $ | (4,788,925) | | | | | $ | (1,197,231) | | | | | $ | — | | | | | $ | (9,971) | | |
Denominator:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本和稀释后加权平均流通股
|
| | | | 23,000,000 | | | | | | 5,750,000 | | | | | | — | | | | | | 5,000,000 | | | | | | 23,000,000 | | | | | | 5,750,000 | | | | | | — | | | | | | 5,000,000 | | |
每股基本和摊薄净亏损
|
| | | $ | (0.06) | | | | | $ | (0.06) | | | | | $ | — | | | | | $ | (0.00) | | | | | $ | (0.21) | | | | | $ | (0.21) | | | | | $ | — | | | | | $ | (0.00) | | |
Description
|
| |
Amount at
Fair Value |
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| ||||||||||||
June 30, 2022 | | | | | | | | | | | | | | | | | | | | | | | | | |
Assets
|
| | | | | | | | | | | | | | | | | | | | | | | | |
信托账户中持有的投资
|
| | | $ | 236,098,332 | | | | | $ | 236,098,332 | | | | | $ | — | | | | | $ | — | | |
Liabilities
|
| | | | | | | | | | | | | | | | | | | | | | | | |
衍生负债 - 远期购买和支持证券
|
| | | $ | 383,390 | | | | | $ | — | | | | | $ | — | | | | | $ | 383,390 | | |
| | |
As of March 23, 2022
(Initial Measurement) |
| |||
远期买入和后备证券的公允价值
|
| | | $ | 10.34 | | |
远期买入和后备证券现值
|
| | | $ | 10.00 | | |
业务合并时间(年)
|
| | | | 0.52 | | |
Risk-free rate
|
| | | | 0.95% | | |
Discount factor
|
| | | | 99.50% | | |
预期赎回率
|
| | | | 85.00% | | |
完成初始业务合并的概率
|
| | | | 32.50% | | |
远期买入和后备证券的公允价值
|
| | | $ | 448,380 | | |
| | |
At June 30,
2022 |
| |||
Fair value of unit
|
| | | $ | 10.08 | | |
Unit forward price
|
| | | $ | 10.00 | | |
业务合并时间(年)
|
| | | | 0.25 | | |
Risk-free rate
|
| | | | 1.72% | | |
Discount factor
|
| | | | 99.60% | | |
预期赎回率
|
| | | | 85.00% | | |
完成初始业务合并的概率
|
| | | | 20.00% | | |
远期买入和后备证券的公允价值
|
| | | $ | 383,390 | | |
|
Fair value as of December 31, 2021
|
| | | $ | — | | |
|
Initial measurement as of March 23, 2022
|
| | | | 448,380 | | |
|
Change in fair value
|
| | | | 591,310 | | |
|
Fair value as of March 31, 2022
|
| | | | 1,039,690 | | |
|
Change in fair value
|
| | | | (656,300) | | |
|
Fair value as of June 30,2022
|
| | | $ | 383,390 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
| | | | | | | | |
As Restated
|
| |||
ASSETS
|
| | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | $ | 21,136 | | | | | $ | 15,875 | | |
Other current assets
|
| | | | 1,406 | | | | | | 774 | | |
Total current assets
|
| | | | 22,542 | | | | | | 16,649 | | |
Intangible assets, net
|
| | | | 176,321 | | | | | | 186,644 | | |
Goodwill
|
| | | | 83,979 | | | | | | 83,979 | | |
财产和设备,净额
|
| | | | 6,795 | | | | | | 3,480 | | |
Operating lease assets
|
| | | | 13,332 | | | | | | 2,499 | | |
Other assets
|
| | | | 1,496 | | | | | | 2,129 | | |
Total assets
|
| | | $ | 304,465 | | | | | $ | 295,380 | | |
负债和母公司净投资
|
| | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 2,924 | | | | | $ | 469 | | |
Accrued liabilities
|
| | | | 3,746 | | | | | | 3,956 | | |
或有负债的流动部分
|
| | | | 2,538 | | | | | | 2,115 | | |
递延收入的当前部分
|
| | | | 10,790 | | | | | | 7,157 | | |
经营租赁负债的当期部分
|
| | | | 578 | | | | | | 579 | | |
融资租赁负债的当期部分
|
| | | | 1 | | | | | | 1 | | |
流动负债总额
|
| | | | 20,577 | | | | | | 14,277 | | |
长期或有负债
|
| | | | 4,826 | | | | | | 5,089 | | |
递延所得税净额
|
| | | | 21,962 | | | | | | 28,925 | | |
长期经营租赁负债
|
| | | | 13,272 | | | | | | 2,012 | | |
递延收入的长期部分
|
| | | | 9,226 | | | | | | 8,232 | | |
其他长期负债
|
| | | | 295 | | | | | | 1,308 | | |
Total liabilities
|
| | | | 70,158 | | | | | | 59,843 | | |
承付款和或有事项(附注10) | | | | | | | | | | | | | |
母公司净投资: | | | | | | | | | | | | | |
母公司净投资
|
| | | | 234,307 | | | | | | 235,537 | | |
总负债和母公司净投资
|
| | | $ | 304,465 | | | | | $ | 295,380 | | |
| | |
Year Ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
| | | | | | | | |
As Restated
|
| |
As Restated
|
| ||||||
Revenues: | | | | | | | | | | | | | | | | | | | |
许可证和里程碑收入
|
| | | $ | 14,664 | | | | | $ | 11,385 | | | | | $ | 12,750 | | |
Service revenue
|
| | | | 20,084 | | | | | | 11,883 | | | | | | 5,568 | | |
Total revenue
|
| | | | 34,748 | | | | | | 23,268 | | | | | | 18,318 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | |
研发
|
| | | | 39,232 | | | | | | 24,796 | | | | | | 13,208 | | |
一般和行政
|
| | | | 16,947 | | | | | | 10,225 | | | | | | 8,651 | | |
无形资产摊销
|
| | | | 12,968 | | | | | | 11,800 | | | | | | 10,304 | | |
其他运营费用(收入),净额
|
| | | | 1,210 | | | | | | 2,070 | | | | | | (818) | | |
总运营费用
|
| | | | 70,357 | | | | | | 48,891 | | | | | | 31,345 | | |
Loss from operations
|
| | | | (35,609) | | | | | | (25,623) | | | | | | (13,027) | | |
Other income (expense): | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (7) | | | | | | (5) | | | | | | — | | |
Other income, net
|
| | | | 1,266 | | | | | | 1,900 | | | | | | — | | |
Total other income
|
| | | | 1,259 | | | | | | 1,895 | | | | | | — | | |
Loss before income tax
|
| | | | (34,350) | | | | | | (23,728) | | | | | | (13,027) | | |
所得税优惠(费用)
|
| | | | 7,308 | | | | | | 6,171 | | | | | | (562) | | |
Net loss
|
| | | $ | (27,042) | | | | | $ | (17,557) | | | | | $ | (13,589) | | |
| | |
Parent company
net investment |
| |||
Opening balance at January 1, 2019
|
| | | $ | 204,882 | | |
Net loss (as restated)
|
| | | | (13,589) | | |
股份薪酬的母公司分配
|
| | | | 6,660 | | |
母公司净转账(重述)
|
| | | | 20,290 | | |
Balance at December 31, 2019 (as restated)
|
| | | | 218,243 | | |
Net loss (as restated)
|
| | | | (17,557) | | |
股份薪酬的母公司分配
|
| | | | 9,165 | | |
母公司净转账(重述)
|
| | | | 25,686 | | |
Balance at December 31, 2020 (as restated)
|
| | | | 235,537 | | |
Net loss
|
| | | | (27,042) | | |
股份薪酬的母公司分配
|
| | | | 15,065 | | |
母公司净转账
|
| | | | 10,747 | | |
Balance at December 31, 2021
|
| | | $ | 234,307 | | |
| | |
Year Ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
| | | | | | | | |
As Restated
|
| |
As Restated
|
| ||||||
经营活动 | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (27,042) | | | | | $ | (17,557) | | | | | $ | (13,589) | | |
将净亏损与经营活动提供(用于)的现金净额进行调整:
|
| | | | | | | | | | | | | | | | | | |
或有负债估计公允价值变动
|
| | | | 1,210 | | | | | | 2,070 | | | | | | (818) | | |
折旧及摊销
|
| | | | 16,252 | | | | | | 13,137 | | | | | | 10,917 | | |
基于股份的薪酬
|
| | | | 15,065 | | | | | | 9,165 | | | | | | 6,660 | | |
递延所得税净额
|
| | | | (7,325) | | | | | | (6,185) | | | | | | 557 | | |
短期投资收益
|
| | | | (1,265) | | | | | | — | | | | | | — | | |
出售知识产权许可的收益
|
| | | | — | | | | | | (1,900) | | | | | | — | | |
Other
|
| | | | 64 | | | | | | 161 | | | | | | — | | |
扣除收购后的营业资产和负债变动:
|
| | | | | | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | | 6,019 | | | | | | 339 | | | | | | (4,290) | | |
Other current assets
|
| | | | (632) | | | | | | (497) | | | | | | (14) | | |
Other long-term assets
|
| | | | (938) | | | | | | 1,621 | | | | | | (20) | | |
应付账款和应计负债
|
| | | | 1,513 | | | | | | 2,759 | | | | | | (570) | | |
Deferred revenue
|
| | | | (6,717) | | | | | | 1,328 | | | | | | (1,875) | | |
其他长期负债
|
| | | | (1,876) | | | | | | (822) | | | | | | (2,153) | | |
经营活动提供(使用)的现金净额
|
| | | | (5,672) | | | | | | 3,619 | | | | | | (5,195) | | |
投资活动 | | | | | | | | | | | | | | | | | | | |
出售短期投资的收益
|
| | | | 1,265 | | | | | | — | | | | | | — | | |
为收购支付的现金,扣除现金和限制现金获得的净额
|
| | | | — | | | | | | (27,127) | | | | | | (11,840) | | |
购置房产和设备
|
| | | | (4,070) | | | | | | (1,753) | | | | | | (255) | | |
出售知识产权许可的收益
|
| | | | — | | | | | | 1,900 | | | | | | — | | |
Payments to CVR holders
|
| | | | (720) | | | | | | — | | | | | | — | | |
Other
|
| | | | (500) | | | | | | — | | | | | | — | | |
投资活动中使用的净现金
|
| | | | (4,025) | | | | | | (26,980) | | | | | | (12,095) | | |
融资活动 | | | | | | | | | | | | | | | | | | | |
Payment to CVR holders
|
| | | | (1,050) | | | | | | (2,325) | | | | | | (3,000) | | |
Net transfer from parent
|
| | | | 10,747 | | | | | | 25,686 | | | | | | 20,290 | | |
融资活动提供的现金净额
|
| | | | 9,697 | | | | | | 23,361 | | | | | | 17,290 | | |
现金、现金等价物和受限现金净增长
|
| | | | — | | | | | | — | | | | | | — | | |
年初的现金、现金等价物和限制性现金
|
| | | | — | | | | | | — | | | | | | — | | |
年终现金、现金等价物和限制性现金
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
现金流量信息补充披露: | | | | | | | | | | | | | | | | | | | |
在应收账款中记录的递延收入
|
| | | $ | 11,344 | | | | | $ | 8,451 | | | | | $ | 1,425 | | |
在应付账款中记录的固定资产购置
|
| | | $ | 1,231 | | | | | $ | — | | | | | $ | 471 | | |
| | |
December 31, 2020
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
Assets: | | | | | | | | | | | | | | | | | | | |
Accounts receivable
|
| | | $ | 8,870 | | | | | $ | 7,005 | | | | | $ | 15,875 | | |
Total current assets
|
| | | $ | 9,644 | | | | | $ | 7,005 | | | | | $ | 16,649 | | |
Intangible assets, net
|
| | | $ | 186,592 | | | | | $ | 52 | | | | | $ | 186,644 | | |
Goodwill
|
| | | $ | 84,066 | | | | | $ | (87) | | | | | $ | 83,979 | | |
Total assets
|
| | | $ | 288,410 | | | | | $ | 6,970 | | | | | $ | 295,380 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
Accrued liabilities
|
| | | $ | 3,456 | | | | | $ | 500 | | | | | $ | 3,956 | | |
融资租赁负债的当期部分
|
| | | $ | 14 | | | | | $ | (13) | | | | | $ | 1 | | |
流动负债总额
|
| | | $ | 13,790 | | | | | $ | 487 | | | | | $ | 14,277 | | |
递延所得税净额
|
| | | $ | 29,185 | | | | | $ | (260) | | | | | $ | 28,925 | | |
其他长期负债
|
| | | $ | 1,295 | | | | | $ | 13 | | | | | $ | 1,308 | | |
Total liabilities
|
| | | $ | 59,603 | | | | | $ | 240 | | | | | $ | 59,843 | | |
母公司净投资: | | | | | | | | | | | | | | | | | | | |
母公司净投资
|
| | | $ | 228,807 | | | | | $ | 6,730 | | | | | $ | 235,537 | | |
总负债和母公司净投资
|
| | | $ | 288,410 | | | | | $ | 6,970 | | | | | $ | 295,380 | | |
| | |
Year ended December 31, 2020
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
研发
|
| | | $ | 24,894 | | | | | $ | (98) | | | | | $ | 24,796 | | |
一般和行政
|
| | | $ | 10,240 | | | | | $ | (15) | | | | | $ | 10,225 | | |
总运营费用
|
| | | $ | 49,004 | | | | | $ | (113) | | | | | $ | 48,891 | | |
Loss from operations
|
| | | $ | (25,736) | | | | | $ | 113 | | | | | $ | (25,623) | | |
Loss before income tax
|
| | | $ | (23,841) | | | | | $ | 113 | | | | | $ | (23,728) | | |
所得税优惠(费用)
|
| | | $ | 5,945 | | | | | $ | 226 | | | | | $ | 6,171 | | |
Net loss
|
| | | $ | (17,896) | | | | | $ | 339 | | | | | $ | (17,557) | | |
| | |
December 31, 2020
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
母公司净投资 - 2020年1月1日
|
| | | $ | 218,185 | | | | | $ | 58 | | | | | $ | 218,243 | | |
Net loss
|
| | | $ | (17,896) | | | | | $ | 339 | | | | | $ | (17,557) | | |
母公司净转账
|
| | | $ | 19,353 | | | | | $ | 6,333 | | | | | $ | 25,686 | | |
母公司净投资 - 2020年12月31日
|
| | | $ | 228,807 | | | | | $ | 6,730 | | | | | $ | 235,537 | | |
| | |
Year ended December 31, 2020
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
经营活动: | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (17,896) | | | | | $ | 339 | | | | | $ | (17,557) | | |
将净亏损与经营活动提供(用于)的现金净额进行调整:
|
| | | | | | | | | | | | | | | | | | |
递延所得税净额
|
| | | $ | (5,960) | | | | | $ | (225) | | | | | $ | (6,185) | | |
Other
|
| | | $ | — | | | | | $ | 161 | | | | | $ | 161 | | |
扣除收购后的营业资产和负债变动:
|
| | | | | | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | $ | (1,096) | | | | | $ | 1,435 | | | | | $ | 339 | | |
应付账款和应计负债
|
| | | $ | 2,337 | | | | | $ | 422 | | | | | $ | 2,759 | | |
Deferred revenue
|
| | | $ | 9,779 | | | | | $ | (8,451) | | | | | $ | 1,328 | | |
Other
|
| | | $ | 1,323 | | | | | $ | (14) | | | | | $ | 1,309 | | |
经营活动提供的现金净额
|
| | | $ | 9,952 | | | | | $ | (6,333) | | | | | $ | 3,619 | | |
融资活动: | | | | | | | | | | | | | | | | | | | |
Net transfer from parent
|
| | | $ | 19,353 | | | | | $ | 6,333 | | | | | $ | 25,686 | | |
融资活动提供的现金净额
|
| | | $ | 17,028 | | | | | $ | 6,333 | | | | | $ | 23,361 | | |
现金流量信息补充披露: | | | | | | | | | | | | | | | | | | | |
在应收账款中记录的递延收入
|
| | | $ | — | | | | | $ | 8,451 | | | | | $ | 8,451 | | |
| | |
December 31, 2019
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
Assets: | | | | | | | | | | | | | | | | | | | |
Accounts receivable
|
| | | $ | 7,774 | | | | | $ | 150 | | | | | $ | 7,924 | | |
Total current assets
|
| | | $ | 7,795 | | | | | $ | 150 | | | | | $ | 7,945 | | |
Goodwill
|
| | | $ | 77,108 | | | | | $ | (86) | | | | | $ | 77,022 | | |
Total assets
|
| | | $ | 262,320 | | | | | $ | 64 | | | | | $ | 262,384 | | |
Liabilities: | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 806 | | | | | $ | 71 | | | | | $ | 877 | | |
融资租赁负债的当期部分
|
| | | $ | — | | | | | $ | 7 | | | | | $ | 7 | | |
流动负债总额
|
| | | $ | 6,139 | | | | | $ | 78 | | | | | $ | 6,217 | | |
递延所得税净额
|
| | | $ | 35,388 | | | | | $ | (86) | | | | | $ | 35,302 | | |
其他长期负债
|
| | | $ | 295 | | | | | $ | 14 | | | | | $ | 309 | | |
Total liabilities
|
| | | $ | 44,135 | | | | | $ | 6 | | | | | $ | 44,141 | | |
母公司净投资: | | | | | | | | | | | | | | | | | | | |
母公司净投资
|
| | | $ | 218,185 | | | | | $ | 58 | | | | | $ | 218,243 | | |
总负债和母公司净投资
|
| | | $ | 262,320 | | | | | $ | 64 | | | | | $ | 262,384 | | |
| | |
Year ended December 31, 2019
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
许可证和里程碑收入
|
| | | $ | 12,685 | | | | | $ | 65 | | | | | $ | 12,750 | | |
Service revenue
|
| | | $ | 5,528 | | | | | $ | 40 | | | | | $ | 5,568 | | |
Total revenue
|
| | | $ | 18,213 | | | | | $ | 105 | | | | | $ | 18,318 | | |
研发
|
| | | $ | 13,137 | | | | | $ | 71 | | | | | $ | 13,208 | | |
一般和行政
|
| | | $ | 7,976 | | | | | $ | 675 | | | | | $ | 8,651 | | |
总运营费用
|
| | | $ | 30,599 | | | | | $ | 746 | | | | | $ | 31,345 | | |
Loss from operations
|
| | | $ | (12,386) | | | | | $ | (641) | | | | | $ | (13,027) | | |
Loss before income tax
|
| | | $ | (12,386) | | | | | $ | (641) | | | | | $ | (13,027) | | |
所得税优惠(费用)
|
| | | $ | (657) | | | | | $ | 95 | | | | | $ | (562) | | |
Net loss
|
| | | $ | (13,043) | | | | | $ | (546) | | | | | $ | (13,589) | | |
| | |
December 31, 2019
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
Net loss
|
| | | $ | (13,043) | | | | | $ | (546) | | | | | $ | (13,589) | | |
母公司净转账
|
| | | $ | 19,686 | | | | | $ | 604 | | | | | $ | 20,290 | | |
母公司净投资 - 2019年12月31日
|
| | | $ | 218,185 | | | | | $ | 58 | | | | | $ | 218,243 | | |
| | |
Year ended December 31, 2019
|
| |||||||||||||||
| | |
Reported
|
| |
Adjustment
|
| |
Restated
|
| |||||||||
经营活动: | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (13,043) | | | | | $ | (546) | | | | | $ | (13,589) | | |
将净亏损与经营活动提供(用于)的现金净额进行调整:
|
| | | | | | | | | | | | | | | | | | |
递延所得税净额
|
| | | $ | 653 | | | | | $ | (96) | | | | | $ | 557 | | |
扣除收购后的营业资产和负债变动:
|
| | | | | | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | $ | (5,565) | | | | | $ | 1,275 | | | | | $ | (4,290) | | |
应付账款和应计负债
|
| | | $ | (648) | | | | | $ | 78 | | | | | $ | (570) | | |
Deferred revenue
|
| | | $ | (450) | | | | | $ | (1,425) | | | | | $ | (1,875) | | |
Other
|
| | | $ | (1,959) | | | | | $ | 110 | | | | | $ | (1,849) | | |
经营活动中使用的净现金
|
| | | $ | (4,591) | | | | | $ | (604) | | | | | $ | (5,195) | | |
融资活动: | | | | | | | | | | | | | | | | | | | |
Net transfer from parent
|
| | | $ | 19,686 | | | | | $ | 604 | | | | | $ | 20,290 | | |
融资活动提供的现金净额
|
| | | $ | 16,686 | | | | | $ | 604 | | | | | $ | 17,290 | | |
现金流量信息补充披露: | | | | | | | | | | | | | | | | | | | |
在应收账款中记录的递延收入
|
| | | $ | — | | | | | $ | 1,425 | | | | | $ | 1,425 | | |
| | |
Year-ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019(1)
|
| |||||||||
Partner A
|
| | | | 28% | | | | | | 26% | | | | | | 17% | | |
Partner B
|
| | | | 24% | | | | | | 21% | | | | | | 12% | | |
Partner C
|
| | | | 11% | | | | | | 10% | | | | | | 11% | | |
| | |
Year ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
License fees
|
| | | $ | 4,500 | | | | | $ | 4,260 | | | | | $ | 5,700 | | |
Milestone revenue
|
| | | | 10,164 | | | | | | 7,125 | | | | | | 7,050 | | |
Service revenue
|
| | | | 20,084 | | | | | | 11,883 | | | | | | 5,568 | | |
| | | | $ | 34,748 | | | | | $ | 23,268 | | | | | $ | 18,318 | | |
|
母公司净投资中包含的现金
|
| | | $ | 47 | | |
|
采用有限寿命 - 核心技术的无形资产
|
| | | | 5,155 | | |
| | | | | $ | 5,202 | | |
|
包括在母公司净投资和其他资产中的现金
|
| | | $ | 240 | | |
|
Accrued liabilities
|
| | | | (142) | | |
|
递延纳税负债净额
|
| | | | (320) | | |
|
采用有限寿命 - 核心技术的无形资产
|
| | | | 7,298 | | |
| | | | | $ | 7,076 | | |
|
财产和设备,净额
|
| | | $ | 1,173 | | |
|
预付款和其他资产
|
| | | | 588 | | |
|
Liabilities assumed
|
| | | | (812) | | |
|
Deferred revenue
|
| | | | (3,685) | | |
|
Deferred tax assets, net
|
| | | | 821 | | |
|
Acquired intangibles
|
| | | | 12,800 | | |
| Goodwill(1) | | | | | 9,055 | | |
| | | | | $ | 19,940 | | |
|
Cash and other assets
|
| | | $ | 28 | | |
|
应付账款和应计负债
|
| | | | (83) | | |
|
递延纳税负债净额
|
| | | | (196) | | |
|
采用有限寿命 - 核心技术的无形资产
|
| | | | 7,400 | | |
| Goodwill(1) | | | | | 4,862 | | |
| | | | | $ | 12,011 | | |
| | |
December 31, 2021
|
| |
December 31, 2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
水晶或有负债(1)
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 800 | | | | | $ | 800 | | |
Icagen或有负债(2)
|
| | | | — | | | | | | — | | | | | | 7,364 | | | | | | 7,364 | | | | | | — | | | | | | — | | | | | | 6,404 | | | | | | 6,404 | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 7,364 | | | | | $ | 7,364 | | | | | $ | — | | | | | $ | — | | | | | $ | 7,204 | | | | | $ | 7,204 | | |
|
截至2020年1月1日的3级金融工具的公允价值
|
| | | $ | 2,659 | | |
|
对CVR持有人的付款和其他或有付款
|
| | | | (2,325) | | |
|
或有负债的公允价值调整
|
| | | | 2,070 | | |
|
收购ICAGEN的或有负债
|
| | | | 4,800 | | |
|
截至2020年12月31日的3级金融工具的公允价值
|
| | | $ | 7,204 | | |
|
或有负债付款
|
| | | | (1,770) | | |
|
或有负债的公允价值调整
|
| | | | 1,210 | | |
|
xCella资产收购的或有负债(1)
|
| | | | 720 | | |
| | | | | $ | 7,364 | | |
| | |
December 31,
2021 |
| |
December 31,
2020 |
| ||||||
Assets | | | | | | | | | | | | | |
Operating lease assets
|
| | | $ | 13,332 | | | | | $ | 2,499 | | |
Liabilities | | | | | | | | | | | | | |
当期经营租赁负债
|
| | | | 578 | | | | | | 579 | | |
长期经营租赁负债
|
| | | | 13,272 | | | | | | 2,012 | | |
经营租赁总负债
|
| | | $ | 13,850 | | | | | $ | 2,591 | | |
Maturity Dates
|
| |
Operating
Leases |
| |||
2022
|
| | | $ | 2,122 | | |
2023
|
| | | | 2,178 | | |
2024
|
| | | | 2,249 | | |
2025
|
| | | | 2,384 | | |
2026
|
| | | | 2,433 | | |
Thereafter
|
| | | | 10,414 | | |
Total lease payments
|
| | | | 21,780 | | |
Less imputed interest
|
| | | | (3,603) | | |
租户改善津贴减少
|
| | | | (4,327) | | |
经营租赁负债现值
|
| | | $ | 13,850 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Lab and office equipment
|
| | | $ | 6,410 | | | | | $ | 3,872 | | |
租赁改进
|
| | | | 3,495 | | | | | | 732 | | |
计算机设备和软件
|
| | | | 182 | | | | | | 182 | | |
| | | | | 10,087 | | | | | | 4,786 | | |
减去累计折旧和摊销
|
| | | | (3,292) | | | | | | (1,306) | | |
| | | | $ | 6,795 | | | | | $ | 3,480 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
活着的无限无形资产 | | | | | | | | | | | | | |
Goodwill
|
| | | $ | 83,979 | | | | | $ | 83,979 | | |
已确定的无形资产 | | | | | | | | | | | | | |
Complete technology
|
| | | | 227,403 | | | | | | 224,758 | | |
减去:累计摊销
|
| | | | (60,099) | | | | | | (48,321) | | |
客户关系
|
| | | | 11,100 | | | | | | 11,100 | | |
减去:累计摊销
|
| | | | (2,083) | | | | | | (893) | | |
总商誉和其他可识别无形资产净额
|
| | | $ | 260,300 | | | | | $ | 270,623 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Compensation
|
| | | $ | 2,320 | | | | | $ | 1,495 | | |
Professional fees
|
| | | | 67 | | | | | | 22 | | |
欠第三方的版税
|
| | | | 296 | | | | | | 272 | | |
Subcontractor
|
| | | | — | | | | | | 482 | | |
收购相关负债
|
| | | | 1,000 | | | | | | 1,500 | | |
Other
|
| | | | 63 | | | | | | 185 | | |
| | | | $ | 3,746 | | | | | $ | 3,956 | | |
| | |
Year ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
当期费用(福利): | | | | | | | | | | | | | | | | | | | |
Federal
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | |
State
|
| | | | 17 | | | | | | 14 | | | | | | 5 | | |
| | | | | 17 | | | | | | 14 | | | | | | 5 | | |
递延费用(福利): | | | | | | | | | | | | | | | | | | | |
Federal
|
| | | | (6,756) | | | | | | (3,662) | | | | | | (2,779) | | |
State
|
| | | | (569) | | | | | | (2,523) | | | | | | 3,336 | | |
| | | | | (7,325) | | | | | | (6,185) | | | | | | 557 | | |
所得税支出(福利)
|
| | | $ | (7,308) | | | | | $ | (6,171) | | | | | $ | 562 | | |
| | |
Year ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
按联邦法定税率征税
|
| | | $ | (7,214) | | | | | $ | (4,983) | | | | | $ | (2,736) | | |
州,扣除联邦福利后的净额
|
| | | | (350) | | | | | | (188) | | | | | | (207) | | |
或有负债
|
| | | | (168) | | | | | | (12) | | | | | | (172) | | |
基于股份的薪酬
|
| | | | 1,143 | | | | | | 1,253 | | | | | | 847 | | |
研发学分
|
| | | | (1,064) | | | | | | (573) | | | | | | — | | |
不确定税收状况的变化
|
| | | | 119 | | | | | | (6) | | | | | | — | | |
State tax rate change
|
| | | | 37 | | | | | | (1,596) | | | | | | 2,840 | | |
估值免税额变动
|
| | | | 228 | | | | | | — | | | | | | — | | |
Other
|
| | | | (39) | | | | | | (66) | | | | | | (10) | | |
| | | | $ | (7,308) | | | | | $ | (6,171) | | | | | $ | 562 | | |
| | |
December 31,
|
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
Deferred assets: | | | | | | | | | | | | | |
净营业亏损结转
|
| | | $ | 6,618 | | | | | $ | 4,492 | | |
研究学分结转
|
| | | | 2,803 | | | | | | 1,991 | | |
Stock compensation
|
| | | | 1,703 | | | | | | 1,373 | | |
Deferred revenue
|
| | | | 1,768 | | | | | | 772 | | |
经营性租赁负债
|
| | | | 3,088 | | | | | | 577 | | |
Other
|
| | | | 1,488 | | | | | | 1,015 | | |
递延税项资产计价准备
|
| | | | (526) | | | | | | (403) | | |
Net deferred tax assets
|
| | | $ | 16,942 | | | | | $ | 9,817 | | |
递延纳税义务: | | | | | | | | | | | | | |
已确定的无形资产
|
| | | | (35,114) | | | | | | (37,479) | | |
Operating lease assets
|
| | | | (2,973) | | | | | | (560) | | |
Other
|
| | | | (817) | | | | | | (703) | | |
递延纳税净负债
|
| | | $ | (38,904) | | | | | $ | (38,742) | | |
递延所得税净额
|
| | | $ | (21,962) | | | | | $ | (28,925) | | |
| | |
Year ended December 31,
|
| |||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
年初余额
|
| | | $ | 766 | | | | | $ | 589 | | | | | $ | 556 | | |
根据与本年度相关的纳税头寸进行的增加
|
| | | | 128 | | | | | | 94 | | | | | | — | | |
新增往年纳税头寸
|
| | | | — | | | | | | 87 | | | | | | 33 | | |
前几年的减税情况
|
| | | | — | | | | | | (4) | | | | | | — | | |
Balance at end of year
|
| | | $ | 894 | | | | | $ | 766 | | | | | $ | 589 | | |
| | |
June 30, 2022
|
| |
December 31, 2021
|
| ||||||
| | |
(Unaudited)
|
| | | | | | | |||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Accounts receivable, net
|
| | | $ | 8,180 | | | | | $ | 21,136 | | |
Prepaid expenses
|
| | | | 1,081 | | | | | | 785 | | |
Other current assets
|
| | | | 3,970 | | | | | | 621 | | |
Total current assets
|
| | | | 13,231 | | | | | | 22,542 | | |
递延所得税净额
|
| | | | 822 | | | | | | — | | |
Intangible assets, net
|
| | | | 169,050 | | | | | | 176,321 | | |
Goodwill
|
| | | | 83,979 | | | | | | 83,979 | | |
财产和设备,净额
|
| | | | 16,090 | | | | | | 6,795 | | |
Operating lease assets
|
| | | | 22,011 | | | | | | 13,332 | | |
Other assets
|
| | | | 1,451 | | | | | | 1,496 | | |
Total assets
|
| | | $ | 306,634 | | | | | $ | 304,465 | | |
负债和母公司净投资 | | | | | | | | | | | | | |
流动负债: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 7,383 | | | | | $ | 2,924 | | |
Accrued liabilities
|
| | | | 2,982 | | | | | | 3,746 | | |
或有负债的流动部分
|
| | | | 2,179 | | | | | | 2,538 | | |
递延收入的当前部分
|
| | | | 10,199 | | | | | | 10,790 | | |
经营租赁负债的当期部分
|
| | | | 1,225 | | | | | | 578 | | |
融资租赁负债的当期部分
|
| | | | 3 | | | | | | 1 | | |
流动负债总额
|
| | | | 23,971 | | | | | | 20,577 | | |
长期或有负债
|
| | | | 4,323 | | | | | | 4,826 | | |
递延所得税净额
|
| | | | 18,304 | | | | | | 21,962 | | |
长期经营租赁负债
|
| | | | 25,411 | | | | | | 13,272 | | |
递延收入的长期部分
|
| | | | 7,384 | | | | | | 9,226 | | |
其他长期负债
|
| | | | 298 | | | | | | 295 | | |
Total liabilities
|
| | | | 79,691 | | | | | | 70,158 | | |
承付款和或有事项(附注5) | | | | | | | | | | | | | |
母公司净投资: | | | | | | | | | | | | | |
母公司净投资
|
| | | | 226,943 | | | | | | 234,307 | | |
总负债和母公司净投资
|
| | | $ | 306,634 | | | | | $ | 304,465 | | |
| | |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
| ||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | |
Service revenue
|
| | | $ | 4,735 | | | | | $ | 4,485 | | | | | $ | 9,994 | | | | | $ | 9,377 | | |
许可证和里程碑收入
|
| | | | 2,325 | | | | | | 1,100 | | | | | | 6,426 | | | | | | 3,814 | | |
Royalty revenue
|
| | | | 139 | | | | | | — | | | | | | 402 | | | | | | — | | |
Total revenues
|
| | | | 7,199 | | | | | | 5,585 | | | | | | 16,822 | | | | | | 13,191 | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | |
研发
|
| | | | 11,484 | | | | | | 8,941 | | | | | | 22,256 | | | | | | 18,282 | | |
一般和行政
|
| | | | 5,003 | | | | | | 4,821 | | | | | | 9,115 | | | | | | 8,906 | | |
无形资产摊销
|
| | | | 3,113 | | | | | | 3,231 | | | | | | 6,518 | | | | | | 6,462 | | |
其他运营费用(收入),净额
|
| | | | 165 | | | | | | (764) | | | | | | (278) | | | | | | 271 | | |
总运营费用
|
| | | | 19,765 | | | | | | 16,229 | | | | | | 37,611 | | | | | | 33,921 | | |
Loss from operations
|
| | | | (12,566) | | | | | | (10,644) | | | | | | (20,789) | | | | | | (20,730) | | |
Other expense: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | — | | | | | | — | | | | | | — | | | | | | (6) | | |
Loss before income taxes
|
| | | | (12,566) | | | | | | (10,644) | | | | | | (20,789) | | | | | | (20,736) | | |
Income tax benefit
|
| | | | 2,290 | | | | | | 2,019 | | | | | | 4,231 | | | | | | 4,656 | | |
Net loss
|
| | | $ | (10,276) | | | | | $ | (8,625) | | | | | $ | (16,558) | | | | | $ | (16,080) | | |
| | |
Parent company
net investment |
| |||
Balance at December 31, 2020
|
| | | $ | 235,537 | | |
Net loss
|
| | | | (7,455) | | |
股份薪酬的母公司分配
|
| | | | 3,379 | | |
母公司净转账
|
| | | | (3,861) | | |
Balance at March 31, 2021
|
| | | $ | 227,600 | | |
Net loss
|
| | | | (8,625) | | |
股份薪酬的母公司分配
|
| | | | 4,417 | | |
母公司净转账
|
| | | | 3,011 | | |
Balance at June 30, 2021
|
| | | $ | 226,403 | | |
Balance at December 31, 2021
|
| | | $ | 234,307 | | |
Net loss
|
| | | | (6,282) | | |
股份薪酬的母公司分配
|
| | | | 3,146 | | |
母公司净转账
|
| | | | (6,250) | | |
Balance at March 31, 2022
|
| | | $ | 224,921 | | |
Net loss
|
| | | | (10,276) | | |
股份薪酬的母公司分配
|
| | | | 3,848 | | |
母公司净转账
|
| | | | 8,450 | | |
Balance at June 30, 2022
|
| | | $ | 226,943 | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
经营活动: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (16,558) | | | | | $ | (16,080) | | |
将净亏损与经营活动提供的现金净额进行调整: | | | | | | | | | | | | | |
或有负债估计公允价值变动
|
| | | | (277) | | | | | | 271 | | |
折旧及摊销
|
| | | | 8,927 | | | | | | 7,484 | | |
基于股份的薪酬
|
| | | | 6,994 | | | | | | 7,796 | | |
递延所得税净额
|
| | | | (4,477) | | | | | | (4,410) | | |
Other
|
| | | | 37 | | | | | | 43 | | |
经营性资产和负债变动:
|
| | | | | | | | | | | | |
Accounts receivable, net
|
| | | | 17,256 | | | | | | 13,022 | | |
Other current assets
|
| | | | (365) | | | | | | (79) | | |
Other long-term assets
|
| | | | 1,755 | | | | | | 416 | | |
应付账款和应计负债
|
| | | | (1,100) | | | | | | (328) | | |
Deferred revenue
|
| | | | (6,673) | | | | | | (3,746) | | |
其他长期负债
|
| | | | 2,269 | | | | | | (878) | | |
经营活动提供的现金净额
|
| | | | 7,788 | | | | | | 3,511 | | |
投资活动: | | | | | | | | | | | | | |
购置物业和设备
|
| | | | (8,237) | | | | | | (1,611) | | |
投资活动中使用的净现金
|
| | | | (8,237) | | | | | | (1,611) | | |
融资活动: | | | | | | | | | | | | | |
Payments to CVR holders
|
| | | | (1,545) | | | | | | (1,050) | | |
延期支付交易费用
|
| | | | (206) | | | | | | — | | |
Net transfer from (to) parent
|
| | | | 2,200 | | | | | | (850) | | |
融资活动提供(使用)的现金净额
|
| | | | 449 | | | | | | (1,900) | | |
现金、现金等价物和限制性现金的净变化
|
| | | | — | | | | | | — | | |
期初现金、现金等价物和限制性现金
|
| | | | — | | | | | | — | | |
期末现金、现金等价物和限制性现金
|
| | | $ | — | | | | | $ | — | | |
现金流量信息补充披露: | | | | | | | | | | | | | |
在应付账款中记录的固定资产购置
|
| | | $ | 3,601 | | | | | $ | 54 | | |
| | |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
| ||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
Royalty revenue
|
| | | $ | 139 | | | | | $ | — | | | | | $ | 402 | | | | | $ | — | | |
License fees
|
| | | | 1,050 | | | | | | 1,100 | | | | | | 2,055 | | | | | | 1,750 | | |
Milestone revenue
|
| | | | 1,275 | | | | | | — | | | | | | 4,371 | | | | | | 2,064 | | |
Service revenue
|
| | | | 4,735 | | | | | | 4,485 | | | | | | 9,994 | | | | | | 9,377 | | |
| | | | $ | 7,199 | | | | | $ | 5,585 | | | | | $ | 16,822 | | | | | $ | 13,191 | | |
| | |
June 30, 2022
|
| |
December 31, 2021
|
| ||||||||||||||||||||||||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||||||||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Icagen或有负债(1)
|
| | | $ | — | | | | | $ | — | | | | | $ | 5,542 | | | | | $ | 5,542 | | | | | $ | — | | | | | $ | — | | | | | $ | 7,364 | | | | | $ | 7,364 | | |
xCella或有负债(2)
|
| | | | — | | | | | | — | | | | | | 960 | | | | | | 960 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 6,502 | | | | | $ | 6,502 | | | | | $ | — | | | | | $ | — | | | | | $ | 7,364 | | | | | $ | 7,364 | | |
|
截至2021年12月31日的3级金融工具的公允价值
|
| | | $ | 7,364 | | |
|
Payments to CVR holders
|
| | | | (1,545) | | |
|
或有负债的公允价值调整
|
| | | | (277) | | |
|
xCella资产收购产生的或有负债
|
| | | | 960 | | |
|
截至2022年6月30日的3级金融工具的公允价值
|
| | | $ | 6,502 | | |
Assets
|
| |
June 30,
2022 |
| |
December 31,
2021 |
| ||||||
Operating lease assets
|
| | | $ | 22,011 | | | | | $ | 13,332 | | |
Liabilities | | | | | | | | | | | | | |
当期经营租赁负债
|
| | | | 1,225 | | | | | | 578 | | |
长期经营租赁负债
|
| | | | 25,411 | | | | | | 13,272 | | |
租赁总负债
|
| | | $ | 26,636 | | | | | $ | 13,850 | | |
Maturity Dates
|
| |
Operating
Leases |
| |||
截至2022年12月31日的剩余六个月
|
| | | $ | 1,699 | | |
2023
|
| | | | 3,398 | | |
2024
|
| | | | 3,406 | | |
2025
|
| | | | 3,582 | | |
2026
|
| | | | 3,787 | | |
2027
|
| | | | 3,885 | | |
Thereafter
|
| | | | 14,597 | | |
Total lease payments
|
| | | | 34,355 | | |
Less imputed interest
|
| | | | (6,362) | | |
租户改善津贴减少
|
| | | | (1,357) | | |
租赁负债现值
|
| | | $ | 26,636 | | |
| | |
June 30,
2022 |
| |
December 31,
2021 |
| ||||||
Lab and office equipment
|
| | | $ | 13,582 | | | | | $ | 6,410 | | |
租赁改进
|
| | | | 6,572 | | | | | | 3,495 | | |
计算机设备和软件
|
| | | | 442 | | | | | | 182 | | |
| | | | | 20,596 | | | | | | 10,087 | | |
减去:累计折旧和摊销
|
| | | | (4,506) | | | | | | (3,292) | | |
总财产和设备,净额
|
| | | $ | 16,090 | | | | | $ | 6,795 | | |
| | |
June 30,
2022 |
| |
December 31,
2021 |
| ||||||
活着的无限无形资产 | | | | | | | | | | | | | |
Goodwill
|
| | | $ | 83,979 | | | | | $ | 83,979 | | |
确定的活体无形资产 | | | | | | | | | | | | | |
Complete technology
|
| | | | 226,650 | | | | | | 227,403 | | |
减去:累计摊销
|
| | | | (66,022) | | | | | | (60,099) | | |
客户关系
|
| | | | 11,100 | | | | | | 11,100 | | |
减去:累计摊销
|
| | | | (2,678) | | | | | | (2,083) | | |
总商誉和其他可识别无形资产净额
|
| | | $ | 253,029 | | | | | $ | 260,300 | | |
| | |
June 30,
2022 |
| |
December 31,
2021 |
| ||||||
Compensation
|
| | | $ | 1,757 | | | | | $ | 2,320 | | |
Professional fees
|
| | | | 993 | | | | | | 67 | | |
欠第三方的版税
|
| | | | 137 | | | | | | 296 | | |
收购相关负债
|
| | | | — | | | | | | 1,000 | | |
Other
|
| | | | 95 | | | | | | 63 | | |
应计负债总额
|
| | | $ | 2,982 | | | | | $ | 3,746 | | |
| | |
Three Months Ended June 30,
|
| |
Six Months Ended June 30,
|
| ||||||||||||||||||
| | |
2022
|
| |
2021
|
| |
2022
|
| |
2021
|
| ||||||||||||
sbc - 研发费用
|
| | | $ | 2,254 | | | | | $ | 2,430 | | | | | $ | 4,164 | | | | | $ | 4,507 | | |
sbc - 一般和管理费用
|
| | | | 1,594 | | | | | | 1,987 | | | | | | 2,830 | | | | | | 3,289 | | |
| | | | $ | 3,848 | | | | | $ | 4,417 | | | | | $ | 6,994 | | | | | $ | 7,796 | | |
| | |
Page
|
| |||
Article I DEFINITIONS
|
| | | | A-3 | | |
Section 1.1
Definitions
|
| | | | A-3 | | |
Section 1.2
Cross References
|
| | | | A-16 | | |
Section 1.3
Interpretation
|
| | | | A-18 | | |
Article II THE MERGER
|
| | | | A-19 | | |
Section 2.1
The Merger
|
| | | | A-19 | | |
Section 2.2
Closing
|
| | | | A-19 | | |
Section 2.3
关闭交付成果;生效时间
|
| | | | A-19 | | |
Section 2.4
尚存公司的注册证书和章程;尚存公司的董事和高级管理人员
|
| | | | A-21 | | |
Section 2.5
Governance Matters
|
| | | | A-21 | | |
第三条股份转股
|
| | | | A-21 | | |
Section 3.1
Effect on Capital Stock
|
| | | | A-21 | | |
Section 3.2
Surrender and Payment
|
| | | | A-22 | | |
Section 3.3
Earnout
|
| | | | A-25 | | |
Section 3.4
Appraisal Rights
|
| | | | A-26 | | |
Section 3.5
SpinCo股权奖的待遇
|
| | | | A-26 | | |
第四条公司与公司有关的陈述和保证
|
| | | | A-26 | | |
Section 4.1
公司的组织机构
|
| | | | A-26 | | |
Section 4.2
Due Authorization
|
| | | | A-26 | | |
Section 4.3
政府意见书
|
| | | | A-27 | | |
Section 4.4
No Conflict
|
| | | | A-27 | | |
Section 4.5
诉讼和诉讼程序
|
| | | | A-27 | | |
Section 4.6
Brokers’ Fees
|
| | | | A-27 | | |
Section 4.7
Internal Controls
|
| | | | A-27 | | |
Section 4.8
Company Equity Awards
|
| | | | A-28 | | |
公司关于SpinCo的第五条陈述和担保
|
| | | | A-28 | | |
Section 5.1
Organization of SpinCo
|
| | | | A-28 | | |
Section 5.2
Due Authorization
|
| | | | A-28 | | |
Section 5.3
SpinCo的大小写
|
| | | | A-29 | | |
Section 5.4
Subsidiaries
|
| | | | A-29 | | |
Section 5.5
子公司资本化
|
| | | | A-30 | | |
Section 5.6
政府意见书
|
| | | | A-30 | | |
Section 5.7
No Conflict
|
| | | | A-30 | | |
Section 5.8
SpinCo资产的充分性
|
| | | | A-30 | | |
Section 5.9
Financial Statements
|
| | | | A-30 | | |
Section 5.10
没有未披露的负债
|
| | | | A-31 | | |
Section 5.11
诉讼和诉讼程序
|
| | | | A-31 | | |
Section 5.12
Real Property
|
| | | | A-31 | | |
Section 5.13
Tax Matters
|
| | | | A-32 | | |
Section 5.14
Absence of Changes
|
| | | | A-32 | | |
| | |
Page
|
| |||
Section 5.15
Material Contracts
|
| | | | A-32 | | |
Section 5.16
Labor Relations
|
| | | | A-34 | | |
Section 5.17
依法合规;许可
|
| | | | A-35 | | |
Section 5.18
SpinCo Benefit Plans
|
| | | | A-35 | | |
Section 5.19
知识产权
|
| | | | A-37 | | |
Section 5.20
环境问题
|
| | | | A-39 | | |
Section 5.21
Affiliate Matters
|
| | | | A-39 | | |
Section 5.22
Brokers’ Fees
|
| | | | A-40 | | |
Section 5.23
代理声明;注册声明
|
| | | | A-40 | | |
Section 5.24
董事会和股东批准
|
| | | | A-40 | | |
Section 5.25
Parent Capital Stock
|
| | | | A-40 | | |
Section 5.26
医疗监管事项
|
| | | | A-40 | | |
Section 5.27
Data Privacy
|
| | | | A-41 | | |
Section 5.28
反贿赂、反腐败、反洗钱
|
| | | | A-42 | | |
Section 5.29
制裁、进口和出口管制
|
| | | | A-42 | | |
Section 5.30
没有其他陈述和保证
|
| | | | A-42 | | |
第六条母公司和合并子公司的陈述和担保
|
| | | | A-43 | | |
Section 6.1
上下级组织结构
|
| | | | A-43 | | |
Section 6.2
Due Authorization
|
| | | | A-44 | | |
Section 6.3
股本及其他事项
|
| | | | A-44 | | |
Section 6.4
政府意见书
|
| | | | A-45 | | |
Section 6.5
No Conflict
|
| | | | A-46 | | |
Section 6.6
内部控制;上市;财务报表
|
| | | | A-46 | | |
Section 6.7
没有未披露的负债
|
| | | | A-47 | | |
Section 6.8
诉讼和诉讼程序
|
| | | | A-47 | | |
Section 6.9
Tax Matters
|
| | | | A-47 | | |
Section 6.10
Absence of Changes
|
| | | | A-48 | | |
Section 6.11
Brokers’ Fees
|
| | | | A-48 | | |
Section 6.12
代理声明;注册声明
|
| | | | A-48 | | |
Section 6.13
SEC Filings
|
| | | | A-48 | | |
Section 6.14
Trust Account.
|
| | | | A-49 | | |
Section 6.15
投资公司法;就业法案。
|
| | | | A-49 | | |
Section 6.16
Indebtedness
|
| | | | A-49 | | |
Section 6.17
Stock Market Quotation
|
| | | | A-49 | | |
Section 6.18
Business Activities
|
| | | | A-50 | | |
Section 6.19
Section 280G
|
| | | | A-50 | | |
Section 6.20
没有其他陈述和保证
|
| | | | A-50 | | |
Article VII COVENANTS
|
| | | | A-51 | | |
Section 7.1
母公司和合并子公司在合并前的业务行为
|
| | | | A-51 | | |
Section 7.2
合并前SpinCo业务的开展情况
|
| | | | A-52 | | |
Section 7.3
Tax Matters
|
| | | | A-55 | | |
Section 7.4
编制注册说明书和招股说明书;母公司股东大会
|
| | | | A-56 | | |
Section 7.5
建议中的修改
|
| | | | A-58 | | |
| | |
Page
|
| |||
Section 7.6
合理的最大努力
|
| | | | A-59 | | |
Section 7.7
[故意省略]
|
| | | | A-60 | | |
Section 7.8
Access to Information
|
| | | | A-60 | | |
Section 7.9
Exclusivity
|
| | | | A-61 | | |
Section 7.10
Public Announcements
|
| | | | A-62 | | |
Section 7.11
Defense of Litigation
|
| | | | A-62 | | |
Section 7.12
Section 16 Matters
|
| | | | A-63 | | |
Section 7.13
控制对方的业务
|
| | | | A-63 | | |
Section 7.14
SpinCo Share Issuance
|
| | | | A-63 | | |
Section 7.15
Domestication
|
| | | | A-63 | | |
Section 7.16
交易单据
|
| | | | A-64 | | |
Section 7.17
NASDAQ Listing
|
| | | | A-64 | | |
Section 7.18
Takeover Statutes
|
| | | | A-64 | | |
Section 7.19
合并子公司和SpinCo的义务
|
| | | | A-64 | | |
Section 7.20
Further Assurances
|
| | | | A-64 | | |
Section 7.21
唯一股东批准
|
| | | | A-64 | | |
Section 7.22
财务信息
|
| | | | A-64 | | |
第八条合并的条件
|
| | | | A-65 | | |
Section 8.1
SpinCo、公司、母公司和合并子公司实施合并的义务条件
|
| | | | A-65 | | |
Section 8.2
公司和SpinCo义务的附加条件
|
| | | | A-66 | | |
Section 8.3
母公司和兼并子公司义务的附加条件
|
| | | | A-67 | | |
Article IX TERMINATION
|
| | | | A-68 | | |
Section 9.1
Termination
|
| | | | A-68 | | |
Section 9.2
Effect of Termination
|
| | | | A-69 | | |
Section 9.3
Termination Fee.
|
| | | | A-69 | | |
Section 9.4
Fees and Expenses
|
| | | | A-70 | | |
第十条其他
|
| | | | A-70 | | |
Section 10.1
Trust Account Waiver
|
| | | | A-70 | | |
Section 10.2
陈述、保证和协议不再有效
|
| | | | A-71 | | |
Section 10.3
管辖法律;管辖
|
| | | | A-71 | | |
Section 10.4
Notices
|
| | | | A-72 | | |
Section 10.5
Headings
|
| | | | A-73 | | |
Section 10.6
Entire Agreement
|
| | | | A-73 | | |
Section 10.7
Amendments and Waivers
|
| | | | A-73 | | |
Section 10.8
转让;利害关系方;非相关方
|
| | | | A-73 | | |
Section 10.9
Specific Performance
|
| | | | A-73 | | |
Section 10.10
WAIVER OF JURY TRIAL
|
| | | | A-74 | | |
Section 10.11
Severability
|
| | | | A-74 | | |
Section 10.12
Counterparts
|
| | | | A-74 | | |
Section 10.13
Disclosure Schedules
|
| | | | A-74 | | |
Section 10.14
冲突和特权
|
| | | | A-75 | | |
EXHIBITS
|
| | | |
Exhibit A
分离和分销协议
|
| | | |
Exhibit B
税务协议格式
|
| | | |
Exhibit C
员工事务协议
|
| | | |
Exhibit D-1
过渡服务协议格式(公司提供)
|
| | | |
Exhibit D-2
过渡服务协议格式(SpinCo提供)
|
| | | |
Exhibit E
A&R登记权协议格式
|
| | | |
Exhibit F
赞助商内幕协议表
|
| | | |
Exhibit G
Form of Parent Charter
|
| | | |
Exhibit H
Form of Parent Bylaws
|
| | | |
Exhibit I
应收账款远期采购协议
|
| | | |
Term
|
| |
Section
|
|
A&R注册权协议 | | |
Recitals
|
|
Antitrust Division | | |
Section 7.6(b)
|
|
合并证 | | |
Section 2.3(d)
|
|
Chosen Courts | | |
Section 10.3
|
|
CICA | | |
Recitals
|
|
A类合并考虑事项 | | |
Section 3.1(a)(i)
|
|
Closing | | |
Section 2.2
|
|
Closing Date | | |
Section 2.2
|
|
COBRA | | |
Section 5.18(h)
|
|
Company | | |
Preamble
|
|
Company Board | | |
Recitals
|
|
公司配税意见书 | | |
Section 7.3(b)
|
|
Company Group | | |
Section 10.14(b)
|
|
DGCL | | |
Recitals
|
|
Distribution | | |
Recitals
|
|
分发单据 | | |
Section 5.23
|
|
驯化母公司普通股 | | |
Recitals
|
|
驯化母公司授权书 | | |
Recitals
|
|
Domestication | | |
Recitals
|
|
Term
|
| |
Section
|
|
Effective Time | | |
Section 2.3(d)
|
|
评估材料 | | |
Section 10.2
|
|
Exchange Agent | | |
Section 3.2(b)
|
|
Exchange代理协议 | | |
Section 3.2(b)
|
|
Exchange Fund | | |
Section 3.2(b)
|
|
FTC | | |
Section 7.6(b)
|
|
政府合同 | | |
Section 5.15(a)(xiv)
|
|
Interim Period | | |
Section 7.1
|
|
Investment | | |
Section 6.3(f)
|
|
JOBS Act | | |
Section 6.6(a)
|
|
Merger | | |
Recitals
|
|
合并考虑因素 | | |
Section 3.1(a)(i)
|
|
Merger Sub | | |
Preamble
|
|
合并子普通股 | | |
Section 3.1(a)(vi)
|
|
合并子股东批准 | | |
Section 7.21
|
|
建议中的修改 | | |
Section 7.5
|
|
Term | | |
Section
|
|
Outside Date | | |
Section 9.1(b)
|
|
Parent | | |
Preamble
|
|
Parent Board | | |
Recitals
|
|
母公司董事会建议 | | |
Recitals
|
|
Parent Bylaws | | |
Section 7.15
|
|
Parent Charter | | |
Section 7.15
|
|
家长驯化纳税意见书 | | |
Section 7.3(d)
|
|
Parent SEC Filings | | |
Section 6.13
|
|
Parent Securities | | |
Section 6.3(a)
|
|
母公司股东大会 | | |
Section 7.4(e)(i)
|
|
Parent Units | | |
Recitals
|
|
Party | | |
Preamble
|
|
人员知识产权合同 | | |
Section 5.19(h)
|
|
Prospectus | | |
Section 10.1
|
|
Remedies Exception | | |
Section 4.2
|
|
SpinCo | | |
Preamble
|
|
SpinCo Board | | |
Recitals
|
|
SpinCo CBA | | |
Section 5.16(c)
|
|
SpinCo材料合同 | | |
Section 5.15(a)
|
|
SpinCo Proposal | | |
Section 7.9(a)
|
|
SpinCo房地产租赁 | | |
Section 5.15(a)(ix)
|
|
SpinCo注册知识产权 | | |
Section 5.19(a)
|
|
SpinCo股东批准 | | |
Section 5.24
|
|
SpinCo Voting Debt | | |
Section 5.3(b)
|
|
赞助商内幕协议 | | |
Recitals
|
|
随后经过审计的SpinCo年度财务 | | |
Section 7.22(a)
|
|
Term
|
| |
Section
|
|
Statements | | | | |
后续期间SpinCo财务报表 | | |
Section 7.22(a)
|
|
随后未经审计的SpinCo财务报表 | | |
Section 7.22(a)
|
|
幸存的公司 | | |
Section 2.1
|
|
Tax-Free Status | | |
Section 7.3(a)
|
|
交易诉讼 | | |
Section 7.11
|
|
交易建议 | | |
Section 7.4(e)(ii)
|
|
Trust Account | | |
Section 10.1
|
|
未支付的交易费用 | | |
Section 2.3(c)
|
|
WARN | | |
Section 5.16(e)
|
|
| | |
Page
|
| |||
第一条定义和解释
|
| | | | B-2 | | |
Section 1.1
General
|
| | | | B-2 | | |
Section 1.2
参考文献;解释
|
| | | | B-15 | | |
第二条分离
|
| | | | B-15 | | |
Section 2.1
General
|
| | | | B-15 | | |
Section 2.2
重组:转移资产;承担负债
|
| | | | B-16 | | |
Section 2.3
共享合同的处理方式
|
| | | | B-17 | | |
Section 2.4
公司间账户、贷款和协议
|
| | | | B-18 | | |
Section 2.5
责任限制;公司间合同
|
| | | | B-18 | | |
Section 2.6
未在分发时间或之前生效的转账;转账被视为自分发时间起生效
|
| | | | B-18 | | |
Section 2.7
转易和假设工具
|
| | | | B-20 | | |
Section 2.8
进一步保证;附属协议
|
| | | | B-20 | | |
Section 2.9
责任更新;赔偿
|
| | | | B-21 | | |
Section 2.10
担保;信用支持工具
|
| | | | B-22 | | |
Section 2.11
陈述和保证免责声明
|
| | | | B-23 | | |
Section 2.12
现金管理;考虑因素
|
| | | | B-24 | | |
第三条分发完成
|
| | | | B-25 | | |
Section 3.1
分发前的操作
|
| | | | B-25 | | |
Section 3.2
影响分销
|
| | | | B-26 | | |
Section 3.3
分配条件
|
| | | | B-26 | | |
第四条某些公约
|
| | | | B-27 | | |
Section 4.1
Cooperation
|
| | | | B-27 | | |
Section 4.2
Retained Names
|
| | | | B-27 | | |
Section 4.3
Ligand Limited License
|
| | | | B-28 | | |
Section 4.4
不限制竞争
|
| | | | B-28 | | |
第五条赔偿
|
| | | | B-28 | | |
Section 5.1
发布预售报销单
|
| | | | B-28 | | |
Section 5.2
由Ligand赔偿
|
| | | | B-31 | | |
Section 5.3
OmniAb和APAC的赔偿
|
| | | | B-31 | | |
Section 5.4
赔偿程序
|
| | | | B-32 | | |
Section 5.5
防务和结算合作
|
| | | | B-34 | | |
Section 5.6
赔款
|
| | | | B-34 | | |
Section 5.7
扣除保险收益和其他金额后的赔偿义务
|
| | | | B-34 | | |
Section 5.8
Contribution
|
| | | | B-35 | | |
Section 5.9
其他事项;赔偿存续
|
| | | | B-35 | | |
第六条记录的保存;信息的获取;机密性;特权
|
| | | | B-36 | | |
Section 6.1
保存公司记录
|
| | | | B-36 | | |
Section 6.2
Access to Information
|
| | | | B-36 | | |
| | |
Page
|
| |||
Section 6.3
Auditors and Audits
|
| | | | B-37 | | |
Section 6.4
Witness Services
|
| | | | B-38 | | |
Section 6.5
报销;其他事项
|
| | | | B-38 | | |
Section 6.6
Confidentiality
|
| | | | B-38 | | |
Section 6.7
Privilege Matters
|
| | | | B-40 | | |
Section 6.8
信息所有权
|
| | | | B-41 | | |
Section 6.9
个人信息处理
|
| | | | B-41 | | |
Section 6.10
Other Agreements
|
| | | | B-41 | | |
第七条争议解决
|
| | | | B-41 | | |
Section 7.1
Negotiation
|
| | | | B-41 | | |
Section 7.2
Relief in Court
|
| | | | B-42 | | |
Section 7.3
服务的连续性和性能
|
| | | | B-42 | | |
ARTICLE VIII INSURANCE
|
| | | | B-42 | | |
Section 8.1
Insurance Matters
|
| | | | B-42 | | |
第九条其他
|
| | | | B-43 | | |
Section 9.1
完整协议;施工
|
| | | | B-43 | | |
Section 9.2
Ancillary Agreements
|
| | | | B-44 | | |
Section 9.3
Counterparts
|
| | | | B-44 | | |
Section 9.4
Survival of Agreements
|
| | | | B-44 | | |
Section 9.5
Expenses
|
| | | | B-44 | | |
Section 9.6
Notices
|
| | | | B-44 | | |
Section 9.7
Consents
|
| | | | B-45 | | |
Section 9.8
Assignment
|
| | | | B-45 | | |
Section 9.9
Successors and Assigns
|
| | | | B-45 | | |
Section 9.10
终止和修改
|
| | | | B-45 | | |
Section 9.11
Payment Terms
|
| | | | B-46 | | |
Section 9.12
Subsidiaries
|
| | | | B-46 | | |
Section 9.13
第三方受益人
|
| | | | B-46 | | |
Section 9.14
Title and Headings
|
| | | | B-46 | | |
Section 9.15
Exhibits and Schedules
|
| | | | B-46 | | |
Section 9.16
管辖法律和地点;提交司法管辖权;选择论坛;陪审团放弃审判
|
| | | | B-47 | | |
Section 9.17
Specific Performance
|
| | | | B-47 | | |
Section 9.18
Severability
|
| | | | B-48 | | |
Section 9.19
Interpretation
|
| | | | B-48 | | |
Section 9.20
无复制;无双恢复
|
| | | | B-48 | | |
Section 9.21
付款的税务处理
|
| | | | B-48 | | |
Section 9.22
No Waiver
|
| | | | B-48 | | |
Section 9.23
不承认责任
|
| | | | B-48 | | |
| List of Schedules | | |||
|
1.1(75)
配对保留负债
|
| | | |
|
1.1(76)
Ligand Retained Names
|
| | | |
|
1.1(86)(ii)
OmniAb Assets — General
|
| | | |
|
1.1(86)(v)
OmniAb Assets - 租赁/转租
|
| | | |
|
1.1(86)(vi)
OmniAb Assets — Contracts
|
| | | |
|
1.1(86)(vii)
OmniAb资产 - 知识产权
|
| | | |
|
1.1(86)(x)
OmniAb Assets — IT Assets
|
| | | |
|
1.1(97)(ii)
OmniAb Liabilities — General
|
| | | |
|
1.1(97)(vii)
OmniAb Liabilities — Actions
|
| | | |
|
2.3(a)
Shared Contracts
|
| | | |
|
2.10(a)(i)
OmniAbGroup提供担保
|
| | | |
|
2.10(a)(ii)
Ligand Group提供担保
|
| | | |
|
2.12(c)
其他可报销费用
|
| | ||
| List of Exhibits | | | | |
|
Exhibit A
Reorganization Plan
|
| | | |
|
Exhibit B
根据第2.12(C)节进行的说明性调整
|
| | | |
| | | | Sincerely, | | | | |
| | | | Avista收购LP II | | |||
| | | | By: | | | /s/ Benjamin Silbert | |
| | | | | | |
Name:
Benjamin Silbert
|
|
| | | | | | |
Title:
Authorized Signatory
|
|
| | | | | | |
email:
Silbert@avistacap.com
|
|
| | | | | | |
Address:
65 East 55th Street
|
|
| | | | | | |
18th Floor
|
|
| | | | | | |
New York, NY 10022
|
|
| | | | /s/ Thompson Dean | |
| | | |
Thompson Dean
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ David Burgstahler | |
| | | |
David Burgstahler
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ Sriram Venkataraman | |
| | | |
Sriram Venkataraman
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ Robert Girardi | |
| | | |
Robert Girardi
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ Amanda Heravi | |
| | | |
Amanda Heravi
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ John Cafasso | |
| | | |
John Cafasso
|
|
| | | | 已发行和已发行的方正股票数量:0 | |
| | | | /s/ Benjamin Silbert | |
| | | |
Benjamin Silbert
|
|
| | | | 已发行和未发行数量 | |
| | | | Founder Shares: 0 | |
| | | | /s/ William E. Klitgaard | |
| | | |
William E. Klitgaard
|
|
| | | | 已发行和已发行的方正股票数量:35,000股 | |
| | | | /s/ Lâle White | |
| | | |
Lâle White
|
|
| | | | 已发行和已发行的方正股票数量:35,000股 | |
| | | | /s/ Wendel Barr | |
| | | |
Wendel Barr
|
|
| | | | 已发行和已发行的方正股票数量:35,000股 | |
| By: | | | /s/ Benjamin Silbert | | | | |
| | | |
Name: Benjamin Silbert
|
| | | |
| | | | 职务:总法律顾问 | | | | |
| | | | 电子邮件:silbert@avista ap.com | | | | |
| | | |
Address: 65 East 55th Street
18th Floor New York, NY 10022 |
| | | |
| | | | 联系人:本杰明·西尔伯特 | | | | |
| | | | 电子邮件:silbert@avista ap.com | | | | |
| By: | | | /s/ Matthew W. Foehr | | | | |
| | | |
Name: Matthew W. Foehr
|
| | | |
| | | | 职务:总裁兼首席执行官 | | | | |
| | | |
通知地址:霍顿街5980号
Suite 405 Emeryville, CA 94608 |
| | | |
| | | | Attn: Matt Foehr | | | | |
| | | | Email: matt@omniab.com | | |
By: /s/ Benjamin Silbert |
|
By: /s/ Benjamin Silbert |
|
By: /s/ Matthew W. Foehr |
|
| | |
Page
|
| |||
ARTICLE I
DEFINITIONS
|
| | | | | | |
1.1
General
|
| | | | E-1 | | |
ARTICLE II
PAYMENTS AND TAX REFUNDS
|
| | | | | | |
2.1
联邦税收分配
|
| | | | E-7 | | |
2.2
国家税收分配情况
|
| | | | E-8 | | |
2.3
外国税收分配
|
| | | | E-9 | | |
2.4
某些交易税
|
| | | | E-9 | | |
2.5
关于税收分配和归属的确定
|
| | | | E-9 | | |
2.6
就业税分配
|
| | | | E-10 | | |
2.7
Tax Refunds
|
| | | | E-10 | | |
2.8
Tax Benefits
|
| | | | E-10 | | |
2.9
Prior Agreements
|
| | | | E-10 | | |
ARTICLE III
纳税申报单的编制和归档
|
| | | | | | |
3.1
Remainco的责任
|
| | | | E-10 | | |
3.2
Spinco’s Responsibility
|
| | | | E-11 | | |
3.3
查看纳税申报单的权利
|
| | | | E-11 | | |
3.4
Cooperation
|
| | | | E-11 | | |
3.5
纳税申报惯例
|
| | | | E-11 | | |
3.6
重组报告
|
| | | | E-11 | | |
3.7
Payment of Taxes
|
| | | | E-12 | | |
3.8
修改后的退货和结转
|
| | | | E-13 | | |
3.9
Tax Attributes
|
| | | | E-13 | | |
ARTICLE IV
分销的免税状态
|
| | | | | | |
4.1
陈述和保修
|
| | | | E-13 | | |
4.2
与分销相关的限制
|
| | | | E-14 | | |
ARTICLE V
赔偿义务
|
| | | | | | |
5.1
赔偿义务
|
| | | | E-16 | | |
5.2
赔款
|
| | | | E-16 | | |
5.3
Payment Mechanics
|
| | | | E-17 | | |
5.4
Treatment of Payments
|
| | | | E-17 | | |
ARTICLE VI
TAX CONTESTS
|
| | | | | | |
6.1
Notice
|
| | | | E-17 | | |
6.2
Separate Returns
|
| | | | E-17 | | |
6.3
Joint Return
|
| | | | E-18 | | |
6.4
继续通知的义务
|
| | | | E-18 | | |
6.5
Settlement Rights
|
| | | | E-18 | | |
6.6
参加税务竞赛
|
| | | | E-18 | | |
| | |
Page
|
| |||
ARTICLE VII
COOPERATION
|
| | | | | | |
7.1
General
|
| | | | E-19 | | |
7.2
Consistent Treatment
|
| | | | E-19 | | |
ARTICLE VIII
保留记录;访问
|
| | | | | | |
8.1
Retention of Records
|
| | | | E-19 | | |
8.2
Access to Tax Records
|
| | | | E-19 | | |
ARTICLE IX
DISPUTE RESOLUTION
|
| | | | | | |
9.1
Dispute Resolution
|
| | | | E-20 | | |
ARTICLE X
杂项规定
|
| | | | | | |
10.1
完整协议;施工
|
| | | | E-20 | | |
10.2
逾期付款利息
|
| | | | E-20 | | |
10.3
Successors and Assigns
|
| | | | E-20 | | |
10.4
Subsidiaries
|
| | | | E-20 | | |
10.5
Assignability
|
| | | | E-20 | | |
10.6
没有信托关系
|
| | | | E-21 | | |
10.7
Further Assurances
|
| | | | E-21 | | |
10.8
Survival
|
| | | | E-21 | | |
10.9
Notices
|
| | | | E-21 | | |
10.10
Counterparts
|
| | | | E-21 | | |
10.11
Consents
|
| | | | E-21 | | |
10.12
Expenses
|
| | | | E-21 | | |
10.13
终止和修改
|
| | | | E-21 | | |
10.14
Titles and Headings
|
| | | | E-22 | | |
10.15
Severability
|
| | | | E-22 | | |
10.16
Interpretation
|
| | | | E-22 | | |
10.17
无复制;无双恢复
|
| | | | E-22 | | |
10.18
No Waiver
|
| | | | E-22 | | |
10.19
Governing Law
|
| | | | E-22 | | |
10.20
Distribution Time
|
| | | | E-22 | | |
| | | | OMNIAB, INC. | |
| | | |
By:
|
|
| | | |
Name:
|
|
| | | |
Title:
|
|
| | | |
Ligand制药公司
|
|
| | | |
By:
|
|
| | | |
Name:
|
|
| | | |
Title:
|
|
| | | | COMPANY: | |
| | | | OMNIAB, INC. | |
| | | |
By:
Name:
Title: |
|
| | | | HOLDERS: | |
| | | | Avista收购LP II | |
| | | | 作者:Avista收购GP LLC II,其普通合作伙伴 | |
| | | |
By:
Name: David Burgstahler
Title: Manager |
|
| | | | WILLIAM KLITGAARD | |
| | | |
By:
Address:
|
|
| | | | LÂLE WHITE | |
| | | |
By:
Address:
|
|
| | | | WENDEL BARR | |
| | | |
By:
Address:
|
|
| | | | NEW HOLDERS: | |
| | | | [ ] | |
| | | | By: [ ] | |
| | | |
[ ]
[ ] |
|
| | | | 仅针对第2.2.1条第4条和第6.14节 | |
| | | |
Ligand制药公司
|
|
| | | |
By:
Name:
Title: |
|
| | |
Page
|
| |||
Article I — Corporate Offices
|
| | | | I-1 | | |
1.1
Registered Office
|
| | | | I-1 | | |
1.2
Other Offices
|
| | | | I-1 | | |
第二条股东 - 会议
|
| | | | I-1 | | |
2.1
Place of Meetings
|
| | | | I-1 | | |
2.2
Annual Meeting
|
| | | | I-1 | | |
2.3
Special Meeting
|
| | | | I-1 | | |
2.4
会议前应提交的业务通知
|
| | | | I-1 | | |
2.5
董事会选举提名通知书
|
| | | | I-4 | | |
2.6
股东大会通知
|
| | | | I-7 | | |
2.7
发出通知的方式;通知誓章
|
| | | | I-7 | | |
2.8
Quorum
|
| | | | I-7 | | |
2.9
休会;通知
|
| | | | I-8 | | |
2.10
Conduct of Business
|
| | | | I-8 | | |
2.11
Voting
|
| | | | I-8 | | |
2.12
股东会议及其他用途的记录日期
|
| | | | I-9 | | |
2.13
Proxies
|
| | | | I-9 | | |
2.14
有投票权的股东名单
|
| | | | I-9 | | |
2.15
Inspectors of Election
|
| | | | I-10 | | |
2.16
向公司发货
|
| | | | I-10 | | |
2.17
股东未经会议书面同意采取行动
|
| | | | I-10 | | |
Article III — DIRECTORS
|
| | | | I-11 | | |
3.1
Powers
|
| | | | I-11 | | |
3.2
Number of Directors
|
| | | | I-11 | | |
3.3
董事的选举、任职资格和任期
|
| | | | I-11 | | |
3.4
辞职和空缺
|
| | | | I-11 | | |
3.5
会议地点;电话会议
|
| | | | I-11 | | |
3.6
Regular Meetings
|
| | | | I-12 | | |
3.7
Special Meetings; Notice
|
| | | | I-12 | | |
3.8
Quorum
|
| | | | I-12 | | |
3.9
董事会在未开会的情况下采取书面同意的行动
|
| | | | I-12 | | |
3.10
董事的费用和报酬
|
| | | | I-12 | | |
3.11
Removal of Directors
|
| | | | I-12 | | |
Article IV — COMMITTEES
|
| | | | I-13 | | |
4.1
董事委员会
|
| | | | I-13 | | |
4.2
Committee Minutes
|
| | | | I-13 | | |
4.3
委员会的会议和行动
|
| | | | I-13 | | |
4.4
Subcommittees
|
| | | | I-13 | | |
| | |
Page
|
| |||
Article V — OFFICERS
|
| | | | I-14 | | |
5.1
Officers
|
| | | | I-14 | | |
5.2
军官任命
|
| | | | I-14 | | |
5.3
Subordinate Officers
|
| | | | I-14 | | |
5.4
官员被免职和辞职
|
| | | | I-14 | | |
5.5
Vacancies in Offices
|
| | | | I-14 | | |
5.6
代表其他公司的股份
|
| | | | I-14 | | |
5.7
军官的职权和职责
|
| | | | I-14 | | |
5.8
Compensation
|
| | | | I-14 | | |
Article VI — RECORDS
|
| | | | I-15 | | |
Article VII — GENERAL MATTERS
|
| | | | I-15 | | |
7.1
公司合同和文书的执行情况
|
| | | | I-15 | | |
7.2
Stock Certificates
|
| | | | I-15 | | |
7.3
证书特殊称号
|
| | | | I-15 | | |
7.4
Lost Certificates
|
| | | | I-16 | | |
7.5
没有证书的股票
|
| | | | I-16 | | |
7.6
构造;定义
|
| | | | I-16 | | |
7.7
Dividends
|
| | | | I-16 | | |
7.8
Fiscal Year
|
| | | | I-16 | | |
7.9
Seal
|
| | | | I-16 | | |
7.10
Transfer of Stock
|
| | | | I-16 | | |
7.11
股票转让限制;股票没收
|
| | | | I-17 | | |
7.12
注册股东
|
| | | | I-17 | | |
7.13
Waiver of Notice
|
| | | | I-17 | | |
Article VIII — NOTICE
|
| | | | I-17 | | |
8.1
递送通知;电子传输通知
|
| | | | I-17 | | |
Article IX — INDEMNIFICATION
|
| | | | I-18 | | |
9.1
董事和高级管理人员的赔偿
|
| | | | I-18 | | |
9.2
赔偿他人
|
| | | | I-18 | | |
9.3
Prepayment of Expenses
|
| | | | I-18 | | |
9.4
Determination; Claim
|
| | | | I-19 | | |
9.5
权利的非排他性
|
| | | | I-19 | | |
9.6
Insurance
|
| | | | I-19 | | |
9.7
其他赔偿
|
| | | | I-19 | | |
9.8
继续赔付
|
| | | | I-19 | | |
9.9
修改或废除;解释
|
| | | | I-19 | | |
Article X — AMENDMENTS
|
| | | | I-20 | | |
Article XI — DEFINITIONS
|
| | | | I-20 | | |
|
“Affiliate”
|
| | 就任何人而言,指通过一个或多个中间人直接或间接控制该人、由该人控制或与其共同控制的任何其他人,以及(A)就自然人而言,包括但不限于该人的配偶、父母、子女、兄弟姐妹、兄弟姊妹,不论是通过血缘、婚姻或领养,或居住在该人家中的任何人,为前述任何人、公司、(B)就实体而言,应包括直接或通过一个或多个中介机构直接或间接控制、控制或与上述实体共同控制的合伙企业、公司或任何自然人或实体。 | |
|
“Applicable Law”
|
| | 对任何人而言,是指任何政府当局适用于该人的法律、法规、条例、规则、条例、许可证、证书、判决、决定、法令或命令的所有规定。 | |
|
“Articles”
|
| | 是指本公司经修订和重述的公司章程。 | |
|
“Audit Committee”
|
| | 是指根据本章程设立的公司董事会审计委员会或任何继任委员会。 | |
|
“Auditor”
|
| | 指当其时执行本公司核数师职责的人士(如有)。 | |
|
“Business Combination”
|
| | 指涉及本公司与一个或多个业务或实体(以下称目标业务)的合并、换股、资产收购、购股、重组或类似的业务合并,该等业务组合:(A)只要本公司的证券已在纳斯达克资本市场上市,必须发生在签署签订最终协议时,一家或多家目标企业合计公平市值至少占信托账户资产的80%(不包括递延承保折扣和信托账户收入的应付税款) | |
| | | | 此类业务合并;及(B)不得仅与另一家空头支票公司或名义上有业务的类似公司进行合并。 | |
|
“business day”
|
| |
指周六、周日或法定节假日以外的任何日子,或法律授权或有义务在纽约市关闭银行机构或信托公司的日子。
|
|
|
“Clearing House”
|
| |
指股票(或其存托凭证)在该司法管辖区的证券交易所或交易商间报价系统上市或报价的、经该司法管辖区法律认可的结算所。
|
|
|
“Class A Share”
|
| |
指本公司股本中面值0.0001美元的A类普通股。
|
|
|
“Class B Share”
|
| |
指本公司股本中面值0.0001美元的B类普通股。
|
|
|
“Company”
|
| |
指上述公司。
|
|
|
“Company’s Website”
|
| |
指公司的网站和/或其网址或域名(如果有)。
|
|
|
“Compensation Committee”
|
| |
是指根据本章程设立的本公司董事会薪酬委员会或任何继任委员会。
|
|
|
“Designated Stock Exchange”
|
| |
指本公司证券在其上市交易的任何美国全国性证券交易所,包括纳斯达克资本市场。
|
|
|
“Directors”
|
| |
指本公司当其时的董事。
|
|
|
“Dividend”
|
| |
指根据细则议决就股份支付的任何股息(不论中期或末期)。
|
|
|
“Electronic Communication”
|
| |
指以电子方式发送的通讯,包括以电子方式张贴于本公司网站、传送至任何号码、地址或互联网站(包括证券交易委员会的网站)或董事另行决定及批准的其他电子交付方式。
|
|
|
“Electronic Record”
|
| |
的含义与《电子交易法》中的含义相同。
|
|
|
《电子交易法》
|
| |
指开曼群岛的《电子交易法》(修订本)。
|
|
|
“Equity-linked Securities”
|
| |
指可转换、可行使或可交换在与企业合并相关的融资交易中发行的A类股票的任何债务或股权证券,包括但不限于私募股权或债务。
|
|
|
“Exchange Act”
|
| |
指经修订的1934年美国证券交易法或任何类似的美国联邦法规以及证券交易委员会在此基础上的规则和条例,所有这些均应在当时有效。
|
|
|
《远期采购协议》
|
| |
指规定以私募方式出售股权证券的协议,该私募将基本上与完成交易同时完成
|
|
| | | |
Business Combination.
|
|
|
“Forward Purchase Share”
|
| |
指根据远期购买协议将发行的A类股。
|
|
|
“Forward Purchase Warrant”
|
| |
指根据远期购买协议将发行的购买A类股的认股权证。
|
|
|
“Founders”
|
| |
指紧接IPO完成前的所有会员。
|
|
|
“Independent Director”
|
| |
的含义与指定证券交易所的规则和条例或《交易法》下的规则10A-3中的含义相同。
|
|
|
“IPO”
|
| |
指本公司首次公开发行证券。
|
|
|
“Member”
|
| |
的含义与《规约》中的含义相同。
|
|
|
“Memorandum”
|
| |
指经修订及重述的本公司组织章程大纲。
|
|
|
“Nominating Committee”
|
| |
指根据本章程设立的本公司董事会提名委员会或任何继任委员会。
|
|
|
“Officer”
|
| |
是指被任命在公司担任职务的人。
|
|
|
“Ordinary Resolution”
|
| |
指由简单多数成员以有权亲自或(如允许委派代表)在股东大会上委托代表在股东大会上投票而通过的决议,并包括一致的书面决议。当要求以投票方式表决时,在计算多数时,应考虑到每一成员根据章程细则有权获得的票数。
|
|
|
“Over-Allotment Option”
|
| |
指承销商选择以相当于每单位10美元的价格,减去承销折扣和佣金,购买最多15%的首次公开招股发行的公司单位(如章程所述)。
|
|
|
“Preference Share”
|
| |
指本公司股本中面值0.0001美元的优先股。
|
|
|
“Public Share”
|
| |
是指作为IPO发行单位(如章程所述)发行的A类股。
|
|
|
“Redemption Notice”
|
| |
指经本公司批准的形式的通知,公众股份持有人有权要求本公司赎回其公众股份,但须受其中所载任何条件的规限。
|
|
|
“Register of Members”
|
| |
指按照《章程》保存的会员登记册,包括(除另有说明外)任何分会会员登记册或重复的会员登记册。
|
|
|
“Registered Office”
|
| |
指本公司当其时的注册办事处。
|
|
|
“Representative”
|
| |
指保险人的代表。
|
|
|
“Seal”
|
| |
指公司的法团印章,包括每个复印件。
|
|
|
“美国证券交易委员会”
|
| |
指美国证券交易委员会。
|
|
|
“Share”
|
| |
指A类股、B类股或优先股,包括本公司股份的一小部分。
|
|
|
“Special Resolution”
|
| |
除第29.4条和第47.2条另有规定外,其含义与《规约》中的相同,包括一致的书面决议。
|
|
|
“Sponsor”
|
| |
指开曼群岛豁免的有限合伙企业Avista Acquisition LP II及其继承人或受让人。
|
|
|
“Statute”
|
| |
指开曼群岛的《公司法》(经修订)。
|
|
|
“Treasury Share”
|
| |
指根据章程以本公司名义作为库存股持有的股份。
|
|
|
“Trust Account”
|
| |
指本公司于首次公开招股完成后设立的信托账户,并将首次公开招股所得款项净额,连同与首次公开招股截止日期同时进行的认股权证私募所得款项,存入该账户。
|
|
|
“Underwriter”
|
| |
指IPO的不定期承销商和任何继任承销商。
|
|
| Ligand制药公司 | | | | |
|
By:
/s/ Matthew Korenberg
Name: Matthew Korenberg
Title:
财务执行副总裁兼首席财务官总裁
|
| | ||
| OMNIAB, INC. | | | ||
|
By:
/s/ Matthew W. Foehr
Name: Matthew W. Foehr
Title:
总裁和首席执行官
|
| | ||
| Avista公共收购公司。II | | | ||
|
By:
/s/ Benjamin Silbert
Name: Benjamin Silbert
Title:
General Counsel
|
| | ||
| ORWELL MERGER SUB INC. | | | ||
|
By:
/s/ David Burgstahler
Name: David Burgstahler
Title:
President
|
| |
| |
OMNIAB, INC.
2022 INCENTIVE AWARD PLAN |
| |
| |
OMNIAB, INC.
2022员工购股计划 |
| |
Exhibit
Number |
| |
Description
|
|
2.1+** | | | Avista Public Acquisition Corp.II、Orwell Merge Sub Inc.、Ligand PharmPharmticals Inc.和OmniAb,Inc.之间于2022年3月23日签署的合并协议和计划(包括在委托书/招股说明书/信息声明的附件A中)。 | |
2.2+** | | | 分离和分配协议,日期为2022年3月23日,由Avista Public Acquisition Corp.II、Ligand PharmPharmticals Inc.和OmniAb,Inc.签署(作为代理声明/招股说明书/信息声明的附件B)。 | |
3.1** | | | 修订和重新发布Avista Public Acquisition Corp.II的组织备忘录和章程(通过参考Avista Public Acquisition Corp.II于2021年8月12日向美国证券交易委员会提交的当前8-K表格报告的附件3.1而并入)。 | |
3.2** | | |
OmniAb,Inc.注册证书格式,在被驯化后生效(作为委托书/招股说明书/信息说明书附件H)。
|
|
3.3** | | | 《OmniAb,Inc.》章程格式,经归化后生效(作为委托书/招股说明书/信息说明书附件一)。 | |
4.1** | | |
单位证书样本(参考Avista Public Acquisition Corp.II于2021年7月28日向美国证券交易委员会提交的S-1/A表格的附件4.1并入)。
|
|
4.2** | | |
A类普通股证书样本(参考英伟达公共收购公司II于2021年7月28日提交给美国证券交易委员会的S-1/A表格附件4.2并入)。
|
|
4.3** | | |
授权证样本(参考Avista Public Acquisition Corp.II于2021年7月28日提交给美国证券交易委员会的S-1/A表格附件4.3并入)。
|
|
Exhibit
Number |
| |
Description
|
|
4.4** | | | Avista Public Acquisition Corp.II和大陆股票转让信托公司作为权证代理人于2021年8月9日签署的认股权证协议(通过参考Avista Public Acquisition Corp.II于2021年8月12日提交给美国证券交易委员会的Form 8-K表的附件4.1并入)。 | |
4.5** | | | OmniAb,Inc.普通股证书样本 | |
5.1 | | | Weil Gotshal&Manges LLP的意见。 | |
5.2 | | | Maples&Calder(Cayman)LLP的意见。 | |
8.1 | | | Weil Gotshal&Manges LLP的税务意见。 | |
8.2 | | | Latham&Watkins LLP的税务意见。 | |
10.1** | | | 投资管理信托协议,日期为2021年8月9日,由Avista Public Acquisition Corp.II和大陆股票转让信托公司作为受托人签署(合并内容参考Avista Public Acquisition Corp.II于2021年8月12日提交给美国美国证券交易委员会的8-K表格当前报告的附件10.1)。 | |
10.2** | | | Avista Public Acquisition Corp.II、保荐人和其中指定的某些其他证券持有人之间的登记和股东权利协议,日期为2021年8月9日(合并内容参考Avista Public Acquisition Corp.II于2021年8月12日提交给美国美国证券交易委员会的8-K表格当前报告附件10.2)。 | |
10.3** | | | Avista Public Acquisition Corp.II和Avista Acquisition LP II于2021年8月9日签署的私募认股权证购买协议(合并内容参考Avista Public Acquisition Corp.II于2021年8月12日提交给美国美国证券交易委员会的8-K表格当前报告附件10.3)。 | |
10.4** | | | Avista Public Acquisition Corp.II和Avista Acquisition LP II于2021年8月9日签订的行政服务协议(通过引用Avista Public Acquisition Corp.II于2021年8月12日提交给美国证券交易委员会的当前8-K报表附件10.4合并)。 | |
10.5#** | | | Avista Public Acquisition Corp.II、Avista Public Acquisition Corp.II的每位高级管理人员和董事以及Avista Acquisition LP II之间的信函协议格式,日期为2021年8月9日(通过引用Avista Public Acquisition Corp.II于2021年8月12日提交给美国证券交易委员会的当前8-K报表附件10.5并入)。 | |
10.6** | | | Avista Public Acquisition Corp.II、其每名高级管理人员和董事与Avista Acquisition LP II之间日期为2021年8月9日的赔偿协议格式(通过引用Avista Public Acquisition Corp.II于2021年8月12日提交给美国证券交易委员会的当前Form 8-K报告的附件10.6并入)。 | |
10.7** | | | Avista Public Acquisition Corp.II和Avista Acquisition LP II于2021年8月9日签订的远期购买协议(合并内容参考Avista Public Acquisition Corp.II于2021年8月12日提交给美国美国证券交易委员会的8-K表格当前报告的附件10.7)。 | |
10.8** | | | Avista Public Acquisition Corp.II与保荐人签订的证券认购协议,日期为2021年2月12日(通过参考Avista Public Acquisition Corp.II于2021年7月28日提交给美国证券交易委员会的S-1/A表附件10.7而并入)。 | |
10.9** | | | Avista Public Acquisition Corp.II和Avista Acquisition LP II之间日期为2021年2月12日的本票(通过引用Avista Public Acquisition Corp.II于2021年7月28日提交给美国证券交易委员会的S-1/A表格10.5并入)。 | |
10.10** | | | 日期为2022年3月14日的期票,由Avista Public Acquisition Corp.II向保荐人发行(通过参考Avista Public Acquisition Corp.II于2022年3月14日提交给美国证券交易委员会的当前8-K报表附件10.1合并而成)。 | |
10.11** | | | OmniAb,Inc.、Avista Public Acquisition Corp.II、Avista Acquisition LP II和其他签署方签署的保荐人内幕协议,日期为2022年3月23日 | |
Exhibit
Number |
| |
Description
|
|
| | | (作为委托书/招股说明书/资料说明书附件C)。 | |
10.12** | | | 由Avista Public Acquisition Corp.II、Avista Acquisition LP II和OmniAb,Inc.修订和重新签署的远期购买协议,日期为2022年3月23日(作为委托书/招股说明书/信息声明的附件D)。 | |
10.13+** | | | Avista Public Acquisition Corp.II、Orwell Merge Sub Inc.、Ligand PharmPharmticals Inc.和OmniAb,Inc.于2022年8月18日修订并重新签署了《员工事项协议》(作为委托书/招股说明书/信息声明的附件K)。 | |
10.14+** | | | Ligand PharmPharmticals Inc.和OmniAb,Inc.之间的税务协议格式(作为委托书/招股说明书/信息说明书的附件E)。 | |
10.15+** | | | Ligand PharmPharmticals Inc.和OmniAb,Inc.之间关于Ligand PharmPharmticals Inc.向OmniAb,Inc.提供的服务的过渡服务协议格式(包括在委托书/招股说明书/信息声明的附件F-1中)。 | |
10.16+** | | | Ligand PharmPharmticals Inc.和OmniAb,Inc.之间关于OmniAb,Inc.向Ligand PharmPharmticals Inc.提供的服务的过渡服务协议格式(包括在委托书/招股说明书/信息声明的附件F-2中)。 | |
10.17** | | | Avista Public Acquisition Corp.II、Avista Acquisition LP II及其他各方签署的经修订及重订的登记及股东权利协议格式(载于委托书/招股说明书/资料说明书附件G)。 | |
10.18#** | | | OmniAb,Inc.2022奖励计划表格(作为委托书/招股说明书/信息说明书的附件L)。 | |
10.19#** | | | OmniAB,Inc.2022员工股票购买计划表格(包括在委托书/招股说明书/信息声明的附件M中)。 | |
10.20#** | | |
2022年注册服务提供商承担奖励计划的表格。
|
|
10.21#** | | |
2022年OmniAb服务提供商表格承担奖励计划。
|
|
10.22#** | | |
OmniAb,Inc.非员工董事薪酬计划表格。
|
|
10.23#** | | |
OmniAb,Inc.高管控制权变更协议格式。
|
|
10.24#** | | |
OmniAb,Inc.遣散费计划表格。
|
|
10.25** | | |
OmniAb,Inc.董事和高级管理人员赔偿协议格式。
|
|
10.26+** | | |
金刚砂站办公室二期有限责任公司与Ligand PharmPharmticals Inc.之间的办公室/实验室租约,日期为2021年6月8日,经修订。
|
|
10.27†** | | |
CNA Development LLC与OmniAb,Inc.之间的抗体许可协议,日期为2012年12月20日。
|
|
10.28†** | | |
囊性纤维化基金会与Icagen,LLC之间的研究、开发和商业化协议,日期为2018年5月1日,经修订。
|
|
10.29†** | | |
修改并重新签署了F.Hoffmann-La Roche Ltd、Hoffmann-La Roche lnc之间的许可协议。和Icagen,LLC,日期为2020年5月29日,经修订。
|
|
21.1** | | |
OmniAb,Inc.子公司列表
|
|
23.1 | | |
Consent of Marcum LLP.
|
|
23.2 | | |
Consent of Ernst & Young LLP.
|
|
23.3 | | |
Weil Gotshal&Manges LLP同意(作为附件5.1的一部分)。
|
|
23.4 | | |
Maples和Calder(Cayman)LLP同意(作为附件5.2的一部分)。
|
|
Exhibit
Number |
| |
Description
|
|
24.1** | | |
授权书(包括在最初提交注册声明的签字页上)。
|
|
24.2** | | |
Power of Attorney.
|
|
99.1** | | |
Avista Public Acquisition Corp.II特别股东大会代理卡表格。
|
|
99.2** | | |
约翰·L·希金斯同意命名为董事。
|
|
99.3** | | |
莎拉·博伊斯同意被命名为董事。
|
|
99.4** | | |
詹妮弗·科克伦同意将其命名为董事。
|
|
99.5** | | |
Sunil Patel同意将其命名为董事。
|
|
99.6** | | |
卡罗琳·贝尔托齐同意将其命名为董事。
|
|
99.7** | | |
马修·W·福尔同意将其命名为董事。
|
|
99.8** | | |
约书亚·塔马罗夫同意将其命名为董事。
|
|
101 | | | Interactive Data File. | |
107** | | |
Filing Fee Table.
|
|
| By: | | | /s/ John Cafasso | | | By: | | | /s/ David Burgstahler | |
| | | |
Name: John Cafasso
职务:首席财务官 |
| | | | |
Name: David Burgstahler
职务:总裁兼首席执行官 |
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ David Burgstahler
David Burgstahler
|
| |
董事首席执行官总裁和首席执行官
(首席执行官) |
| |
September 27, 2022
|
|
|
/s/ John Cafasso
John Cafasso
|
| |
Chief Financial Officer
(首席财务会计官) |
| |
September 27, 2022
|
|
|
*
Thompson Dean
|
| |
Executive Chairman
|
| |
September 27, 2022
|
|
|
*
William E. Klitgaard
|
| |
Director
|
| |
September 27, 2022
|
|
|
*
Lâle White
|
| |
Director
|
| |
September 27, 2022
|
|
|
*
Wendel Barr
|
| |
Director
|
| |
September 27, 2022
|
|
|
*
Charles Harwood
|
| |
Director
|
| |
September 27, 2022
|
|
| *By: | | | /s/ John Cafasso | | | | ||||
| | | |
Name: John Cafasso
职务:首席财务官 |
| | | | | | |